Shock assisted ventilation. by Todd, Susan Katharine.
■ . . xvrf-
j
f  .•
:q
>- - . '
^  r  ■ ■  '  .  j  I  _  B
j ■
' .  r r :  ::
■■
/ ' ' ' I f  ■ '■
: i -
v r . ■
• L
■
-L \ . / _
J ;. . . .  - . -Vr -  rü- • ■ .1 • ^  ■
. . V.
. '  ■■ ■••V. i r - '  —.■. . .  fl _ ■
■. I & . ■ . .
r- :
t -  ' ■ .  ,  1
 ^ ■■ • : I., z ^  ■■. •
■ ■ H  ■ w  ^  mm ■■■ J■■ V j : ^ .  -"■ . 7■ ■ -J  vh.
' . '  . f  : : .  - 4
-d  ' i  u ■.
a
Li-
ProQuest Number: 10131179
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10131179
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
SHOCK A SSISTED  V ENTILATIO N
Susan K atharine Todd B .Sc
University of Surrey
Subm itted to the University of Surrey 
for the degree of 
Doctor of Philosophy 
November 1999
A b s tra c t
Respiratory distress syndrome is the major cause of mortality in premature babies. In­
creasing numbers of neonates are now surviving the disease due to advances in techniques used 
in neonatal intensive care units. Mechanical ventilation is an essential part of the treatm ent 
for respiratory distress syndrome and is an area in which improvements and modifications are 
constantly being made. In the early 1980's a new infant ventilator was introduced involving 
ventilation by a distal jet. As yet, the mechanisms by which the distal jet ventilator enhances 
gas exchange are unknown.
Original experiments are carried out to record the attenuation and speeds of the pressure 
wave produced by the distal jet ventilator. The observed changes in wave shape and the high 
wave speed imply tha t the ventilator produces waves operating within an acoustic régime.
An understanding of the gas exchange mechanisms active in shock assisted ventilation is 
initiated by a comprehensive investigation of the transport properties of acoustic waves. The 
advection and diffusion tha t result from a linear concentration gradient in an acoustic fiow are 
analysed, from the Eulerian and Lagrangian viewpoints.
The Eulerian investigation shows tha t the total flux of tracer through a given pipe can be 
optimized by choosing the frequency appropriately.
The Lagrangian transport is increased as both frequency and radius increase. For all values 
of parameters, Lagrangian streaming is observed, with a steady net fiow in the pipe core away 
from the tube entrance and an opposing net flow near the tube walls.
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Sum m ary
Chapter 1 provides the background for the project. A physiological setting is provided for 
the development of neonatal lungs and the likely cause for the need of ventilatory support 
(a more detailed discussion of the physiological background is contained in Appendix C). A 
description of the main categories of ventilators follows. Various types of artificial ventilators 
are compared and the distal jet ventilator (DJV) is introduced. This ventilator is the subject 
of the subsequent study.
Experimental measurements of the D JV ’s performance are described in Chapter 2 in prepa­
ration for a mathematical model. A simple model of a lung is designed and ventilated. Long, 
thin tubes are also tested to provide information on the flow properties of the wave produced 
by the ventilator.
In Chapter 3, the results of the experiments are discussed with a view to presenting a 
mathematical model. It is decided to model the wave as an acoustic wave, which has not been 
done before in the study of ventilation. The waveforms predicted by the mathematical model 
are compared with the experimental results.
In Chapter 4, the mathematical model is used to analyse the transport of a passive solute 
by advection and diffusion. The transport qualities of an acoustic wave have not been stud­
ied previously. A comparison is made between the results discovered in this thesis and the 
presently known results for incompressible fiow. The conclusions of Chapter 4 have im portant 
consequences for transport in tubes.
A Lagrangian analysis of transport is undertaken in Chapter 5. Trajectories of a non­
diffusing tracer are found for an acoustic wave in a tube, information which until now has 
been unknown. The particles are then allowed to diflfuse, giving an insight into the transport 
properties of an acoustic wave propagating in a tube.
Chapter 6 pulls together the results and conclusions of this thesis in a reasonably detailed 
summary.
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Chapter 1
Clinical Background
This chapter provides a physiological description of the relevant stages of development of the 
neonatal lung. Treatments for premature babies with breathing difficulties are discussed plac­
ing an emphasis on mechanical ventilation. Existing methods of mechanical ventilation are 
discussed, particularly the SLE 2000 distal jet ventilator. To summarise, this chapter describes 
the background for the problem.
1.1 The Prem ature Lung
At delivery, a premature baby may not be sufficiently developed to survive in our environment. 
Suddenly, the functions of the placenta need to be replaced by the lungs, kidneys and gastroin­
testinal tract. If this transition is unsuccessful, medical support is needed for the neonate so 
tha t development and growth can take place successfully.
1.1.1 Lung D evelopm ent
By the 17th week of gestation the bronchial and bronchiolar branching of the lung is complete 
as far as the terminal bronchioles. This represents the formation of the conducting airways, 
which purely conduct air and do not take part in gas exchange. From week 17 of gestation the 
acini, or sites of gas exchange, begin their development. The potential air spaces first appear 
as smooth-walled, blind-ending tubes. The air spaces and the capillary networks surrounding 
them approach each other, forming structures called saccules distal to the terminal bronchioles.
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At around the 24th week of gestation, the lungs begin to contain pulmonary surfactant, a 
lipoprotein tha t lowers surface tension at air-liquid interfaces; it is essential to the mechanics 
of respiration.
At the birth of a healthy baby, various mechanical and biomechanical stimuli trigger the 
first breath. Some fetal lung liquid is squeezed out during the passage through the birth canal 
and most of the rest is absorbed through the pulmonary lymphatics. The remaining lung liquid 
forms a thin continuous layer over the epithelium of the lung.
R e s p ira to ry  d is tre ss  sy n d ro m e  or R D S  occurs commonly in infants born at less than 36 
weeks’ gestation and is observed in 10 % of all premature infants, with the greatest incidence 
(60 %) in those weighing less than 1500g (Morley, 1960). Susceptibility to RDS increases 
with increasing prematurity and is associated with structural immaturity and a deficiency of 
pulmonary surfactant.
The primary symptom of RDS is tha t the neonate experiences great difficulty in breath­
ing. Usually there is a raised respiratory rate, an audible grunt on expiration, cyanosis (blue 
colouration of the skin due to hypoxia) and subcostal chest wall recession. The muscular effort 
of breathing can become so great tha t fatigue of the ventilatory muscles occurs and respiratory 
failure eventually follows. Artificial ventilation is needed to maintain oxygen levels in the blood 
and to remove carbon dioxide.
H y a lin e  m em b ran e  d isease  or H M D  is associated with respiratory distress syndrome in 
80 % of cases. HMD is characterised by smooth, pink, hyaline (glassy) membranes lining the 
terminal bronchioles and alveolar ducts.
1.1.2 Surfactant
Following speculation tha t low surface tension is an important attribute of the lining of air 
passages, Avery and Mead (1959) made an important observation. They found th a t the material 
responsible for a low surface tension in the lung was absent in the lungs of infants under 
1100-1200g and in those dying with hyaline membrane disease. This surface-active material is 
p u lm o n a ry  su rfa c tan t.
At a liquid-gas interface there is an imbalance in molecular forces. In the case of a lung 
filled with gas, the forces between adjacent molecules in the bulk of the liquid are stronger than
those between adjacent molecules of the liquid-gas interface. This imbalance, known as surface 
tension, causes the surface area of the liquid lining the lung to become as small as possible. 
This minimisation of surface area contributes to alveolar collapse or atelectasis. Surface tension 
is inversely proportional to the radius of curvature of an alveolus.
Pulmonary surfactant forms a monolayer at the liquid-gas interface tha t profoundly lowers 
the surface tension of the fluid lining the lung. This lowering of surface tension increases lung 
compliance and reduces the work involved in expanding the lung with each breath. Pulmonary 
surfactant promotes alveolar stability, reducing the tendency for small alveoli to ‘empty’ into 
large alveoli. The mechanism by which surfactant contributes to alveolar stability is not yet 
fully understood.
Conventional theories involving surfactant are based on two assumptions. The first is that 
surfactant only acts at an air-liquid interface and the second is that the liquid layer is continuous. 
These assumptions are open to debate, as discussed in Hills (1990).
Natural pulmonary surfactant contains phospholipids, neutral lipids and proteins. The 
principal surface-active component in pulmonary surfactant is a phospholipid called dipalmi- 
toylphosphatidycholine, or DPPC. The proteins contained in surfactant consist of contami­
nating proteins from plasma or lung tissue and surfactant associated proteins. Surfactant 
associated proteins play a major role in the pulmonary defence system and enhance the surface 
active properties of DPPC. The comparative smallness of a preterm infant’s airways combined 
with surfactant deficiency leads to severe respiratory problems.
1.1.3 E xogenous Surfactant Therapy
It is possible to artificially replace pulmonary surfactant found to be absent in infants suffering 
with RDS. This treatm ent is called exogenous su rfa c ta n t th e ra p y . Exogenous surfactants 
can be produced synthetically or from natural sources; for example, trials have involved bovine, 
porcine and human surfactant.
Ideally, clinical trials would tell us which is the most effective surfactant in the treatm ent of 
RDS. Although clinical trials do tell us tha t exogenous surfactant administration is beneficial 
in the treatm ent of RDS, see Fuji war a et a i (1990), the trials contain so many variables tha t 
a straightforward comparison is not yet reliable. Variables include the time, dose, and the
method of administration, as well as the use of assisted ventilation. A poor outcome from a 
surfactant trial could be due to a variation in the above variables rather than to the surfactant 
itself. See Appendix D for a detailed discussion of surfactant therapies and their optimization.
1.2 M echanical V entilation
Ventilation provides a mechanism by which oxygen from the atmosphere reaches the blood, 
and carbon dioxide from the blood is expelled into the atmosphere. In order to understand the 
different techniques of mechanical ventilation it is necessary to be familiar with some of the 
principles behind the working of the lungs.
1.2.1 M echanics o f B reath ing
The driving force for ventilation is the pressure difference between the atmosphere and the 
alveoli (intrapulmonary pressure). In a healthy lung, inspiration is an active process. This is 
because muscular contraction increases the volume of the lung. As a result, a subatmospheric 
intrapulmonary pressure is produced. Gas is then driven into the lungs by the pressure gradient.^ 
The elasticity of the lung causes it to return to its original size. This is called recoil and is 
aided by the surface tension in the alveoli. The reduction of lung volume provides the pressure 
gradient for expiration, which is a passive process.
The relationship between pressure and volume in the lung is different during inflation and 
expiration. The lung volume at any given pressure is larger during deflation than during 
inspiration. This feature is called h y ste res is  and has important consequences when mechanical 
ventilation is being used.
Traditionally, it was believed that gas mixing in the lung was by bulk convection only. The 
lung was thought to consist of two distinct regions, the alveolar space and the dead space. The 
d ead  space  is the total volume of conducting airways tha t do not take part in gas exchange. 
Based on this ‘classical’ view, it was once thought that ventilation would not occur if the volume 
entering the lungs during a breath, called the t id a l  volum e, was less than the dead space. It 
is now common in neonatal intensive care units for babies to be successfully ventilated with a 
tidal volume much less than the dead space.
In order to model gas transport in the lung, many theories have been put forward. In the 
following sections, the currently known relevant mechanisms of gas exchange are described. It 
is also explained how the gas exchange in different parts of the lung and for different types of 
ventilation is dominated by various gas exchange mechanisms (see the review by Kamm et a l 
(1984) for a fuller discussion).
In the large airways, the fluid inertia of a bulk flow provides the dominant mechanism for 
gas transport. As the inertia is concentrated in the axial component of the fluid velocity, this 
mechanism is also known as axial advection. The medical term for convective transport in this 
way is d ire c t a lveo lar v en tila tio n .
It is reasoned tha t as the lung consists of airways with varying path lengths, the shortest 
are likely to enable direct ventilation of some regions of the lung. Because of this, adequate 
oxygenation by direct ventilation is attainable at tidal volumes a little less than the dead space. 
Bulk advection is not effective at very low tidal volumes. As expected, the rate of gas exchange 
due to bulk advection also increases as the tidal volume increases.
As the total cross-sectional area of the airways increases and the total flow rate decreases, 
other mechanisms come into play. One suggested mechanism is Pendelluft, although a quan­
titive theoretical model has not yet been produced; Lehr et al. suggest tha t due to varying 
impedances in the airways, alveoli may be ventilated asynchronously. It is suggested tha t the 
resulting phase difference between adjacent alveolar zones, produces a ‘sloshing’ motion which 
then creates a uniform concentration of gas. Although it is hypothesised tha t the effect of 
Pendelluft is greater during ventilation at high frequencies, it cannot suflJciently explain the 
efficacy of high frequency ventilation.
The interaction of advection and diffusion can enhance transport. In the presence of a 
concentration gradient, Poiseuille flow enhances the apparent diffusivity of a tracer in a lon­
gitudinal direction. Explained naively, the tracer diffuses further longitudinally than if there 
were no flow. The term for this phenomenon is augmented dispersion.
Steady streaming is a gas exchange mechanism in which the time-averaged flow over a cross 
section is bi-directional. In certain situations, the fluid in the core of a duct has an overall 
tendency to drift in the opposite direction to fluid at the duct walls.
Augmented dispersion and steady streaming can be modelled mathematically and are dis-
cussed in depth in Chapter 4.
1.2.2 C onventional M echanical V entilation
C o n v en tio n a l m echan ica l v e n tila tio n  or C M V  refers to a type of mechanical ventilation 
tha t is close to a normal pattern of breathing. In particular, similar respiratory rates and 
tidal volumes are used. However, the mean airway pressure generated by CMV is higher than 
tha t generated by spontaneous breathing. This is because the pressure gradient necessary for 
inspiration is produced by raising the pressure at the mouth above atmospheric pressure. For 
this reason CMV is also known as positive pressure ventilation or interm ittent positive pressure 
ventilation. Positive pressure ventilation itself has many variations, most of which are involved 
in the weaning process. The w ean ing  p rocess is designed to decrease the patient’s dependency 
on mechanical ventilation. The following are variations of positive pressure ventilation:
I n te rm i t te n t  M a n d a to ry  V en tila tio n  This allows the patient to take spontaneous breaths 
between artificial breaths.
P a t ie n t  T rig g ered  V en tila tio n  The patient initiates a breath and the ventilator then re­
sponds and takes over. A back-up rate is preset in case the patient fails to breathe.
S y n ch ro n ised  In te rm it te n t  M a n d a to ry  V e n tila tio n  Patient triggered ventilation is used 
for every nth  breath and the patient breathes without assistance throughout the rest of 
the cycle. Again a back-up rate is preset in case the patient fails to respond.
C o n tin u o u s  P o s itiv e  A irw ay  P re s su re  Continuous positive airway pressure is the applica­
tion of positive end expiratory pressure (see below) to a spontaneously breathing patient 
who is not being ventilated.
P o s itiv e  en d  e x p ira to ry  p re ssu re  or P E E P  is the application of a pressure at the end 
of expiration that is greater than atmospheric pressure. PEEP restores the functional residual 
capacity to almost normal values during mechanical ventilation and improves gas exchange. 
F u n c tio n a l re s id u a l c ap ac ity  is the volume of air left in the lungs at the end of expiration.
Clinicians generally believe that an increase in peak airway pressures resulting from applied 
PEEP leads to an increased incidence of barotrauma (damage caused by high pressure) and
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circulatory problems. The large pressure and volume cycles associated with CMV are capable 
of causing extensive damage to the pulmonary epithelium, especially if the closing pressure of 
the alveoli is above the applied level of PEEP. However, the application of PEEP that is above 
the closing pressure would result in dangerously high peak inspiratory pressures. It is a priority 
to use forms of mechanical ventilation tha t would decrease the incidence of such problems.
1.2.3 H igh Frequency P ositive  Pressure V entilation
H ig h  freq u en cy  p o sitiv e  p re ssu re  v e n tila tio n  or H F P P Y  was introduced by Sjostrand in 
1967, see Sjostrand (1980). An increased ventilator frequency and low tidal voliime decreases 
airway pressures. HFPPV would therefore result in a decrease in the incidence of barotraum a 
and cardiovascular consequences associated with CMV. HFPPV is essentially CMV operated at 
frequencies of the order of 60-200 breaths per minute (b.p.m) and employs tidal volumes that 
are usually of the order of the dead space. HFPPV is used in many different clinical situations 
including bronchoscopy, laryngoscopy and thoracic surgery.
1.2.4 H igh  Frequency O scillation
H ig h  freq u en cy  o sc illa tio n  or H F O  is operated at frequencies of 60-3000 breaths per minute 
and is associated with tidal volumes less than the dead space. Initially it was thought tha t 
the main advantage of HFO would be decreased mean airway pressures. The Hi-Fi Study 
Group (1989) compared HFO and CMV, in a trial based on a low pressure strategy. They 
concluded tha t HFO is associated with undesirable side effects. However, numerous authors, 
including Thompson et al. (1982), McCulloch et al. (1988), Bryan (1989) and Clark et al. 
(1992), observed that a high pressure strategy incorporating volume recruitment manoeuvres 
is the most effective method of HFO ventilation in the treatment of respiratory failure caused 
by HMD in neonates.
A vo lu m e re c ru itm e n t m an o eu v re  is usually an inflation involving a temporarily high 
mean airway pressure. This can be static, pulsatile or else take the form of large conventional 
breaths. The aim of a volume recruitment manoeuvre is to establish an adequate lung volume 
to support gas exchange and reduce shunting. In this context, shunting refers to blood tha t re­
enters the arterial system without passing through ventilated areas of lung. Volume recruitment
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is essential in a good ventilation strategy.
A volume recruitment manoeuvre uses the hysteresis properties of the lung. During a volume 
recruitment manoeuvre the lung is inflated and then maintained at a high pressure. Sufficient 
time is left for the pressure-volume relationship of the lung to transfer to the expiratory phase, 
resulting in a larger lung volume for a given lung pressure. This is referred to as volume 
recruitment or alveolar expansion.
In HFO, not enough time is left between breaths for transfer between the inspiratory and 
expiratory phases of the pressure-volume relationship. Unless a volume recruitment manoeuvre 
is used ventilation will occur on the inspiratory curve only. The Hi-Fi trial (1989) used a low 
pressure HFO ventilation strategy, and so ventilation occurred on the inspiratory curve for 
ventilation, see Figure 1.1. However, Clark et al. (1992) used volume recruitment manoeuvres 
to transfer the ventilation to the expiratory part of the curve resulting in higher lung volumes 
for given pressures when compared to the Hi-Fi trial.
Alveolar expansion or volume recruitment will occur only when the lung is inflated above 
its closing capacity. Below the closing capacity, some alveoli and airways become atelectatic 
(closed and airless). Lung hysteresis implies tha t there are two pulmonary pressures associated 
with the closing capacity; these are the opening pressure and the closing pressure. The open ing  
p re s su re  is the pressure at which atelectatic lung begins to open on inflation. The closing 
p re s su re  is the pressure below which atelectasis is likely to occur on exhalation.
If HFO ventilation is performed on the inspiratory curve, lung pressure must always exceed 
the opening pressure, to prevent atelectasis. However, if an HFO ventilation strategy is per­
formed on the expiratory phase of the curve, the pressure may go below the opening pressure 
provided that it remains above the closing pressure (see Figure 1.1).
Clinical studies have shown that when used with an appropriate strategy, HFO is at least 
as effective as CMV in the treatm ent of HMD. A successful strategy results in improvements 
in oxygenation and lung mechanics whilst preventing further formation of hyaline membranes. 
For a fuller discussion of the comparative merits of CMV and HFO in the treatm ent of Hyaline 
membrane Disease, refer to Appendix C.
VOLUME
closing
capacity
CLARK
Hi-Fi
closing opening
PRESSURE
pressure pressure
Figure 1.1: The Pressure-Volume Relationship of the Lung
1.2.5 H igh Frequency Jet V entilation
H ig h  freq u en cy  je t  v e n tila tio n  or H F J V  is commonly operated a t frequencies of around 
100-200 breaths per minute, although various protocols that use higher frequencies have been 
explored. Initially, trials did not show promising results as far as a comparison between HFJV 
and CMV was concerned. HFJV was used only after every other method of treatm ent had 
failed. This is the nature of a clinical trial introducing a new treatm ent concept and does 
not encourage an unbiased outcome. Patients had received extensive CMV previously and 
often suffered from multisystem failure. Carlon et al. (1983), stated in a summary of clinical 
observations on HFJV that a change in the modality of respiratory support could not be 
expected to radically improve the outcome in such a situation. However, Carlon observed that 
the synchronisation of HFJV with the cardiac cycle reduced the depression of cardiac output 
that is usually associated with high levels of PEEP in CMV. Carlon notes th a t although no 
obvious benefits were demonstrated with HFJV over CMV, oxygenation and ventilation were 
maintained at lower tidal volumes and peak inspiratory pressures.
More recent neonatal trials have uncovered advantages and problems associated with HFJV. 
HFJV has been found to be particularly useful in the management of respiratory failure due 
to air leaks, diaphragmatic hernia and airway obstruction, as well as RDS. HFJV has been 
associated with tracheal lesions (damage to the tissue in the main airways) by many investiga­
tors. Boros et al. (1985) and Pokora et a l (1984) suggested that inadequate humidification of 
the air entering the patient was the cause of these tracheal injuries, whereas Neu et a i (1983) 
thought tha t wall shear and high inspiratory pressures were to blame.
Consequences of inadequate humidification include airway obstruction due to reduced mu­
cociliary clearance, see Tarnow-Mordi et a i (1986). In other words, there is a build-up of 
mucus tha t blocks the trachea. Tracheal obstructions from thick secretions have been observed 
in at least one study of HFJV, see Pokora et a l (1984). Humidification of the patient’s air 
supply can be achieved by entrained mist or an infusion of saline solution into the jet.
Smith and Lin (1989) found tha t HFJV can excite resonance of the respiratory system in 
pigs. Smith and Lin hypothesise tha t the excitation of resonance by ventilation frequency may 
be significant on two counts; Firstly, larger pressures and gas movements may give an increased 
risk of barotrauma. Secondly, resonance may actually enhance gas exchange. Further studies 
are necessary to investigate both of these claims.
1.2.6 B ronchopulm onary D ysplasia
The success of CMV, HFPPV, HFO and HFJV combined with exogenous surfactant therapy 
has meant th a t an increasing number of neonates survive RDS. Since the advent of the use of 
mechanical ventilation there has been an increase in the incidence of chronic lung disease or 
b ro n c h o p u lm o n a ry  d y sp las ia  or B P D  in neonates. A reliable indicator of BPD is oxygen 
dependence at the expected date of delivery, as this measure takes into account problems due 
to extreme prematurity. It is thought that BPD represents a late repair stage of severe RDS in 
premature infants tha t otherwise would have died. The incidence of BPD is associated with lung 
immaturity, the use of mechanical ventilation, surfactant therapy and the oxygen concentration 
of inspired air. The concentration of oxygen in inspired air is usually increased if mechanical 
ventilation is unsuccessful. However, prolonged exposure to a high oxygen concentration of 
inspired air is undesirable as it can result in fibrosis (formation of scar tissue) in the lungs and
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possibly blindness (retinopathy of prematurity).
Techniques of respiratory support are being continually refined and the incidence of survival 
of extremely premature babies is increasing. Although there are now more successful recoveries 
from RDS there are also more surviving neonates with a diminished quality of life due to severe 
lung disease. Ironically, much of this lung disease is as a result of the life-saving ventilatory 
support received (see Appendix D for a detailed discussion).
1.3 Ventilators
This section begins with a brief description of the ventilator circuits for CMV, HFPPV, HFO 
and HFJV. It also discusses a new type of ventilator on which this project is based.
1.3,1 C haracterisation  of V entilators
Ventilators can be divided into two groups according to the method by which the gas is driven 
into the patient. There are flow generators and pressure generators. Most neonatal ventilators 
are p re s su re  g e n e ra to rs  (or pressure limited) as inspiration is terminated when a particular 
mouth pressure is achieved. F low  g en e ra to rs  are not widely used in neonatal ventilation 
because the tidal volumes involved here are extremely small (of the order of 4.5ml/kg body- 
weight) and are difficult to measure accurately. The inaccuracy arises because the tidal volume 
is much smaller than the total volume of gas contained in the ventilator circuit. Only pressure 
generators are discussed in this report.
Ventilators are also characterised by their cycling mechanism; most are controlled by a 
timing device and are therefore tim e  cycled. A mixing device, a humidification system, a 
heater and a bacterial filter are usually incorporated into the ventilator circuit. The mixing 
device controls the oxygen concentration of the inspired gas whereas the essential humidification 
and heating systems provide the neonate with acceptably warm, moist air at 37°C and 100% 
humidity.
On a pressure limited ventilator the pressure at the airway opening is cycled between p eak  
in s p ira to ry  p re ssu re  (P IP ) and p o sitiv e  en d  e x p ira to ry  p re ssu re  (P E E P ). The ven­
tilator rate is determined by the inspiratory and expiratory times. These times are usually
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expressed as a ratio which is commonly referred to as the I:E  ra tio . The appropriate pressure 
and time settings depend greatly on the individual patient. Clinicians generally determine the 
ventilator settings by careful observation of the patient. For example, the monitoring of chest 
movement provides information about lung compliance.
Each type of ventilator produces its own characteristic pressure waveform. Different pressure 
waves determine the way tha t gas mixing and gas exchange occur in the lungs. For example, 
large, slow pressure swings encourage gas mixing dominated by bulk convection, whereas small, 
rapid pressure fluctuations produce gas mixing by steady streaming.
1.3.2 V entilator C ircuits
The method by which CMV and HFFPV deliver a tidal volume is based on a simple physical 
principle. A continuous gas flow is allowed to escape from a pressure source through a regulator. 
If the pressure of the gas exceeds the PIP, the gas leaves the system through an expiratory port. 
The patient is connected to the system via a T-piece tube in the circuit. When the expiratory 
port is occluded by a valve, the gas flows into the patient’s lungs until the airway pressure is 
equal to the PIP. When the pressure reaches this preset value, the valve opens, assisting passive 
exhalation. In modern ventilators this simple system is refined by the use of a sophisticated 
time cycling mechanism. PEEP can be applied by various methods at the expiratory port. 
Simple (but not necessarily ideal) devices for producing PEEP include dipping the tube under 
water and adding weights, springs or valves.
An HFO ventilator can be driven by a piston, an oscillating diaphragm or by bellows. Gas 
is actively driven into the lungs and actively withdrawn. The various HFO driving mechanisms 
produce an approximately sinusoidal pressure waveform. The effects of this waveform on gas 
mixing in the lung have been studied mathematically by authors including Paloski et a i (1987). 
Grotberg (1984) and Hydon (1994).
A high frequency jet ventilator delivers gas intermittently from a high pressure source 
through a small-bore tube positioned in the airway. The jet is produced by an electrically 
controlled solenoid valve. Expiration is driven solely by passive recoil of the patient’s lung and 
chest wall. A jet ventilator provides a characteristic sharply-peaked pressure waveform. The 
effects of this pressure wave on gas mixing have not, as yet, been investigated mathematically.
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Figure 1.2: A Simple Diagram of the Valveless Ventilator (Chakrabarti and W hitham, 1983) 
1.3.3 A  N ew  T ype o f Infant V entilator
A new valve-less ventilator was developed in the early 1980's by Chakrabarti and Whitwam 
(1983). This ventilator provides positive pressure ventilation using an air jet that acts as a 
pneumatic piston, see Figure 1.2.
The driving gas is independent of the respiratory gas because the jet is situated in the 
expiratory limb of the breathing circuit. This is in contrast to ‘true’ jet ventilators where 
the je t is in the airway and driving gas enters the patient. This feature of the valve-less 
ventilator avoids problems associated with HFJV such as ‘jet traum a' and reduces the problem 
of humidification of the air jet. The driving jet delivers interm ittent pulses of air at high 
pressure, providing the pressure gradients necessary for ventilation of the patient. PEEP is 
provided by a continuous opposing jet also in the expiratory part of the circuit (not shown 
in the diagram). The breathing circuit is open to the atmosphere at all times, in contrast to 
CMV (for which the exit of gas is limited by a valve). This feature facilitates HFPPV, whereas 
the high flow rates needed for CMV can result in high resistance at the exit valve, causing 
dangerously high levels of PEEP. This new type of ventilation will subsequently be referred to 
as d is ta l je t  v e n tila tio n  or D JV .
A clinical trial was carried out by Chan et al, (1988) comparing DJV to CMV in the 
treatm ent of severe respiratory disease in neonates. The patients all had progressively worsening 
respiratory failure and were being ventilated on CMV. On the new ventilator with the same
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settings as CMV, there was a dramatic improvement in blood gases within the first 20 to 30 
minutes and this improvement was successfully maintained.
This distal jet ventilator is manufactured as the 8LB 2000 (Scientific Laboratory Equipment, 
Croydon) and is commonly used in neonatal intensive care units throughout the country. The 
SLE 2000 HFO model has incorporated a new type of high frequency oscillator into the system. 
Rotating jets in the expiratory limb of the circuit create a sinusoidal pressure waveform that 
provides effective ventilation. The oscillator can be combined with the DJV facility although 
this technique needs more investigation into its effective clinical use.
It is of great interest to understand why this valve-less ventilator is more effective than 
CMV during positive pressure ventilation. Although clinical trials are proving its superiority, 
an analysis of the fluid-mechanical features of the flow and their contribution to gas mixing 
is also needed. The valve-less ventilator produces a characteristic square pressure wave. The 
wave also maintains high pressures at high frequencies, unlike CMV. The valve-less ventilator 
can also be used with a smaller diameter endo-tracheal tube (the tube inserted into the airway) 
than is feasible with CMV. The aim of the following chapter is to attem pt to quantify some of 
these observations.
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Chapter 2
E xperim ental Work
The original experimental work in this chapter aims to quantify some of the features of the pres­
sure wave produced by the SLE 2000 distal jet infant ventilator. In particular, the experiments 
concentrate on determining the pressure wave speed and the rate of wave attenuation. These 
experiments were performed on pressure waves with properties as close as possible to those 
produced by the ventilator in a clinical setting. Quantitive results for both the wave speed and 
the rate of attenuation are necessary to give us an appropriate flow régime our mathematical 
model.
We were interested in tubes with dimensions representative of those found within a neonatal 
bronchial tree. Attention was focused on quantifying the behaviour of the pressure wave in order 
to derive a theoretical model.
2.1 The Ventilator
When used in a neonatal intensive care unit, the SLE 2000 infant ventilator is assembled 
according to the instructions given by the manufacturer. In the event of the SLE 2000 being 
used for life support, the ventilator’s adjustable settings are altered in accordance with the 
protocol followed by the staff on the ward.
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2.1.1 V entilator A ssem bly
The ventilator was set up to mimic a clinical situation as closely as possible. Usually, the 
ventilator receives a regulated gas supply from air or oxygen ports built into the wall at the 
hospital ward. These ports supply gas at a pressure of 1 bar (lOOkPa). As these ports were 
not available, a cylinder of compressed air was used to supply this driving pressure.
Plastic tubing provides the connection between the patient and the ventilator. Confusingly, 
this tubing is known as the circuit. The circuit tubing incorporates a heater and humidifier. 
Circuit tubing was used as described in the operation manual except for the removal of the 
heater and humidifier. The introduction of heated, humidified air was not thought appropriate 
for our experiments, because humidified air would have caused extensive condensation in our 
experimental apparatus. It was felt tha t condensation was likely to produce errors in our 
measurements of pressure.
The plastic tubing of the ventilator circuit connects to the e n d o tra ch e a l tu b e  or E -T  
tu b e  at what is known as the E -T  m anifold . All reference pressures were measured at the 
E-T manifold. When possible, E-T tubes were used in the experiments as they would be on an 
intensive care unit.
2.1.2 In tu bation  and V entilator Settin gs
The ventilator settings were set within the range advised in the protocol followed by nursing 
staff on the Neonatal Intensive Care Unit at the Royal Victoria Infirmary at Newcastle-upon- 
Tyne. Firstly, the protocol advises that an endotracheal tube with a diameter between 2.5mm 
and 3.5mm should be used. The diameter of the B-T tube selected depends on the gestation 
and weight of the baby according to particular guidelines. The E-T tube is then cut to a size 
tha t depends on the measured length of the baby’s right foot! During intubation the E-T tube 
is inserted into the trachea, preferably via the nose rather than via the mouth. This is partly 
because babies breathe predominantly through the nose, but mainly because a better seal is 
obtained around the nose than the mouth.
The heater would usually be set to achieve an airway temperature close to tha t of the 
incubator - approximately 37° C. The humidifier saturates the air destined for the airway. As
16
previously mentioned, these items were not activated in the experiments.
The ventilator pressure and time settings were based on the protocol as follows; It is advised 
tha t the peak expiratory end pressure (PEEP) is set between 4-5 cms HgO and the peak 
inspiratory pressure (PIP) is initially set between 22-30 cms H2O. The peak inspiratory pressure 
is then adjusted as required, based on the movement of the baby’s chest and the adequacy of 
oxygenation. The initial respiratory rate is usually set at around 60 breaths per minute and 
the initial inspiratory time at between 0.3s and 0.5s. The inspiratory time over the expiratory 
time gives a ratio of between 1:3 and 1:2 , known as the I:E ratio.
2.2 Experim ental Equipm ent
In order to record pressure output, appropriate equipment was required. Pressure transducers 
were used to convert pressure output into electrical signals. A data storage oscilloscope, man­
ufactured by Gould Instruments Inc. captured the transducer output on screen. The data was 
then saved and plotted using a PC package called ‘Transition’ (Data Acquisition).
2.2.1 P ressure Transducers
A change in the electrical resistance of a pressure transducer is linearly related to the pressure 
change applied to it. A s tra in  gauge is contained in the transducer to convert the action of 
pressure into electrical resistance. A strain gauge consists of a conducting grid made of foil or 
wire mounted on a diaphragm. When pressure is applied to the diaphragm, a strain occurs 
which alters the dimensions of the conducting grid, resulting in a change in resistance. For very 
small pressure measurements, a piezorestive transducer containing a silicon diaphragm can be 
used.
Two commonly used types of pressure transducer are gauge transducers and differential 
transducers. A gauge tra n s d u c e r  is open to the atmosphere on one side, so all measurements 
are in relation to the atmospheric pressure. A d ifferen tia l t ra n s d u c e r  gives a choice of 
pressure input on either side of the strain gauge and therefore measures the pressure differential. 
A differential pressure transducer can be transformed into a gauge transducer by leaving one 
port open to the atmosphere. Transducers can also be described as having either w et or d ry
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ports, capable of accepting liquid or gaseous media respectively. The pressure transducers used 
in these experiments accepted both liquid and gas applications.
When a pressure transducer is used, the resulting output is expressed in volts. Manufac­
turers sometimes quote a linear pressure relationship for individual transducers. This relation 
enables the conversion of transducer output into appropriate units of pressure. C a lib ra tio n  
of a pressure transducer is standard to certify tha t it complies with the manufacturer’s speci­
fications.
A pressure transducer is calibrated by applying a known pressure to it and noting the voltage 
at intervals within a particular pressure range. This is done for both increasing and decreasing 
pressure to determine the hy ste res is  curve.
For the calibration of our differential pressure transducer, a known pressure, in the form of a 
known height of water was applied to one port whilst the other was left open to the atmosphere. 
The height was increased to 40 inches of water at 5 inch intervals and the voltage output was 
recorded. The height was then decreased in the same way and the data set was plotted. The 
linearity of the transducer was calculated using the sum of least squares method. The linearity 
of the transducer was found to be 5.034 mV/cmHgO.
Two pressure transducers were used in the experiments, one of which was more sensitive 
than the other. To determine the linearity of the new transducer, both transducers were set up 
to receive the same pressure signal. The signal magnitudes were compared, in volts, and the 
linearity of the new transducer was thus calculated.
2.3 The Lung M odel
The aim of this first experiment was to construct and then ventilate a model of a neonatal 
lung tha t would behave as realistically as possible in terms of structure. In particular, we were 
initially interested in the effect of the bronchial bifurcations on the speed and attenuation of 
the DJV pressure waveform.
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Figure 2 .1: A Representation of the Lung Model
P2
P4
2.3.1 M eth od
Unfortunately, no morphometric data for the airways is available for neonatal lungs. Conse­
quently, airway diameters in our model were estimated. We used rigid, nylon, plastic, Y-shaped 
tubing of decreasing diameter to build our model. This consisted of one 10mm diameter Y-piece. 
two 7mm diameter Y-pieces, four 6mm diameter Y-pieces and eight 5mm diameter Y-pieces. 
The angle between branches on each Y-piece was 60°. The Y-pieces were connected together to 
form a simple planar model of the bronchial tree down to four generations. A tiny balloon was 
fixed to each 5mm tube to provide an ending to each airway. The Y-pieces were fixed together 
to form a model shown schematically in Figure 2 .1 .
Holes were drilled halfway along each branch for the insertion of a pressure probe. As the 
holes in the 1st, 2nd and 3rd generations were drilled through two overlapping Y-pieces, they 
could be sealed simply by twisting one Y-piece. The pressure probe consisted of a long, metal 
probe attached to a pressure transducer. The probe was inserted into the plastic tubing and 
positioned so that it was flush with the tube wall.
Two pressure traces at a time were taken while the model lung was being ventilated. The
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oscilloscope was triggered to start both pressure traces simultaneously. This enabled the cal­
culation of phase speed.
Four pairs of pressure traces were collected, each consisting of the reference pressure trace 
and a branch pressure trace. The reference pressure P r e f  was taken to be the pressure at the 
junction of the ventilator tubing and the E-T tube. The ventilator settings required to produce 
P r e f  remained unaltered throughout this experiment. The four branch pressure traces Pi, P2, 
Pg and P4 were taken at branches 1 ,2 ,3  and 4 respectively, see Figure 2.1.
The four pairs of pressure traces were displayed on a data storage oscilloscope and saved 
using the computer package ‘Transition’. The waveforms were then compared.
2.3.2 Lung M odel R esu lts
The rectangular pressure wave, P r e f ,  changes shape significantly as it travels to the transducer 
at P i, see Figure 2 .2 . Between the transducers at P r e f  and Pi, the rectangular waveform of 
P r e f  is smoothed off at the back and remains steep at the front. Over the subsequent airway 
generations of the model, there is no significant change in wave shape, see Figures 2.3, 2.4 and 
2.5.
The reference pressure wave is attenuated to approximately half of its original amplitude 
by the time it reaches the transducer at Pi. Thereafter, there is no substantial variation in 
wave amplitude from Pi to P4. However, the wave amplitude was observed to fluctuate about 
a mean position, sometimes increasing over a generation.
No significant phase change was observed as the pressure wave travelled down the model.
2.3 .3  C onclusion
The change in wave shape and wave amplitude is likely to be due either to a feature of the flow 
produced by the SLE 2000 or due to the interaction of the waves with the lung model. If the 
pressure wave drives a non-linear flow, convective effects will contribute to a change in wave 
shape and amplitude. Similarly, a change in wave shape is expected if the wave is dispersive. A 
dispersive wave has the property that the velocity of propagation of wave components depends 
on wave frequency. Flow non-linearity and dispersive effects are possibly features of the SLE
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2000 pressure wave. The conduction of heat and the molecular structure of the gas used in the 
experiments will also influence the wave shape and rate of wave attenuation.
As the wave reaches the lung model, the wave shape and amplitude are vulnerable to change 
from the influence of entrance effects, the geometry of the model and viscous eflFects a t the tube 
wall. Entrance effects are im portant at discontinuities in the tube walls, i.e. the end of the E-T 
tube and the Y-piece junctions. The geometry of the lung model is expected to influence the 
wave shape and amplitude as bifurcating geometries are known to affect flow. Viscous effects 
also become im portant for flow in tubes of a small enough diameter.
The observed change in wave shape and amplitude may have contributions from any of the 
effects described above. It is also possible tha t two or more of the aforementioned mechanisms 
are balancing each other, with no apparent change in wave shape. The results suggest that 
the factor most influencing the change in wave shape and wave amplitude lies between the 
transducers at P r e f  and P i .
2.3 .4  D iscussion
Further experiments needed to be carried out to calculate the pressure wave speed and to 
determine the dominant effects influencing the changes in wave speed and attenuation. These 
experiments are discussed in detail in §2.4.
Firstly, as the tubes in the lung model were too short to accurately detect a change in wave 
speed, we ventilated tubes of longer lengths. We tested various lengths of tube until we had a 
length sufficient for a reasonable phase change to be observed.
We needed to find the mechanism that most influenced the change in wave shape tha t we 
observed. Flow non-linearity, dispersion and viscous effects were the mechanisms considered. 
We tried ventilating tubes of smaller radii than in the lung model. Tubes of smaller diameters, 
namely 2mm and 2.5mm, displayed a significant influence on both wave shape and rate of
attenuation. This suggests tha t viscous effects are important.
No prominent steepening of wave profile was observed, so non-linearity was assumed not to 
be a dominant mechanism. Had shock waves been present, we would have expected a steepening 
of the wavefront, perhaps accompanied by dissipation of energy as sound.
For both 2mm and 2.5mm tubes, which were 10m in length, traces were taken for both 50
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and 100 beats per minute (or bpm). No significant change was observed, so it was decided to 
concentrate on viscous effects rather than the detection of dispersive effects in the next set of 
experiments.
2.4 The Tube Experim ents
This set of experiments investigates the wave speed, wave shape and rate of attenuation in long 
tubes of various radii. The aim of these experiments is to determine the influence of viscous 
effects on the pressure wave properties.
2.4.1 M eth od
Four silicon tubes of radii 0.3mm, 0.6mm, 2.0mm, 2.5mm and one nylon tube of radius 1.0mm 
respectively were used. Silicon tubes have the property that they are slightly distensible, 
whereas nylon tubes are more rigid. Each tube was of a length of up to 10 metres. For each 
tube the apparatus was assembled as follows:
One end of the tube was connected directly to the E-T manifold. The pressure trace here 
is called Prefi as in the lung model experiment. A probe to another pressure transducer was 
inserted, flush with the wall, at a given distance along the tube. This distance was either 2m, 
5m or 10m. The pressure trace received here is called P e n d -  The tube was extended by a length 
of Im  beyond the distal transducer to minimise end effects. Between the two transducers, the 
tube was kept loosely coiled.
Most of the experiments were performed at a ventilator frequency of 100 breaths per minute, 
except for two ventilations, which were repeated at 50 breaths per minute. The tubes were all 
loosely coiled except for one experiment, using the 1.0mm radius nylon tube. The nylon tube 
was ventilated both when coiled and uncoiled.
The data storage oscilloscope was triggered to start both traces P r e f  and P e n d  simulta­
neously, as in the lung model experiment described in §2.3.1. The data was again saved using 
the PC package ‘Transition’.
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Figure 2.8: Printout for ventilation of nylon tube, radius 1.0mm, length 5m - Experiment C
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Figure 2.9: Printout for ventilation of silicon tube, radius 2.0mm, length 10m - Experiments D 
and F
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Figure 2.10: Printout for ventilation of silicon tube, radius 2.5mm, length 10m - Experiments 
E  and G
Expt Tube
Radius
(mm)
Tube
Length
(m)
Frequency
(b.p.m.)
Insp.
Time
(s)
Delay
Time
(ms)
Sound
Speed
(m/s)
Total 
Attenuation 
1 APend
Attenuation 
per metre
 ^ APreF length
A 0.3 2 99 0.15 36 55.5 0.833 0.895
B 0.6 5 99 0.15 24 208.0 0.862 0.396
C 1.0 5 99 0.15 20 250.0 0.799 0.321
D 2.0 10 100 0.12 32 312.5 0.824 0.174
E 2.5 10 100 0.12 32 312.5 0.634 0.101
F 2.0 10 50 0.12 32 312.5 0.824 0.174
G 2.5 10 50 0.12 32 312.5 0.634 0.101
T able 2.1: Table of R esults
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2.4.2 Tube E xperim ent R esu lts
In each experiment there was sufficient phase difference to enable measurement of the average 
wave speed. The speed and attenuation results were calculated from the graphs saved in 
‘Transition’, see Table 2.1 for results.
In order to calculate the average wave speed, the delay time must be known. The result for 
the delay time is found by calculating the rise time, which is the time at which the pressure 
wave has risen through half of its total height gain. The difference in rise time between P e n d  
and P r e f  is the delay time. As 250 data points were taken in each second, the rise time is 
only accurate to 4ms. The measured delay time is therefore accurate to within 5-10%. In the 
pipes of radii 2.0mm and 2.5mm, the speed of propagation is almost the speed of sound in free 
air. The average wave speed decreases as the tube radius decreases. The two experiments that 
were repeated at 50 breaths per minute showed no difference in wave speed to those tha t used 
100 breaths per minute.
Each wave is strongly attenuated. The attenuation is calculated by taking the ratio of the 
pressure perturbations for the attenuated wave and the reference wave away from 1, thereby 
giving the fraction of the original perturbation pressure lost over the tube. In each experiment 
the perturbed wave is attenuated by at least 0.63 of the height of the original perturbation 
pressure.
The comparison of the pressure trace graphs shows three distinct wave shapes. In the longer, 
wider tubes a ‘transient overshoot’ is observed. The middle range of radii produce a wave whose 
shape resembles that of P r e f  although amplitude is substantially reduced. In the narrowest, 
shortest pipes, the wave is smoothed off at the back and steepness at the front remains.
2.4 .3  C onclusion
The reduction of the average wave speed with decreasing tube radius suggests tha t viscous 
dissipation at the tube walls is an im portant influence here. Viscous effects would also be 
expected to have a smoothing effect on a rectangular wave shape.
Changes in wave shape appear to depend on both the tube radius and tube length. A 
possible mechanism producing the ‘overshoot’ observed in the larger, longer pipes could be flow
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non-linearity. A possible explanation for the wave shape observed in the middle range of pipe 
radii and lengths is that viscosity and heat dissipation at the walls is sufficient to balance the 
non-linearity but not influential enough to smooth the wave shape. The pressure traces from 
the smaller lengths and radii of pipe appear to display the smoothing effects of a dissipative 
influence such as viscosity.
The attenuation is likely to depend on the tube radius and tube length, although it is 
difficult to suggest a relation from the experimental data. The rate of attenuation may be 
strongly affected at the entrance of the tube.
2.4 .4  D iscussion
An appropriate sequel to the tube experiments would be an experiment designed to specifically 
determine the main cause of the pressure wave attenuation observed in §2.4.2 and §2 .2 . The 
passage of the wave from the E-T manifold to the tube entrance may be a strong source of the 
substantial decrease in wave amplitude, but this is not yet clear from the above results. Such 
an experiment would involve the placement of several transducers along the tube and around 
the junction in question.
To ascertain a relationship between the effect of tube length, tube radius and ventilation 
frequency on attenuation, a large set of experiments would need to be carried out where one pa­
rameter at a time is changed. Ideally, these experiments would be performed with a monatomic 
gas such as Helium to restrict the causes of wave attenuation, for reasons explained later in 
§3.1.2.
2.5 Future Experim ents
The experiments have provided us with information that will contribute towards the construc­
tion of a mathematical model. The data set has directed us towards an acoustic flow régime: 
this has not been used to model ventilation before.
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2.5.1 F low  A nalysis
Gas flow within the lung is determined by the interaction of many different influences such as 
lung geometry, ventilation frequency, and gas humidity (to name but a few). Simple experiments 
can enable understanding of the contribution to the flow from individual effects. The aim for 
the future is to combine all of these effects in a complex geometry representing a real lung in 
order to predict flow and therefore transport properties.
The preceding experiments have succeeded in isolating some mechanisms tha t have a strong 
influence on the flow. A methodical and sensible approach for future work would be to formulate 
a mathematical model based on the experimental data and then design more experiments to 
specifically test the proposed theories. This process would be followed for each influence until 
a satisfactory model has been formulated.
2.5.2 A  R ealistic Lung
The perfect experiment would involve measurements on many lungs in vivo. This is not yet 
possible with the techniques available for us today.
For the lung model experiments we considered ventilating an actual neonatal lung taken 
post mortem. It was decided not to do this, as real lungs would have probably been too fragile 
to accept pressure transducers. The possibility of making casts from actual lungs was also 
discussed but the resources required would have been too great for the scale of this project. 
Our lung model was made as small as possible with the resources that were available.
As morphometric data for neonatal lungs is not available, the sizes and the arrangement of 
the bronchial branches for a ‘typical’ neonatal lung were not known. A ‘typical’ compliance of 
a neonatal lung affected with HMD was also unknown, limiting the realistic quality of any lung 
model. Had morphometric data and compliance values been available, we still would not have 
had the dimensions of the perfect neonatal lung. This is due to the great variation between 
individual humans. Data would have merely provided us with a range of values within which 
to work.
It is worth noting that when compared to an adult lung, the level of complexity needed to 
model a neonatal lung is much less. This is due to the fact tha t the lung of a very premature
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baby is likely to  consist of sm ooth  walled, b lind-ending  tubes.
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C hapter 3
A coustic A nalysis
111 this chapter, a model for an acoustic wave propagating in a tube is used to represent the 
flow produced by the SLE 2000 distal je t ventilator pressure wave. The derivation of the model 
solution is given and the features of the resulting flow are discussed. The values of pressure 
wave attenuation and wave speed predicted by the model are compared with the experimental 
results.
3.1 Selection of the Flow M odel
This piece of work selects a suitable model for the representation of the SLE 2000 pressure 
wave. A suitable model must give reasonable approximations for the wave shape, the average 
wave speed and the rate of attenuation as observed in the experiments.
3.1.1 W ave Speed and W ave Shape
The experiments found that the pressure wave produced by the SLE 2000 is capable of travelling 
at almost the speed of sound. This immediately suggests the presence of sound waves and 
therefore implies tha t compressibility effects are likely to be important.
Although the steepness of the pressure wave suggests the possibility of non-linear behaviour, 
the magnitude of the pressure perturbation compared to the steady pressure implies tha t linear 
theory may be adequate. The pressure perturbation is of the order of 20cms H2O whereas 
the steady pressure (consisting of atmospheric pressure and positive end expiratory pressure)
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is of the order of lOOOcms HgO. As acoustic disturbances can usually be regarded as small- 
amplitude perturbations to a steady state, the linear acoustic approximation is taken here to 
be an adequate assumption.
An advantage of the linear analysis of time periodic waves is that Fourier series can be used. 
Fourier series enable a given waveform to be expressed as a superposition of discrete frequency 
components. Subsequently, a waveform can be constructed to resemble that created by the 
ventilator at the entrance to the E-T tube, as observed in the experiments. This also provides 
a convenient means by which to compare the change in wave shape predicted theoretically and 
th a t observed in the experiments.
3.1 .2  D issip ative M echanism s
The experiments demonstrated substantial attenuation of the pressure wave. There are three 
mechanisms of energy dissipation in sound waves; v iscosity , h ea t co n d u c tio n  and re la x a tio n  
p rocesses.
Relaxation processes are dependent on the molecular structure of the atoms in a fluid. 
Each molecule has energy for its own particular modes of motion. Depending on the molecular 
structure, a molecule will have varying proportions of translational, rotational and internal 
vibrational energy. The contributions to attenuation from these irreversible processes can be 
included in the Navier-Stokes equations by the introduction of another term similar to the 
existing viscosity term. B u lk  v iscosity  is the name given to the term added to ‘true’ viscosity 
to represent the contributions from relaxation processes.
This model seeks to include the dominant dissipative mechanisms. A preliminary calculation 
is carried out to determine the importance of the viscous dissipation solely at the wavefront. 
This preliminary model is then extended to take into account viscous dissipation and heat 
conduction, both at the wavefront and at the tube walls.
Relaxation processes due to rotational and vibrational modes of molecular motion have not 
been taken into account in this model.
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3.1.3 Sound W aves
The above considerations lead us to construct a model based on results in the theory of lin­
ear acoustics. There are some important features in the analysis of sound waves which it is
appropriate to discuss here:
In the analysis of sound waves as a reversible process, the dissipation of heat by viscosity and 
conduction is neglected. Relaxation process are ignored in the assumption tha t the molecular 
modes of motion are in equilibrium.
We shall use the subscript zero to denote steady state values of variables, and use dashed 
quantities to denote perturbations to the steady state. It is assumed that the fluid velocity is 
zero in the unperturbed state.
The appropriate equations of motion are then
(3.1)
/5^  +  PoV.v' =  0, (3.2)
A  + p ' =  p(m 4-p%s),
where carets represent dimensional variables, subscripts denote partial differentiation and p'. 
v' and p' represent density, velocity and pressure perturbations of the fluid respectively. The 
quantity s represents entropy, which is constant in isentropic flow. A reversible process in 
a homogeneous medium implies that the flow is isentropic, so tha t pressure is a function of 
density only. Accordingly, we write
P o+p ' =  p (Â ]+ p '). (3.3)
Expanding (3.3) in a Taylor series in p' gives
P' =
Equations (3.1), (3.2) and (3.4) can also be written as a wave equation;
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V V  -  ^  p’u -  0, (3.5)Co
where
Co -  ^ (P o )  (3.6)
and Co is known as the speed of sound.
It is assumed that we are dealing with a perfect gas. A p e rfec t, or ideal gas is a gas whose 
density is sufficiently low that only small numbers of molecules interact with each other i.e. 
intermolecular forces are negligible. A perfect gas obeys Boyle’s Law;
f) =  pR qT, (3.7)
where R q is the real gas constant and is equal to
R  -  8314m^s-%-^
° mean molecular weight
Boyle’s Law yields the following expression for the velocity of sound in a perfect gas for a 
reversible, adiabatic process;
eg =  (3.8)
where 7  is the adiabatic index or ratio of specific heats. It can be shown that, for a perfect gas 
at tem perature To, the gas constant R q satisfies
where Cp is the specific heat capacity at constant pressure. See Lighthill (1978), pages 5-7, for 
the derivation of this result.
An a d ia b a tic  process is one in which there is negligible internal heat flow due to each 
individual fluid element being thermally isolated from its surroundings. This is not to be 
confused with an isothermal process, where the temperature is constant everywhere. Under
adiabatic conditions, the thermodynamic variations in a gas are a succession of equilibrium
states.
From the assumption of constant entropy, we obtain the pressure density relation
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p a  (3.9)
which is known as the pressure density relation for adiabatic, reversible change of a perfect gas 
with constant specific heats; see Batchelor (1967), Chapter 1 for a detailed discussion.
3.2 Flow M odel Including V iscous D issipation at the  
W avefront
This preliminary calculation determines the importance of viscous dissipation solely at the 
wavefront of the pressure wave. Heat conduction, relaxation processes and the dissipative 
effects of viscosity at the tube wall are neglected. An acoustic approximation of the Navier- 
Stokes equation is used, together with a barotropic pressure-density relation in unidirectional 
flow in a perfect gas. A rectangular wave constructed by Fourier series is imposed as an initial 
condition.
The flow produced by sound waves in unidirectional flow can also be thought of as flow in 
the centre of a pipe that is large enough for dissipation at the walls to be negligible.
3.2.1 G overning Equations
The governing equations used here are based on those given in Curie and Davies. Unidirectional 
flow is assumed along the ‘tube’ in the z  direction implying that the fluid speed, v ' =  û'e^ and 
the pressure perturbation, p', are all functions of z only. Using the same variable names and 
notation as §3.1.3, the equations of motion become
P; +  = (3.10)Po G
Pf +  Pqu', = 0, (3.11)
where pq is the the kinematic viscosity or diffusivity of shear and is equal to po/po, where po is 
the viscosity of the fluid. Although viscosity is a quantity that is dependent on temperature.
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linearisation removes all but the leading order viscosity term, which in this case is th a t of the 
unperturbed state.
The equations (3.10) and (3.11) can also be expressed as
%  =  Az +  (3.12)
Therefore, from (3.4) and (3.6),
Pit ~  0^ Pzz +  ~~^Pzzi- (3.13)
Equation (3.13) also holds for p' (from equation(3.8)):
p'ti ^  eg pT +  (3.14)
Non-dimensionalising with respect to the following appropriate scales
LÜZ , .z =  — , ■ (3.15)Co
T =  wf, (3.16)
where ui is the fundamental frequency of the oscillation, equation (3.14) becomes
4i/QW ,P^ TT =  p'zz +  T-rP'zzT- (3.18)3 Cl
W riting we look for solutions of the form
p'7,T) =  K{/„(r)e^™“ }. (3.19)
This leads to the result
p'(z, r)  =  K {yt„ (3.20)
where
Pn =  (1 -  (3.21)
In our experiments 6 was typically 1.7 x 10~®.
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Figure 3.1; The (Unatteniiated) Square Pressure Wave
Note tha t for ail but the very highest wavenumbers, the wave speed is approximately 1. 
For a 10m pipe, the change in z is Az =  0.00294 to 3 sig. fig. Therefore, given a wave with 
harmonic number n  and fundamental wavelength ÿ ,  the attenuation over a 10m pipe for the 
harmonic is approximately jg g-9.87 x lo 7^%^
A quantitive result must be obtained for the attenuation predicted by this model. This is 
given by calculating the wave frequency above which a decay of more than a factor of 0.5 occurs 
in a 10 metre long ‘pipe’. The number of terms required in our series solution to achieve such 
an attenuation are then found. The value for the factor of decay and the distance along the z 
axis are representative of those in the experiments. The order of the number of terms required 
for a decay in amplitude of a factor of 0.5 will give an indication of how important viscosity at 
the wavefront is as dissipative mechanism.
The amplitude decays by more than a factor of 0.5 for approximately
9.87 X I Q - V  > In 0.5
i.e.
n > S X 10“^,
3.2.2 A tten u ation  o f a Square W ave
In our experiments, P r e f  is (roughly) a square wave. The result of §3 .2.1 can be used to 
consider the effect of attenuation on a square wave (see Figure 3.1):
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0 - |  < z < - a ,
f   ^ 1 —CK < z < CK, (3.22)
0 o; <  z < I ,
Then /(z )  can be written as a Fourier series, as follows;
oo 1
/ ( z )  =  2a +  T  /ggg)
n^ O
Clearly, only the very high wavenumber modes will be significantly affected by attenuation. 
These modes will not contribute substantially to the wave profile, except a t the pressure jumps. 
So viscous dissipation at the front will not produce the radical change in wave height tha t was 
observed in some of our experiments.
Other mechanisms need to be included that contribute to the attenuation of the pressure 
wave. The introduction of viscous dissipation at the tube wall and the effects of heat conduction 
are appropriate mechanisms to include in a refined model.
3.3 A coustic W aves Propagating in a Tube
This model aims to predict some of the flow features of the SLE 2000 pressure wave. Results 
modelling the propagation of sound waves in cylindrical tubes within a suitable parameter range 
have been quoted. The analysis takes an acoustic approximation of the Navier Stokes equation 
for axisymmetric flow in a perfect gas. The effects of viscosity and heat conduction are taken 
into account, although relaxation effects have been neglected. The following analysis assumes 
tha t the wavelength of the sound wave is very much greater than the tube radius. A Fourier 
rectangular wave has been taken as a pressure boundary condition and the results have been 
compared quantitatively and qualitatively with the experimental results.
3.3.1 Sound W aves in T ubes
Before giving the governing equations, a brief discussion follows including the reasons for the 
choice of this particular model. A brief review of the literature on the acoustic analysis of sound 
waves in tubes is also given.
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Helmholtz was apparently the first to investigate the problem of the propagation of sound 
waves in tubes in 1863. He quoted a formula for the decrease in sound velocity due to viscosity. 
In 1868 Kundt discovered a few more im portant features about ‘aerial’ waves in pipes in his 
‘dust-tube’ experiments. Kundt tested Helmholtz’s formula and found the dimunition of ve­
locity to be larger than predicted. As a result, Kundt attributed the discrepancy as being due 
to the neglect of heat exchange between air and the sides of the tube. In 1868 Kirchoff then 
presented the full equations including the effects of viscosity and heat conduction. Kirchoff 
investigated the solution to his equations for the case of a ‘wide’ tube. Rayleigh (1945) then 
extended this investigation into the case of ‘narrow’ tubes in ‘The Theory of Sound’. Weston 
(1953) completed this work by investigating the case of a ‘very wide’ tube and the transitions 
between each case.
Many authors have studied the problem of propagation of sound waves in tubes. Investi­
gations have been both analytical and numerical for both the full Kirchoff equations and less 
complicated equations involving simplifying assumptions. One of the more successful solutions 
based on simplifying assumptions was first given by Zwikker and Kosten (1949). Zwikker and 
Kosten assume in their analysis tha t the wavelength of the sound wave is very much greater 
than the tube radius. An analytical solution is found and it is demonstrated by Tijdeman 
(1975) tha t this solution covers the known approximate solutions. Tij deman takes Zwikker and 
Kosten’s solution, naming it the ‘Low Reduced Frequency Solution’ and compares it with the 
results of other authors. To facilitate comparison, Tijdeman rewrites each analytical solution 
in terms of a function, called the propagation constant, of two dimensionless parameters.
3.3.2 G overning E quations
The governing equations and subsequent solution are based on Appendices A and B in T i­
jdem an’s aforementioned paper. The equations of motion in cylindrical co-ordinates for ax­
isymmetric flow are taken, where f  and x  are the dimensional radial and axial coordinates 
respectively. This gives the appropriate forms of the Navier-Stokes equation:
p [ui 4- vuf 4- ûû$] -px  4- M Uxx 4- 4- —Uf.r
1 1+ - 4- "Uf 4- -%3 r (3.24)
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p [v^  +  VVf +  Û%] =  -P f  +  p
The equation of continuity is
1 . ^~Vr — ~  r r"
1+  % +  T3
 ^ , .N y\ , /\ /s , Z'Pi +  '^px +  '^Pf +  p 
The equation of state for a perfect gas is
Ux +  "Or T T 0 .
(3.25)
(3.26)
p — pRoT, (3.27)
and the energy equation is
pcp [fj + -afî +  fiff] =  A
+ p  <2
, , /V /V , ys. / \+  p^ +  up^ +  VPf 
2 “
( Ux )  + i ^ r )  + +  [Vx +  fi'f]2 2 .  ^ . VUx +  Vr +  -r
where Cp is the specific heat capacity at constant pressure, A is the thermal conductivity and 
Ro — As earlier, a caret denotes a quantity with dimension.
Linearisation and Non-Dim ensionalisation
It is assumed that the flow quantities take the form of small sinusoidal perturbations to the 
steady state, varying with angular frequency w. The flow velocity is zero in the unperturbed 
state. The flow quantities are non-dimensionalised with respect to values representative of 
typical physical scales expected in the flow.
At this stage, our non-dimensionalisation differs from Tijdeman’s. Tijdeman has non- 
dimensionalised both the axial and radial flow velocities with respect to the speed of sound 
in the steady state. It is true that an appropriate flow velocity scale for the axial flow is cq, 
but in a pipe very much longer than it is wide, the magnitude of the radial flow velocity would 
be expected to be very much smaller than cq. An appropriate scaling, which we adopt, is the 
pipe radius multiplied by the angular frequency of the oscillation.
Dimensionless coordinates r ,  ^ and ij are introduced to replace f, x  and f  respectively, as 
follows
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r  =  üjt,
Co
(3.28)
(3.29)
This leaves us with
R'
Ù =  Co e” " } ,
V =  e “ ’' } .
P = Po ïî{ (H -p (? ,î? ))  e’"’'} , 
p =  Po5R{(l +  p (^ ,,,) )e ” q .  
f  =  T o î{ { (l +  T (^.,7))e“ 4 ,
where R is the pipe radius and po ^  POÇ^ 7
Following linearisation, equations (3.24) and (3.25) now become
(3.30)
1— IL
(3.31)
. _  1 /  Co /iQ 1
-  ” 7  V ^ j
i f  V+  3 u, + v,  + -
V p i i  +  V p
V f { j jR \+  (  )\  Co /
(3.32)
where is the leading order viscosity coefficient corresponding to that of the steady state. 
The continuity equation (3.26) and the equation of state of a perfect gas (3.27) become
i p U p  +  I I j i  H ---------p (3.33)
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and
p = p- \-T  (3.34)
respectively. The energy equation (3.28) linearises to
2
T™ +  iT „ +  V TVjUo Cp/ \po w
Three dimensionless parameters are prominent in this problem; they are the sh ea r wave 
or W o m ersley  n u m b er
the P r a n d t l  n u m b er,
s = R J — , (3.36)Mo
(3.37:
and the re d u c e d  frequency ,
k = -----. (3.38)Co
T h e  D im ension less  P a ra m e te rs
The Womersley number is analogous to the Reynolds number in tha t it represents a balance of 
inertia terms to viscous terms. Unlike the Reynolds number it is specific to pulsatile flow. It 
is named in honour of J.R. Womersley who made an important contribution to physiological 
fluid dynamics in his work on the pulsatile flow of blood.
For incompressible, oscillatory flow at large values of s, inertial forces are dominant, caused 
by large fluid velocity transients over each period. The viscous boundary layer does not extend 
far from the tube wall, resulting in a fast moving core of fluid with a thin, surrounding boundary 
layer. In calculations for oscillatory flow in pipes for an incompressible fluid the velocity profile is 
markedly blunt at large s, in contrast with the more familiar parabolic velocity profile associated 
with Poiseuille flow that occurs at smaller values of s.
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The P randtl number is the relative magnitude of the diffusivity of shear (or kinematic 
viscosity) and the diffusivity of heat. Both viscosity and thermal conductivity depend on 
tem perature only. Linearisation of the Navier-Stokes and energy equations leads to the retention 
of the leading order terms only, which are those corresponding to the steady state.
The reduced frequency is proportional to the ratio of the tube radius to the wavelength of 
the sound wave being propagated. At the frequencies and radius involved in this problem we 
can safely assume that k will be very small. From the experimental data, s and k are calculated 
to be within the following ranges;
0.255 < s < 2.215 to 3 d.p.
2.767 X 10"^ < A; <  2.306 x lO""^  to 3 sig. fig.
The equations (3.31) to (3.35) are now written in terms of the Womersley number, Prandtl 
number and reduced frequency. Terms of order k and above have been neglected as k is assumed 
to be very small. In each equation the highest order terms have been equated, giving
%u
7
ripij 4- Ujj (3.39)
(3.40)
ip = — Vfj (3.41)
p = p + T (3.42)
and
2o27 } a^s
subject to the following boundary conditions:
4i>) + (3.43)
■a =  V — 0 , T  = 0 , at 7^ = 1; (3.44)
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u ,v ^p ,T  finite at 77 =  0 . (3.45)
The velocity boundary condition at the tube wall is due to the ‘no slip’ condition. Condition
(3.45) is imposed in order to exclude solutions tha t have non-physical singularities at the centre 
of the pipe. For the temperature boundary condition it is assumed tha t the walls of the tube 
are good conductors of heat (compared with the fluid) and therefore they have the steady state 
temperature.
3.3.3 ‘Low R educed  Frequency S o lu tion ’
The equations are solved analytically following Tijdeman’s paper  ^ to give:
u =
7
1 - Jo (2277s)
Jo (22 s )
— Be , (3.46)
V =  — {i + r'} + (7  -  1) J i J i (2277s). 322(TS Jo (720-5) .3725
P =  ^ 7 -  1 L  Jo (2 2CT77s)
7 Jo (720-5)
Jo (22 s )  _
, (3.47)
7
(3.48)
(3.49)
(3.50)
where A  and B  are complex constants and are determined by suitable boundary conditions. 
The quantity F,
F =  r '4 -  2F" \
Jo (22 s )
J 2 (22 s) \ 7 1 +
( 7  -  1 ) J2  ( 2  2 crs)
7  Jo ( 75a s )
(3.51)
is known as the propagation constant. The propagation constant is a complex quantity that
is im portant in characterising the flow. The real part of the propagation constant F' (which 
 ^Tij deman's paper contains errors in the expression for the acoustic variable u, although these errors do not 
appear to originate from the calculations.
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is positive) dictates the wave attenuation. We require that p —)■ 0 as ^ ^  oo, so A =  0 in 
equations (3.46)-(3.50). Then |B| is the amplitude of the pressure perturbation at ^ — 0. 
The imaginary part of the propagation constant, F" represents the phase speed of the wave. 
Tijdeman expresses the relevant analytical solutions in terms of the propagation constant for 
ease of comparison. He found that the propagation constant becomes dependent on the reduced 
frequency in tubes deemed to be in the wide-very-wide transitional case and wider. In these 
régimes, effects such as the attenuation of sound waves in free air become important. For our 
purposes, the 0 (k )  terms are not significant.
The Propagation Constant
From Figures 3.2 and 3.3 it can be seen tha t | F | becomes large for very small s. Then F tends 
to Rayleigh’s narrow tube solution (see Rayleigh(1945), §350).
F =  2(1 +  7)
The resulting flow at small s corresponds to an isothermal approximation for a tube so 
narrow that heat conducts freely within the fluid, and viscous effects alone are significant. As 
s becomes large, F tends to 7, leading to the isentropic solution corresponding to a simple wave 
propagating without dissipation.
The ‘Low Reduced Frequency Solution’ expression for the propagation constant shows that 
the waves are dispersive. This is because s appears in F", implying that at a constant tube 
radius and fluid viscosity, the phase speed is dependent on frequency.
Figure 3.2: F' against s Figure 3.3: F" against s
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F igu re  3.4: T he longitudinal velocity for the  Low Reduced Frequency Solution
longitudinal vefocity for com pressible flow
L o n g itu d in a l an d  R ad ia l V elocity  P ro files
For s < 3.1, the longitudinal velocity profile is parabolic at the extreme of each oscillation (see 
Figure 3.4). For s > 3.1, the velocity profile shows that there is an annular region of fluid whose 
velocity exceeds the centreline velocity. As s increases, this annulus narrows and approaches 
the tube wall. When s > 100, the velocity profile becomes characteristic of a ‘plug’ flow, with 
a flat profile except for in a thin region associated with the boundary layer.
It is also interesting to compare the longitudinal velocity profile a t different values of s for 
the ‘Low Reduced Frequency’ Solution with the analogous case for an incompressible fluid, see 
Figure 3.5. For incompressible flow driven by a sinusoidal pressure gradient, the fastest flowing 
fluid moves from the centre of the pipe and begins to take on an annular distribution a t s — 3.9 
rather than s =  3.1.
3.4 T he R esults Predicted  by the ‘Low R educed Fre­
quency Solution’
The ‘Low Reduced Frequency Solution’ is applied to the results of the tube experiments. Suit­
able boundary conditions and parameter values are chosen.
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F igu re  3.5: T he longitudinal velocity for the  analogous incom pressible flow
longitudinal velocity for Incom pressible flow
3 6 :)
Pressure
----------------1_________^ Tim e
0 pT T T (2-p  ) 2T ^
Figure 3.6: The Pressure Boundary Condition
3.4.1 B oundary C onditions
It is assumed that waves propagate only in the direction of increasing The amplitude of 
the disturbance is assumed to go to zero as ^ becomes very large, thereby implying that the 
constant A  is zero.
It is also assumed that at =  0 the pressure distribution takes the form of a rectangular 
wave as shown in Figure 3.6, given by;
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p(0 , Î?, r)  =  g{r) =  <
0 0 <  r  < /37t
1 /57T < T < 7t(2 — /5)
0 7t(2 — /3) < t < 27t,
where /3 is the LE ratio (see §1.3.1). This can be written as a Fourier series, as follows:
(3.52)
g(r) =  K p  -  /3 -  2 
7^1=1 rnr (3.53)
where L’Hôpital’s rule has been used to calculate the series term for n =  0.
3.4.2 Solution
The solution is a superposition of components given by the ‘Low Reduced Frequency Solution’, 
namely
71 =  1 nn (3.54)
where the propagation constant for each frequency component is
\ \ 7
(7 -  1) J 2
7 . 3 (3.55)
By using a suitable number of terms in the series solution and choosing suitable values for the 
variables, the model can now be compared with the experimental results.
The results predicted by the ‘Low Reduced Frequency Solution’ model were produced with 
the aid of the computer package ‘Maple’. Values of various physical properties were chosen 
tha t correspond with those in dry air of a pressure of one atmosphere at a temperature of 15°C. 
This gives a value of 7  equal to 1.401, a is 0.72 and the kinematic viscosity, //Q, is 0.145cnFs"^. 
The speed of sound cq is 340.6ms“ .^ The first 200 terms have been used in each Fourier series. 
For each of the five experiments the other variable and parameter values are as in Table 3.1.
Figures 3.7 to 3.11 show the predicted output for each of the pressure waveforms. Each 
simulated rectangular wave displays ‘spikes’ near the points of discontinuity. There is a visible 
‘undershoot’ just before the pressure rises sharply and an ‘overshoot’ just after. This is due to 
Gibb’s phenomenon and is expected at regions of discontinuity in a Fourier series.
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Table 3.1: die Experiment Variables
Experiment R X /?
(mm) (m) (s)
A 0.3 2 0.75 0.096
B 0.6 5 0.75 0.096
C 1.0 5 0.75 0.096
D 2.0 10 0.80 0.095
E 2.5 10 0.80 0.095
0.1 0 2 0.3 0 4 OS 0.6 t i m e
Figure 3.7: Predicted result of experiment A
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Figure 3.8: Predicted result of experiment B
R w
Pewp
0.1 0.2 0.3 0.4 O.S 0.6 t i m e
Figure 3.9: P red ic ted  resu lt of experim ent C
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6 NP
0 0.1 0.2 0.3 0.4 0.5 0.6 time
Figure 3.10: Predicted result of experiment D
6Np
0 0.1 0.2 0.3 0 4 0.5 0.6
Figure 3.11: P red ic ted  result of experim ent E
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Tab e 3.2: Comparison of Mode and Experiment
Experiment Experimental Results Theoretical Results
Delay time Total Delay time Total
(ms) Attenuation (ms) Attenuation
A 36 0.833 33 0.365
B 24 0.862 44 0.422
C 20 0.799 22 0.255
D 32 0.824 35 0.234
E 32 0.634 33 0.174
3.5 Com parison of M odel w ith  Experim ents
The results of the mathematical model share some important features with the flow observed 
in the experiments. However, from Table 3.2 it is apparent that there are also some differences 
between the theoretical and experimental results.
The predicted wave speeds are calculated from the graphs output by ‘Maple’ (Figures 3.7 
to 3.11). The wave speed is calculated from the delay time as described in §2.4.2. Except for 
experiment B, the predicted wave speeds are all very near the experimental wave speeds when 
the magnitude of measurement error is considered.
The attenuation predicted by the model is very much less than that seen in the experi­
ments. The predicted wave shapes do bear some resemblance to the pressure waves produced 
in experiments A, B and C. However, the retention of an approximately rectangular profile is 
not predicted in experiments D  and E. The ‘Low Reduced Frequency Solution’ does predict 
the retention of a rectangular wave shape in this model but for a lower value of s. Physically, 
this implies a suitable prediction of wave shape for either a larger radius of pipe or a shorter 
length of tube.
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tiV w e
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Figure 3.12: Maximum Predicted wall shear stress for experiment A 
3.5.1 W all Shear Stress
It has been reported that some types of jet ventilator cause epithelial damage in the airways, 
which may be due to high wall shear stress. Therefore it is of interest to assess the levels of 
wall shear stress produced by the SLE2000 . The wall shear stress has been calculated over one 
period for each of the experiments A to E. This was calculated on ‘Maple’ using the following 
expression:
rw = Wall Shear Stress = sin(n7T/3)e (3.56)
where Sn = sy/n.  From figures 3.12 - 3.16 it can be seen that the wall shear stress is not large. 
It remains to be seen whether or not prolonged exposure to low levels of wall shear stress can 
produce damage.
3.5.2 C onclusion
The mathematical model suitably predicts the pressure wave speed within an accuracy appro­
priate to the error in experimental measurement, except for experiment B. This discrepancy is
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iTw ^
O.l 0.2 0.3 0.4 0.5 0.1 bVifte ( s  ')
Figure 3.13: Predicted wall shear stress for experiment B
C g cw v " 's"* '>
O.l 0.2 0.3 0.4 0.5 0.6 t iV y ie (s ')
Figu re 3.14: M ax im um  P red ic ted  wall shear stress for experim ent C
00
0.1 0.2 0.3 0,4 0.5 0.6
Figure 3.15; Maximum Predicted wall shear stress for experiment D
0.1 0.2 0.3 0.4 0.5 0.6
Figure 3.16: M axim um  Pred ic ted  wall shear stress for experim ent E
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possibly explained by the method of measurement.
The difference in the results for attenuation shows tha t this model is by no means completely 
representative of the dominant dissipative mechanisms. There are three possible reasons for 
this: Firstly, it could be tha t the ‘Low Reduced Frequency Solution’ model is inappropriate - 
this is unlikely as it is obviously capable of predicting the wave speed and a qualitative wave 
shape.
Secondly, the neglect of the contribution to attenuation from relaxation processes could be 
the reason tha t wave attenuation is grossly underestimated in this model. A method of testing 
this hypothesis would be to repeat the tube experiments with a monatomic gas, such as helium. 
Certainly, the neglect of relaxation processes is often a cause for underestimated attenuation 
predictions, although it would not be expected to be of the order observed in these experiments.
The last and most probable reason for the aforementioned discrepancy is tha t tube entrance 
effects are not considered. Entrance effects were purposely ignored in these preliminary calcu­
lations as to model them would have required solving complicated equations numerically. As 
the aim of the tube experiments was to find the influence of viscous effects on wave properties, 
this has to some extent been successfully modelled. To investigate the hypothesis that entrance 
effects are the main contributions to attenuation, more specific experiments would need to be 
designed. One method would be to measure the pressure wave at a suitable distance from the 
entrance to the tube and compare the properties with a wave measured at a suitable distance 
from the end of the tube. The ‘Low Reduced Frequency Solution’ model would then be used 
to predict the change in wave shape. Of course, an appropriate boundary condition must be 
imposed th a t realistically represents the wave at its first place of measurement. Better still, 
if the experiment was performed with a monatomic gas, the suitability of the model would be 
determined quite effectively.
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C hapter 4
T he Transport Problem
This chapter begins with a review of solutions of the advection diffusion equation tha t are 
relevant to modelling gas exchange mechanisms in the lung. A time-averaged solution of the 
advection diffusion equation is then derived for acoustic flow over a cross-section of a tube, 
incorporating a density dependent molecular diffusivity and the velocity distribution of the 
‘Low Reduced Frequency Solution’. Using this solution, an effective diffusivity is calculated for 
transport in a plane acoustic wave. Results are compared to those of Watson (1983) for the 
analogous case of incompressible flow driven by an oscillatory pressure gradient. It is observed 
tha t optimum transport occurs at a particular value of the Womersley number.
4.1 A dvection  and Diffusion
In a fluid composed of a mixture with two components, the concentration distribution changes 
due to two processes. Firstly, there is transport due to mechanical mixing of the fluid or 
ad v ec tio n . Secondly, there is the process by which the random motion of molecules results 
in an equalisation of concentration, namely m o lecu lar diffusion. Fick’s law states tha t the 
total rate of diffusion of tracer across a surface is proportional to the concentration gradient 
normal to the surface. The proportionality is governed by the molecular diffusion coefficient 
and therefore the rate of change of concentration in a fluid of uniform density at rest obeys the 
d iffusion  eq u atio n ,
Q  =  V.(KVC), (4.1)
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where C(x, î) is the concentration of passive solute (i.e. the mass ratio of solute to fluid at Æ, 
at time t) and k  is the molecular diffusivity.
On the introduction of fluid motion, the concentration of solute in an incompressible New­
tonian fluid is governed by the ad v ec tio n  d iffusion  equation;
Q - l-û .V C  =  V.(KVC) (4 .2)
where û  is the velocity vector and the same notation is used as in §3.
When it is appropriate to assume a uniform molecular diffusivity, equation (4.2) becomes
Q  +  Û.VC =  (4.3)
where kq is the (uniform) diffusion coefficient.
A review of the known solutions tha t are relevant to the understanding of transport mech­
anisms in the lung follows. In most of these cases it is assumed that enough time has passed 
for a molecule of tracer to sample the whole cross section by the process of diffusion; only then 
does (4.3) hold.
4.1.1 Shear D isp ersion  in S tead y  Flow
S h ear d isp ers io n  or T aylor d isp e rs io n  is the interaction of radial molecular diffusion (or 
lateral transport) with axial advection. Taylor (1953) investigated (both experimentally and
theoretically) the effect of steady, incompressible, Poiseuille flow on the spreading of a solute
of uniform molecular diffusivity in a small bore tube.
Taylor’s analysis is restricted to the case for which the time taken for appreciable changes in 
concentration due to advection is large compared to the time taken for appreciable changes in 
concentration due to radial molecular diffusion. The effect of molecular diffusion in a longitu­
dinal direction is neglected as Taylor reasons tha t transport due to axial advection is dominant 
along the tube.
Taylor observes tha t relative to axes moving with the mean speed of flow, the cross- 
sectionally averaged solute disperses with a virtual, or effective lo n g itu d in a l d iffusiv ity . 
It is as though the solute is diffused by a process^ obeying the same law as molecular diffusion,
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but w ith a diffusion coefficient «e//, where
=  4& ^ '  (4.4)
Here R  is the radius of the tube, U is the mean velocity and Kq is the molecular diffu­
sion coefficient. It is observed from the above expression that a high molecular diffusivity 
corresponds to a low effective diffusivity. This follows as the faster a solute diffuses radially 
outwards, the less distance it will be carried longitudinally. As the right hand side of (4 .4 ) is the 
effective diffusivity for Taylor’s problem, it is also commonly known as the T aylor d iffusion 
coefficient.
This phenomenon is due to the interaction of radial molecular diffusion and the variation 
in fluid velocity over the cross-section. The parabolic velocity profile increases the radial con­
centration gradients in the fluid to the extent th a t dispersion is enhanced when compared to 
the case of dispersion by diffusion only in the fluid at rest. Although this result shows tha t 
Poiseuille flow enhances dispersion due to diffusion, it can also be interpreted as showing that 
diffusion reduces transport by axial advection in Poiseuille flow.
Aris (1956) extended Taylor’s analysis by investigating the dispersion of a solute in fluid 
flowing through a tube of arbitrary cross-section, with a wider range of parameters. He removes 
the restriction based on the ratio of the rate of advection to tha t of molecular diffusion and 
includes the contribution from longitudinal molecular diffusion. Aris did this by analysing the 
problem in terms of moments of distribution of solute in the direction of flow. The dispersive 
qualities of the flow are expressed with an effective diffusivity, as follows
t^efj — ^0 T ) (4.j)
K q
where p is a pure number dependent on the geometry of the cross section. The first term 
on the right-hand side represents the contribution to the effective diffusivity from longitudinal 
molecular diffusion, which was previously neglected by Taylor. It can be seen, by comparison, 
tha t for Taylor’s case of flow through a cylindrical tube, p =
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T h e  S te a d y  P é c le t N u m b e r
The ratio of advective terms to diffusive terms can be expressed as a dimensionless parameter, 
called the P é c le t n um ber. In the case of the steady flow problem analysed by Taylor and 
Aris, the Péclet number is Pe =  Taylor restricted his analysis to a high Péclet number in 
the range 1 > P e  > 6.9, whereas Aris’ solution covered all values of the Péclet number.
4.1 .2  Shear D ispersion  in O scillatory Flow
Watson (1975) solved the advection diffusion equation for incompressible flow driven by an 
oscillatory pressure gradient, given tha t a uniform concentration gradient exists along the pipe. 
He generalised the problem for pipes of arbitrary cross-section.
Watson found an expression for the effective diffusivity and showed tha t it is always positive, 
proving th a t such an oscillatory flow aids dispersion by diffusion. To analyse the solution, he 
expressed the effective diffusivity in terms of the tidal volume V  of the flow rather than the 
pressure gradient, giving
=  Ko ^ 1  4- f s  (^ S , )  ’ (4 -G )
where fs is a function depending on the pipe shape, the Womersley number squared (also 
known as the Stokes number) and the S ch m id t n u m b e r, Sc. The Schmidt number is the 
kinematic viscosity divided by the molecular diffusivity. A  is the cross sectional area of the 
pipe and R  is the pipe radius.
As the Womersley number tends to zero, Watson found tha t dispersion takes place with 
the effective diffusivity (4.5) where U is the instantaneous velocity. Chatwin (1975) studied 
a similar problem to Watson, but expressed his solution in terms of the oscillatory pressure 
gradient rather than the tidal volume and subsequently concluded tha t dispersion is particularly 
large at low values of the Womersley number.
For large Womersley numbers and large values of the product of the Womersley number and 
the Schmidt number, the variation in velocity and concentration distribution is exponentially 
small, except in boundary layers near the wall. W atson’s expression for effective diffusivity 
in terms of tidal volume led him to conclude tha t at high frequencies the solute flux can be
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increased significantly. However, it may be difficult to achieve a large flux, because the rate of 
work done by the pressure gradient increases rapidly with s. Chatwin concluded that, due to 
the flatness of the velocity and concentration profiles, the contribution to dispersion from the 
flow with a prescribed pressure gradient at high frequencies is very small.
It can be seen from the above discussion th a t the dependence of transport upon s is very 
different when the tidal volume is prescribed to when the pressure gradient is prescribed. 
Conclusions from studies from the tidal volume point of view are limited by the pressure 
gradient tha t it is possible to impose in practice.
T u b e  G e o m e try
Tube geometry has been shown to effect shear dispersion in oscillatory flow in tubes. Smith 
(1996) takes branched tubes and shows tha t transport is enhanced as a result of this geometry. 
The results can also be applied to transport in estuaries.
4.1 .3  S teady Stream ing
S te a d y  s tre am in g  is a very im portant nonlinear mechanism in ventilation and occurs as result 
of many different tube properties. In 1982, Haselton and Scherer showed experimentally tha t 
periodic cycling of a constant stroke volume through branching tubes induced steady axial bi­
directional drift of a marked fluid, a phenomena known as steady streaming. This feature was 
attributed to the difference in axial velocity profiles at bifurcations. To look into this effect, 
Grotberg (1984) analysed a volume-cycled oscillatory flow in a tapered tube, with important 
results. A tapered tube was chosen as a model because the airways in the lungs are known to 
taper out slightly in order to match cross-sectional area with the daughter tubes at junctions. 
It was found tha t in the positive phase, the fluid maintains a parabolic velocity profile, whereas 
in the negative phase, the profile is altered by the tube geometry. Over one period, although 
there is a net flux over a cross-section of zero, the velocity profile is bi-directional. In the case 
of taper, the streaming results in a core of fluid and an outer annulus of fluid flowing in the 
opposite direction. The direction of the streaming is dependent on the frequency of oscillation. 
This result has important consequences as far as HFV is concerned. At high frequencies the 
bi-directional flux caused by streaming creates a higher mean pressure at the alveoli than at the
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mouth. This is a suggested cause of a condition known as ‘hyperinflation’ observed by Simon, 
Weimann and Mitzner (1982), where the patient experiences a high intrapulmonary pressure 
and visible enlargement of the lungs at high frequencies during HFV.
Steady stream ing can also be produced by tube curvature, high amplitude oscillations or os­
cillating tube walls. Steady stream ing can either enhance or impede axial dispersion, depending 
on its interaction with shear dispersion.
4.2 Transport in A coustic Flow
In this section, the advection diffusion equation is derived for compressible flow. The "Low 
Reduced Frequency Solution’ gives the velocity field and, using perturbation methods, we derive
the equations governing the interaction between advection and diffusion to order The
small parameter e is representative of the ratio of the magnitude of the pressure perturbation 
to the steady pressure and k is the reduced frequency, as derived in §3. An expression is 
obtained for the tim e-av erag ed  m ass flux of contaminant dispersed in an ax ial d irec tio n  
by linear plane sound waves.
4.2.1 G overning Equations
The form of the advection diffusion equation for this model differs from (4.3) in that it is ap­
plicable to compressible flow. The inclusion of compressibility effects in the advection diffusion 
equation gives
(pC)^ +  V. (p(ÙC -  KVC)) =  0. (4.7)
For our model we assume that the density-dependent molecular diffusivity satisfies
Kp =  KoPo, (4.8)
where kq and po are the molecular diffusivity and the density of the undisturbed state respec­
tively. This assumption, for which there is good empirical evidence (Cussler (1984)),
neglects the effect of changes in concentration gradient on the pressure and temperature 
of the fluid. At extremely high pressures and temperatures, the diffusion coefficient contains
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contributions from a barodiffusion coefficient and a thermal diffusion coefficient. However, at 
the pressures and temperatures in our problem, these effects can safely be neglected.
Using the assumption (4.8) and the continuity equation,
Pf-b V.(pû) = 0 ,  (4.9)
we can rewrite the advection diffusion equation for a compressible fluid as:
p 4- û.VG^ — k,qPq'^^C.  (4.10)
In cylindrical polar coordinates, (4.10) becomes
p{Ci +  uCx +  vCf)  =  f o^Po ^x(r(%)f +  (4.11)
where û, û, x  and r are the axial and radial velocities and coordinates respectively. As usual, 
partial derivatives are denoted by subscripts.
The expression that we would like to solve is that for the tim e-av e rag ed  m ass flux of 
tracer in an ax ia l d irec tio n  over the pipe cross-section. From the advection diffusion equation 
(4.7), the mass flux is
^  =  27f /  p{uG — kCx)r dr. (4.12)J r=0
Scaling  an d  N o n -D im en sio n a lisa tio n
We assume that the concentration gradient along the pipe is linear at leading order, and tha t 
the unperturbed concentration gradient is
Cx ~  (4.13)
It is convenient to re-scale the concentration C as follows
R cqC
/^ o
Then the concentration gradient with no flow is
(4.14)
(4.15)
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where Pe  =  is the u n s te a d y  P é c le t n u m b e r  and k — ^  is the reduced frequency.u)Rk q Co
The non-dimensionaiisation of the flow variables is the same as that carried out in §3.3,2,
I.e.
T
P
P
T
To’
Po'
Ü
V  =
c =
P =z 
T =
Cq
V
âZâ'
(jJX
Co ’ 
r
(j j Î .
After non-dimensionalisation, the time-averaged m ass Jflux, is
r2;r rl /  \( y  } =  R rqPo /  / pu9 -  — 6>ç 7] dr] drjT—0Jri=0 y R& J
Non-dimensionalising the compressible advection diffusion equation (4.11) gives
(4.16)
6r +  u9^ +  v9tj — h  — (p^ ?])?7
The equations of motion are as follows:
(4.17)
1 1p{Uj +  UU^  +  — ——p^ +  ^ 1 1 , 2 V+  3^' U f  +  -t- -. p . (4.18)
,  . 1 1 1  p{Vr +  UV^  +  UU,,) -  ---j^Pri +  ^ 1 V+  3 U f  V n H—.  P.
(4.19)
(4.20)
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p = pT (4.21)
and
p (Tr T  +  uT^) +  “ T,, +  +  up^ +  vpj^} (4.22)a'^s^
7  —  1 +  2,k‘
Uf + Vn H--77
(4.23)
(4.24)
Here it is assumed that p = po to the order required for our expansions.
4.2 .2  Sm all Param eter E xpansions
Now we expand each variable in terms of a small parameter e, which is equal to the magnitude 
of the pressure perturbation over tha t of the total pressure in the steady, unperturbed state.
^(^,77,4
7/(^,77,T)
p(&?7,T)
p(&?7,T)
% 7 7 ,T )
e $ R { r i “ ( ^ ,  77) e '" " }  +  P)  +  P)c^'''}]  +  0 {e^)
7 7)e"'"} +  7 7) +  7 7)6 '^"^ }) +  O(e^)
1 +  77)e'l +  ?7) 4- +  0 (2 ')
1 +  cU{p^^{G r?)e‘^ } +  P) +  +  0 ( 4 )
1 +  +  4 [T " 4(, 7 7) +  77)4*11 +  0(6^) (4.25]
We know that the parameter k^ strongly influences the flow. To find out whether or not 
k significantly affects transport we will expand each perturbation to first order in /c^ . From 
the advection diffusion equation and the equations of motion, we can see that variables with 
superscripts 11, 20 and 22 will take the forms
=  c“ °(c> 7)+ fcV H «.»?)+ o(fc").
6 6
respectively. For now, we shall assume that k »  e, so that the terms of order are
greater in magnitude than those of order which will be neglected.
Substituting in the perturbation expansions to the mass flux equation and then time- 
averaging, we obtain
(P  ) = 2'kR koPo l  + e^—  { l  + k^ j}]  , (4.26)
where
I  = r  [_f„200 + 77 dp,
J  =
r l  /7 2 OO 1
I  ^ 4  +  4  { « "" (g '"  -  ( / " )  +  -  «P“ “)}
(4.27)
77 dp, (4.28)
and an over bar denotes a complex conjugate.
Equating terms of 0{ek~^) from the equation of momentum in the radial direction gives
=  0 . (4.29)
This expression for enables us to solve the next set of equations.
Equating terms of 0{ek^) in the advection diffusion equation and the equations governing 
the flow gives
- _ L iP e p -  « "°  =  0.
I'LL
(4.30)
(4.31 :
(4.32)
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=  0. (4.33)
,110 „110 110 0 , (4.34)
where
and
1 ____ T.
2o2 WCT^5
110 T__
V ' 7
=  0 at ?7 =  1
(4.35)
(4.36)
9^^  ^ bounded as p —> 0. (4.37)
The expressions for and are in fact those governing the ‘Low Reduced
Frequency Solution’ as seen in §3.3.3.
After a lengthy calculation, 9^^  ^ is found to be
i llO -TB
7 1 +
Pe
P e -
s Ji(i^s)  Jo(i2P e 2p)
Pe^ Jo(^^a) Jii'i^Pe^) Jo (4s)
Jo (4 sp ) -r(
if s Pe. From L’Hôpital’s rule, we obtain
illO -FP
7 ■ 7 J i ( 4 s p )  J o ( 4 s p )^  T / ' —  \ T / ' “ \Jo(«2s) J l(?2s) >-rç
for the case s = Pe.
(4.38)
(4.39)
4 .2 .3  T im e A veraged M ass F lu x
We need to find the quantities I  and J  in terms of the independent variables in this problem. 
The flow variables with superscripts 110 are already known. The concentration and flow vari­
ables of orders above this are not yet known, but it turns out tha t we can express I  and J  (to 
leading order) solely in terms of the known quantities as follows.
Firstly, we will try to simplify the expression for
I =  +  la* -  ( / ' « ) } ]  n  dr,. (4.40)
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To eliminate the term, the time-aver aged, 0{e)  continuity equation can be used; this
IS
la* +  u f o  +  1(27^^™)., =  0. (4.41)
Equation (4.41) is now integrated over the pipe cross-section. Using the boundary condition 
tha t the radial velocity v is zero at the pipe wall and at the pipe centre, we obtain an expression 
which is then integrated with respect to giving
V dp = Cl, (4.42)
where Ci is a constant of integration.
The above expression can now be multiplied by ^ and substituted into the expression for / ,  
giving the much simpler expression
^ = -C i^ +  I  3^% p dp. (4.43).Jo Z  ^ ^
This simplifies further when we consider that as ^ tends to infinity we have imposed the con­
dition tha t the perturbation to the concentration tends to zero, giving
I  — I  ^37 p dp. (4.44)Jo 2 ^
Now a simpler expression for J  must be found. We start by attem pting to express 4°^ with 
lower order terms, because
Pe p dp. (4.45)
Using the 0{e^k^) continuity ecpiation, J  can be simplified by performing similar steps as 
for the simplification of I. The 0(4A:^) continuity equation is integrated over the cross-section 
and then integrated over ^ and the appropriate boundary conditions are imposed, giving
77 d l ]  =  C 2 (4.46)
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where cg is a constant of integration. Then equation (4.46) is multiplied by ^ and substituted 
into J , giving
2^00
J  =  -ÇC2 +  IsR pg  ?7 (4.47)
Eliminating 4°° is our next aim. This is done by using the time-averaged 0(e^k)  terms of 
the advection diffusion equation, which are
1^100111 +  _  ,,201 =  i 2^00 +  (4.48)
As before, we integrate this equation over the cross-section and then integrate over ^ to
oo. The 9'^^ term disappears but we are left with the term Fortunately, equation (4.48) 
can be used as an expression for which is then substituted into J . Although J  now has 
more terms than before, they can be simplified further. Using the product rule, we can use the 
relation
=  -  / “  d ( (4.49)
along with the 0(c^/c^) continuity equation to express J  in terms of orders up to 0{ek^):
J  — J  j  -  wj^^) 4- -  76^^°) 4- 77 dp (4.50)
Taking the conjugate of the 0(e)  and 0 {ek ‘^) continuity equations, J  can be rewritten in 
terms of the dependent variables 9^ ^  ^ and only, leaving
J  =  ^  ^  { 6>^^°(77ü “ ^) 4- 0 ^^ ^ (77ü “ ° )  4- -h 77 dp (4.51)
The first two terms in the above equation can be integrated by parts, finally giving
J =  0. (4.52)
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So the 0 { k ‘^) terms in (4.26) do not significantly affect the net solute transport. The full 
expression of order 0 (c /^c^) for the time-averaged mass flux of solute in the axial direction is
14-(P  ) = 2ttR koPo 
which we also write as
(T  ) =  2tcR kqPo
(4.53)
(4.54)
4.3 Transport M odel R esults
In this section, we analyse the expression for the time-averaged mass flux of solute in the axial 
direction. The predicted magnitude of transport of contaminant is investigated for different 
values of the Womersley number, and our results are compared with W atson’s shear dispersion 
model for an incompressible oscillatory flow.
4.3.1 P red icted  Transport
Solving the O(e^) part of the mass flux equation, with
(4.55)
gives
110 sPe
7  ^ (g4 — Pe^) Jo(^2s) 1 -
is Ji(i  25) Jo(«2P e 2)
Pe5 Jo (î"2s) J i(«2P e 2)
for Pe  7  ^ and
Vl( !Z £ )4 i (!!£) + 1 Jo ('^2 5 )
-2r'ç
47  ^ ''"^ ( ''jo (r#g)Jo (2#s) ' Jo (r# s)J i(2 # g )^
for the case when Pe — s^. Figure 4.1 shows the graph of when plotted against the 
Womersley number s. Here molecular diffusivity of oxygen in air is O.lScnTs"’-, 7  is 1.401 and 
cr is 0.72.
-2F7
(4.56)
(4.57)
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F igu re  4.1: T he varia tion  of w ith  5 .
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The time-averaged mass flux is strongly optimised when the Womersley number is approx­
imately equal to 4. For values of the Womersley number much below 4 and for values above, 
the time-averaged mass flux is very small.
For a given frequency of oscillation there is a tube radius giving optimum solute transport. 
Similarly, for a particular radius of tube, there is an optimum frequency. In addition, if the 
radius and frequency were fixed, there would be an optimum viscosity and therefore an optimum 
molecular diffusivity for the best transport in this régime.
4.3 .2  C om parison w ith  W atson’s M odel
The results for the transport model for an acoustic wave will be compared to the results 
for an incompressible flow given in the paper entitled ‘Diffusion in Oscillatory Pipe Flow’ by 
Watson(1983), briefly mentioned in §4.1.2.
Watson assumes an oscillatory pressure gradient of the form
=  —Pcos(ut)
where P  has the dimensions of pressure over length.
Watson expresses his result in terms of the re la tiv e  increase  of flux, IZw, where
(4.58)
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y 7 7 ^ ^  +  (4.59)
Here A  is the area of the cross-section S  and /  corresponds to the axial component of velocity 
distribution, oscillating with frequency to. Similarly, g corresponds to the component of the 
concentration distribution oscillating w ith w and has the dimension of length.
The quantity IZw is calculated by subtracting the mass flux under the action of diffusion 
only from the mass flux w ith flow and then dividing by the mass flux with no flow. Watson 
defines the effective diffusivity of the flow as k,q{1 +  TZw)-
The results of the acoustic transport problem can be written in a similar form, but with 
71a replacing T l w  Our effective diffusivity is /^o(l where
■Ra =
to leading order.
For the case of flow in a circular pipe (for ^  Pe) Watson writes Tlw as
1 B'(«) f { s B " ' { s )  +  B ' { s ) ) B ' { s S c - ^ )  ]  P^R<^
2 ( 1  -  Sc - '^)  s ’’B { s ) \  ( s S é B " ' ( s S c ^ )  + B ' ( s S c ^ ) ) B ' ( s ) j  Po’^ o
where B{s) = ber^(s) +  bei^(s).
Here ber(s) and bei(s) are Kelvin functions; they are defined by the relation
Jo(z2s) =  ber(s) +  i bei(s).
Sc  is the Schmidt number (see §4.1.2); the expression s'^Sc corresponds to the unsteady Péclet 
number in the acoustic flow problem. P  represents the uniform pressure gradient amplitude 
and all other variable names represent the same quantities as in previous sections.
At this stage, a comparison is complicated by the fact that W atson’s flow is driven by a pres­
sure gradient, whereas ours is driven by a (roughly) square-wave pressure pulse. Furthermore, 
our effective diffusivity is local, because decays exponentially as ^ > oo.
Surprisingly, Watson’s flow displays similar transport behaviour to the acoustic flow. W at­
son’s results imply that there are optimum values for the frecpiency, radius and viscosity corre­
sponding to a Womersley number of around 4. This has not been previously reported.
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Figure 4.2: Watson’s F lo w : ^  against s
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4.3 .3  C onclusions
The reason for the ‘bump’ in the mass flux graph is not certain. At particular values of the 
Womersley number, the velocity profile takes on a characteristically different shape in both the 
compressible and incompressible flows. A tentative explanation is tha t during these changes 
some velocity profiles aid radial diffusion more than others. For example, a plug flow is likely 
to induce less radial diffusion than a parabolic velocity profile. It seems likely that the values of 
the Womersley number producing optimum transport have a flow that coincides with a velocity 
profile presenting most opportunity for radial diffusion (see figures 3.4 and 3.5).
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C hapter 5
Lagrangian Transport in A coustic Flow
This chapter determines the Lagrangian transport of a particle in our acoustic flow. The 
Lagrangian flow for the ‘Low Reduced Frequency Solution’ is (for the first time) determined 
and discussed. A statistical representation of molecular diffusion is then imposed onto the flow, 
in order to model the path of a particle influenced both by advection and diffusion.
5.1 The Lagrangian Perspective
In §3 and §4, the Eulerian description of the velocity field and transport properties of the flow 
were studied. The E u le r ian  perspective gives the spatial distribution of the velocity field at an 
instant in time, whereas the L ag ran g ian  velocity field is obtained when the trajectory of an 
individual fluid particle is followed. The Lagrangian approach to advection-difl'usion problems 
is particularly informative as given the initial particle position, the particle path described 
under the influence of both advective and diffusive effects can be predicted.
The Lagrangian velocity field of a p e rfec t or non-diffusive tracer, consisting of particles 
small enough for inertial effects to be negligible, is described by the system of ecpiations
riic- ^  =  û ( x ( t) , î ) ,  (5.1)
where the vector û  represents the velocity at x. As in previous chapters, a caret represents a 
dimensional variable.
To represent the effect of molecular diffusion, a stochastic term will be introduced into the 
system of equations (5.1). A statistical representation of B ro w n ian  m o tio n  or the W ien e r
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p ro cess  is used. Typically, a random number generator from a Gaussian or normal distribution 
is used; this type of distribution is commonly known as G auss ian  w h ite  noise.
5.1.1 C haotic A dvection
A fully deterministic, non-integrable velocity field depicting laminar flow is fully capable of pro­
ducing a Lagrangian flow field w ith stochastic properties. In the context of following particles 
of a perfect tracer, Aref (1984) names this régime chao tic  advec tion . For a non-integrable 
system the Lagrangian flow field can consist of regions of chaotic and regular motion. For a non- 
difl'usive particle, chaotic regions provide an effective mixing mechanism. However, re g u la r  
reg ions or is lands encourage non-diffusive particles to become trapped in their streamlines, 
thereby reducing the number of positions sampled.
Jones studied the interaction of chaotic advection and diflfusion, see Aref (1995). As in 
the Eulerian approach, the Péclet number is an important parameter of the system. The La­
grangian viewpoint is particularly useful for high values of the Péclet number, when longitudinal 
advection dominates over the effect of molecular diffusion. A non-integrable system is likely to 
give both chaotic and regular flow regions as in the case for non-diffusive particles. However, 
diffusive particles have the ability to diffuse between chaotic and regular regions and therefore 
do not necessarily get trapped in ‘islands’. Jones finds that diffusion reduces the spreading 
time of particles.
5.1.2 R esonant A dvection
R eso n a n t t r a n s p o r t  is a term commonly used in the field of transport problems, both in the 
Eulerian and the Lagrangian description. It can occur in pipe flow when an oscillatory velocity 
field includes a secondary flow, such as in a curved pipe. Resonant advection in such a flow 
becomes an im portant mixing mechanism when the period of the axial fluid motion coincides 
w ith tha t or multiples of the secondary fluid motion, see Pedley and Kamm (1988). Hydon 
(1994) studied transport in oscillatory flow in a curved pipe and found that, when viewed over 
a pipe cross-section, the Poincaré section shows the presence of islands and chaotic regions. 
For sufficiently large Péclet numbers, particles can be trapped in these islands, enhancing 
longitudinal transport considerably.
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5.2 Lagrangian A dvection
In this section we describe the method by which the Lagrangian velocity field for the ‘Low 
Reduced Frequency Solution’ is determined. The flow field and its implications on particle 
advection are then discussed.
5.2.1 G overning E quations
As the flow is axisymmetric and in cylindrical polar coordinates, only two dimensions need be 
studied with regard to the advection of particles. The Lagrangian flow fleld is governed by the 
following equations
rf T
dtrJ "FJ  =  « (£ (£ ),r(t),£).
(5.2)
where ü and v are the Eulerian expressions for the longitudinal and radial velocities respectively.
After non-dimensionalisation with respect to the same typical physical scales as in §4, we 
obtain
dr  ^ =  ■»(?(’■), r?(T).T). (5.3)
Substituting in the longitudinal and radial velocities from the ‘Low Reduced Frequency Solu­
tion’ we obtain, to leading order,
dr
dr]
dr
iT
1 1
Jo {yr]s^
Jo
+ ('y -  1) J i. 3'i2(7S
(5.4)
i (5.5)Jo Jo(^ias^
respectively. This system describes the flow in a semi-infinite pipe, where acoustic waves travel 
in the positive T-direction only.
Solving (5.4) and (5.5) for ^(r) and r]{r) will give particle trajectories from given initial 
points. Equations (5.4) and (5.5) do not lend themselves to an obvious analytical solution and 
therefore need to be dealt with numerically.
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5.2.2 Solving th e S ystem
The equations for the Lagrangian analysis of particle advection due to the propagation of an 
acoustic wave in a tube were solved using the package Dstool. This package provides a user- 
friendly format in which variables and features of the dynamical system can easily be altered. 
The numerical integrator chosen to solve equations (5.4) and (5.5) was the fourth order Runge- 
K utta  algorithm, which Dstool includes as an option.
T h e  In s ta lla tio n  o f th e  S y stem  in to  D sto o l
Dstool is designed so that user defined dynamical systems can be easily added into the source 
code. To introduce a dynamical system into Dstool, the right hand side of each of the governing 
equations (5.4) and (5.5) is written in the programm ing language C. In order that Dstool 
includes the system, initial settings and variables must also be defined.
The dynamical system that we need to introduce has a few added complications. Firstly, it 
contains Bessel functions, which are not defined in C. This necessitates the use of the Fortran 
NAG library, specifically the routine named ‘S17DEF’. Secondly, complex variables need to 
be defined and dealt with in C. The details of the local modification of the Dstool code are 
included in Appendix A.I. The source code defining the dynamical system for the acoustic flow 
can be found in Appendix B.
5.2 .3  R esu lts
The simulation of particle paths in the flow produced by the ‘Low Reduced Frequency Solution’ 
has yielded interesting results. For convenience, we restrict attention to trajectories in the 
region 0 <  ^ < 27t, 0 < rj < 1. The trajectories perform a loop over each period. Figure 5.1 
shows a typical particle path. Regardless of the value of the Womersley number, the average 
drift of particles starting near the middle of the pipe is in the positive ^ direction, whereas 
particles at the edge of the pipe drift in a negative ^ direction. Although this phenomena could 
be regarded as a streaming motion, it will not be referred to as such to differentiate from the 
time independent mechanism of steady streaming. The phenomena seen here can perhaps be 
referred to as L ag ran g ian  d r if t to avoid confusion.
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F igu re 5.1; A T ypical P a rtic le  P a th  in A coustic Flow
During its travel, each particle is exposed to the effect of attenuation. This results in a 
tightening of the loops in the particle trajectory. As expected, the further a particle starts from 
^ =  0 , the less distance it will move (due to attenuation).
As the Womersley number increases, the particle moves further along the pipe before its 
motion is restricted by the effects of wave attenuation. This has been shown in figures 5.2, 5.3 
and 5 .4 , which show the evolution of particles tha t are initially on a line of constant ^ (only 
one point is plotted per period). The trajectories describe an increasingly large disturbance as 
s is increased.
5.3 Lagrangian A dvection w ith  Diffusion
The interaction of diffusion and advection is modelled by introducing a co n tin u o u s ra n d o m  
fu n c tio n  into equations 5.1, giving
X£ =  Û (x(t), i)  +  V2/^on(i). (5.6)
The continuous random function, n(t) needs to fulfill specific requirements statistically in 
order to represent a continuous random process tha t successfully models diffusion. A random 
number generator with a normal distribution is chosen for this model. The reason for this 
choice is explained in the following section.
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Figure 5.2: Acoustic Flow for s =  0.5
Figure 5.3: Acoustic Flow for s =  1
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F igu re  5.4: A coustic Flow for s =  3
• 1
5.3.1 B row nian M otion
Strictly, physical Brownian motion describes the random manner in which a microscopic particle 
moves w ithin a container of gas or liquid. This motion is the result of collisions between the 
particle and the surrounding molecules. The term Brownian motion is also commonly used to 
describe a stochastic process tha t models the continuous random motion of molecules, amongst 
other processes.
A detailed approach to the derivation of the normal continuous random process can be 
found in the paper by Uhlenbeck and Wang (1945). The following section seeks to outline the 
main ideas behind the application of this process to the representation of Brownian motion but 
is by no means a comprehensive description from the probabilistic viewpoint.
Continuous Random Processes
Taking n =  0,1, 2...}, (A„eR) as equispaced positions of a particle at times ^ discrete 
random process in time can be described as a process in which changes in successive values of 
Xn  are not correlated at all. Each collision between molecules due to random motion can be 
described in one dimension as a random walk without drift, which is defined as
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Xn ~  Xn- i  + Zn, 71 — 1,2... (5.7)
where {Z i} , i  — 1, 2 ,... is a sequence of independent identically-distributed random variables. 
Each random variable Z{ has expected value E{Zi) = 0, so tha t the particle moves in no 
preferred direction.
This random walk can be taken for discrete time in a continuous state space, giving a 
piecewise continuous path. Extending this to the case where time increments are small and at 
intervals of random length, a process that is continuous in time and space is required. Brownian 
motion (or the W iener Process) has these properties and is therefore a good model for random 
continuous motion. It is found tha t a random normal (Gaussian) distribution gives a good 
approximation to a large number of discrete jumps (by the Central Limit Theorem).
Particle Velocity
Brownian motion can in general be applied to any random ly fluctuating physical quantity. In 
this particular application the above argument applies to the particle position and an expression 
for the particle velocity is required. The chief difficulty is that the distribution for a particle 
path in Brownian motion is nowhere differentiable.
The Ornstein-Uhlenbeck process gives an expression for the velocity of a particle under 
Brownian motion at time £. As £ —> oo the probability distribution of the increments of the
particle’s velocity tends to a/2koAT(0 , 1), where W(0 , 1) represents a random normal distribution 
with mean 0 and variance 1.
The Fokker-Planck Equation
Neglecting the effects of advection, a Lagrangian velocity field for a particle under Brownian 
motion can now be constructed using the continuous random function representing particle 
velocity, giving
-^0*=  \ / ^ h ( £ ) .  (5.6)dt
It is assumed that the fii{t) have a normal distribution with mean 0, for z =  1, 2,3
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i.e. E{fLi{t)) = 0 (5 .9)
and E{ni{t)nj{t + f ) )  = ôijô{r), (5 .10)
where ôij is the Kronecker delta and <5(f) is the delta function. Equation (5.8) is a simple 
instance of the L angevin  eq u a tio n .
Although random molecular motion is the mechanism behind diffusion, it needs to be ascer­
tained th a t the stochastic process of Brownian motion is in fact representative of the process 
governed by the diffusion equation
(5.11)
The diffusion equation is a simple instance of the F o k k er-P lanck  equation, which has an 
interesting connection with the Langevin equation. It can be shown that the solution of the 
Fokker-Planck equation is the probability density function of the solution to the corresponding 
Langevin equation.
An appropriate and simplified example of the application of the general theory is to take 
the following as an instance of the Langevin equation
^  =  â (x ,î)n ( t) , (5.12)
where x(£) has m components, d(x, i) is a real M x n matrix and n{t) is a vector of n  random 
terms as described earlier.
The corresponding Fokker-Planck equation is then#4 ^^ (5.13)
where P  =  P (x , £) is a probability density function and âij — d(x, £)d^(x, £). The theory 
predicts tha t the P(x, £) is the probability density function of the solution to (5.12).
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5.3.2 G overning E quations
To derive the governing equations, we first take the case in a pipe where no flow is present. 
A slight change of variables is required from polar coordinates to cartesians. The cartesian 
coordinates describing a cross section of the pipe will be called Xi and X2 and the longitudinal 
coordinate Following the typical scales for non-dimensionalisation given in §4 this gives
1—  I  \---------U k ----
P e  1 a r r f  8 x 2 (5.14)
for the diffusion equation, where Pe  is the Péclet number and k is the reduced frequency, as 
before. If this equation were to be expressed in the form of the Fokker-Planck equation (5.13), 
this corresponds to the isotropic diffusion matrix
^ 1 0 0 ^
<7 (x, i) = ^ /2 i^
\
(5.15)
/
0 1 0 
0 0 1
From the corresponding Langevin equation (5.12), it can be seen that the Lagrangian equa­
tions of motion (in dimensionless coordinates X\^X2 and ^) become
dxi
dr
dx2
dr
dr
= \ / 2P e “ 2 m (r )
=  y / 2 P e ~ ^  712 ( r )
=  y/2Pe~^ k 713 (r).
(5.16)
(5.17)
(5.18)
To study the effect of advection and diffusion, the acoustic field is expressed in terms of 
cartesian coordinates and then a diffusion term simply added on. The governing equations then 
become
dxi
dr
dX2
dr
d^
dr
XiV
X2 V
•T V 2 P e  2 m { r )
+  \/2Pe~5 712(r)
(5.19)
u +  \ / 2P e “ 2 k 7i3(r).
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5.3.3 Solving th e S ystem
As w ith the equations modelling advection, the governing equations (5.19) were solved using 
DsTool. This time, a Fortran NAG routine generating a random normal distribution was used. 
The source code and function definitions are to be found in Appendix B. The information 
contained in Appendix A .l is essential for this system also.
5.3 .4  R esu lts
It is informative for results in certain ranges of the Péclet number to be compared with the 
particle trajectory considered w ithout diffusion. At a Péclet number of 1 it can be seen that 
the trajectory describes a rather ‘shaky’ version of figure 5.1.
The particle in figure 5.5 has started at ^ =  0.3 and re =  0.2, as did the particle in figure 5.1. 
It can be seen that the particle has deviated from the trajectory when diffusion is included. It 
must be remembered that in the examples with diffusion, the particle is also capable of moving 
across the tube, so a two-dimensional graph can never be fully representative. In figure 5.5 the 
particle is also going out away from or coming in towards us.
Over a cross-section of the tube, the same trajectory looks very different, see figure 5.6. 
Note th a t the cross-section appears to be elliptical due to an artifact in DsTool. The Péclet 
number is high enough in this example to still see little angular deviation of the trajectory. 
The introduction of diffusion brings an im portant influence into the transport of particles in 
acoustic flow. W ithout diffusion, a particle would perform tighter and tighter loops each period 
due to the effects of attenuation, but w ith the effect of diffusion, it has the opportunity to move 
into other areas of the pipe, where the attenuation will not affect it as much.
5.3.5 C onclusion
The Lagrangian analysis of an acoustic wave has given interesting results that were until now 
unknown. Under the influence of advection and diffusion, the particles demonstrate a definite 
drift, depending on where they are in the pipe. The values of the Womersley number and the 
Péclet number do strongly influence the flow in an quantitative fashion, although they do not 
change the qualitative characteristics. As expected, the higher the Péclet number, the more the
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F igu re 5.5: T ra jec to ry  for 5 =  1 and P e  =  5
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Figure 5.6: Trajectory over cross-section for s =  1 and Pe =  5
0.8
0.6
0.4
0.2
- 0.2
- 0.4
- 0.6
- 0.8
- 0.8 - 0.4- 0.6 - 0,2 0.2 0.4 0.6 0.8
X
86
Figure 5.7; Trajectory for section along the pipe for s — 1,1 and Pe = 1
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Figure 5.8: Trajectory over cross-section for s =  1.1 and Pe = 1
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F igu re  5.9: T ra jec to ry  for section along th e  p ipe for s  —  0.35 and  P e  =  0.1
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Figure 5.10: Trajectory over cross-section for s = 0.35 and Pe =  0.1
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trajectories represent those in acoustic flow of a perfect tracer. As the Péclet number decreases, 
the time taken for the particles to sample the cross-section is decreased. Although the k term 
limits this effect in an axial direction along the pipe, the dispersion appears to be enhanced.
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Chapter 6
Conclusions
This chapter brings together the work done in this thesis and summarises the findings. The 
results and their contribution to the understanding of ventilation is discussed as well as sug­
gestions for future work.
6.1 Sum m ary of R esults
A detailed discussion of the factors involved in neonatal ventilation is presented. An in depth 
review into Hyaline Membrane Disease and associated therapies is given to set the background 
to the problem. Time was spent on a neonatal intensive care unit in order to gather as much 
information as possible about the problem under investigation.
Experiments were performed with the SLE2000 ventilator. Previous experiments have 
looked into pressure wave shapes produced by such ventilators, whereas the experiments pre­
sented here investigate the wave speed and attenuation. The radius of tube being ventilated 
has a strong impact on the wave speed and amplitude. The wave was found to be travelling 
a t.a  higher speed than expected, leading to the conclusion that existing models of artificial 
ventilation are inappropriate for the SLE2000.
Our experiments have shown that an acoustic model gives a fairly good approximation to the 
wave produced by the ventilator. The mathematical model was based on an existing solution 
and then solved according to our boundary conditions. In this manner, the predicted results 
and experimental results could be compared. (A mathematical model of the wave produced by 
the SLE2000 has not been put forward until now).
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The transport properties of the flow were then studied. An effective diffusivity was deter­
mined which represents the extent to which the flow enhances dispersion. The flow is found 
to aid time-averaged dispersion of a passive solute. The result was compared to an analogous 
case for incompressible flow. In both cases the results suggest tha t at a fixed viscosity there is 
a frequency corresponding to each radius (and vice versa) that gives optimum transport over a 
period. In the incompressible case this relation has not previously been documented.
A Lagrangian analysis of the particle paths in acoustic flow was carried out. This has not 
been done until now. The particle paths for a non-diffusive tracer were found to have interesting 
consequences for transport, as Lagrangian drift gives a core flow in one direction with a flow 
in an opposite direction at the walls. It has been shown that even weak diffusion substantially 
modifies this process. The Péclet number and the Womersley number and their relation with 
each other were found to affect the transport greatly. Changes in parameters were found to 
affect the flow quantitively, but not qualitatively.
6.2 Im plications for V entilation
This thesis implies that for the SLE2000 (and possibly other jet ventilators) the effects of com­
pressibility are important. It has also been shown that for both compressible and incompressible 
flows, there is a Womersley number, s e (3,4) a t which transport is optimised (for fixed Pe] 
a t leading order. Our exact solution could be used to determine how to optimise transport 
through an airway of a given size, provided entrance effects are not important (see future work 
in §6.3). Our model predicts tha t the wall shear stress in an airway whose diameter is in the 
range 0.6 — 5.0mm will not be large.
6.3 Future Work
Suggestions for future work include experimental investigations and mathematical studies.
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6.3.1 Further E xperim ents
The significance of entrance effects needs to be investigated experimentally. Useful results can 
be obtained by ventilating tubes tha t have several pressure transducers embedded in the walls 
close to the entrance. The effects of airway branching and curvature can be investigated in a 
similar way.
Ventilating a very small-bore (<  SOO^ Lun) branched-tube lung model would provide data on 
the effect of small airways on the pressure square-wave. This would give an approximation as 
to how much of the steep pressure pulse remains when the wave enters lung regions made up 
of small diameter tubes.
6.3.2 M athem atical Investigations
The SLE2000 HFO sends out a pressure square-wave with the option of superimposing a high 
frequency sinusoidal oscillation. The effect of two such waves together would make an interesting 
mathematical study, as it is possible tha t two régimes are combined: steady stream ing and shear 
dispersion.
We have restricted our investigation to transport by linear acoustic waves in the Low Re­
duced Frequency régime. It may be useful to investigate the effects of nonlinearity or flows 
w ith large k upon transport.
An analysis including the contribution to attenuation from bulk viscosity is necessary to 
determine how important such effects are. The contribution to bulk viscosity from water 
molecules and oxygen molecules is particularly relevant in neonatal ventilation, because the 
respiratory gas is fully humidified and can contain a higher than normal concentration of oxygen.
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A ppendix  A
G enerating C om plex B essel Functions
This appendix contains information for compiling and linking with Fortran from Dstool and 
adding new libraries as well as the source code for the function definitions necessary to manip­
ulate complex numbers and generate Bessel functions of complex arguments.
A .l  Linking and Com piling w ith  Fortran
To instruct Dstool to compile and link with Fortran, a copy of the file lib _ in c l.m k  in the 
directory $ D s to o l/s i te _ s p e c if  ic  must be made, where $Dstool is a set environment. Note 
here tha t $D stoo l represents the directory for all users and D stool is the local user directory 
for one user. This copied file is then renamed l ib _ in c l_ lo c a l  .mk, for example, and placed in 
the local D stool directory in order to be included by the D stool M akefile and the M akefile 
in the models subdirectory. The D stool M akefile must be modified to include this new 
file, by commenting out the line “inc lu d e  $ D s to o l/s i te _ s p e c if ic / l ib _ in c l .m k ” and (not 
surprisingly) replacing it with the line “include  lib _ in c l_ lo c a l.m k ’. The D stool/m odels 
M akefile is similarly modified but the full pathname of the included file must be specified.
Changes are made to the compiling flags in D s to o l/ l ib _ in c l_ lo c a l  .rak according to the 
commented instructions contained w ithin the code. There were a couple of modifications that 
were necessary on our system: Firstly, the location described by the macro “FORTHOME”, repre­
senting the files necessary for Fortran compilation, was different to the template. Secondly, the 
essential linking command “-In ag ” needed to be added into the macro “LDLIBS” ; the order is 
imperative in that the added command must precede the command “$(F\_LIBS)” .
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These steps should ensure that NAG library functions can be called in any programs re­
quiring them.
A .2 A dding Libraries
The Dstool User’s Manual contains very clear instructions on how to include a user-defined 
dynamical system and it is assumed that these have been read. In a dynamical system requiring 
many function calls it is easy to generate large and complex files. The inclusion of user-defined 
function libraries much simplifies the whole procedure and is explained here. It is assumed also 
tha t ANSI C is being used, implying the use of a header file and having associated with each 
function a declaration statement and a function definition.
Once a function definition has been written, the file containing the source code can be listed 
under SOURCES.A in the M ak efile  in the m odels directory. The function declaration is then 
contained in a header file, which in this case has been named “M y.header .h ” . Subsequently, 
each user defined dynamical system must include this header file if it is going to use any of the 
user-defined functions.
A .3 C om plex Operations
Firstly, a complex structure and basic complex operations are defined. The Fortran NAG library 
routine S17DEF is then used to generate the Bessel functions. The declarations for all of the 
following functions must be included in a header file, which in this case is called ‘M y.header . h ’ . 
This header file must of course be included in any file calling any of the functions defined in 
this section. Complex operations were defined as our dynamical system of the velocity field 
in acoustic flow contains the real part of complex expression of complex Bessel functions. If 
Bessel functions alone of complex arguments are required, only the complex structure definition 
is necessary.
Firstly, a complex structure needs to be defined, this is accomplished by placing the following 
piece of code in the header file 'M y.header . h ’;
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y**********************************************************************************/
struct COMPLEX {
double r; /* real element */ 
double i; /* imaginary element */
};typedef struct COMPLEX complex;
/* defines a structure called ‘COMPLEX’ containing a real number and an 
imaginary number */
y**********************************************************************************y
All variables of the type complex are given a name prefixed by ‘cx_’. To initialise the complex 
variable cx_a, the real and imaginary elements in the structure are passed to c x .a .r  and c x .a . i  
respectively.
The following file ‘com plex.c’ contains the definitions for the functions Cadd, Csub, Cmul, Cdiv. 
Conjg, Csqrt, RCmul, Csin and Ceos. With the aid of these functions addition, subtraction, multi­
plication and division of complex numbers can be carried out. The conjugate, square root, sine and
cosine of a complex number can be found as well as the product of a real number and a complex
number. The following code is based on a subroutine given in ‘Numerical Recipes in C’. Any of these 
functions can be called once the following file is included in a library, the implementation of which is 
described in A.2.
"complex.c"
#include <math.h>
#include "My.header.h"
/* My.header.h contains the function decalarations */
complex Cadd(complex cx.a, complex cx.b) 
y* returns the sum of two complex numbers*/
{ complex cx.c; 
cx.c.r = cx.a.r + cx.b.r; 
cx.c.i = cx.a.i + cx.b.i; 
return cx.c;
>
complex Csub(complex cx.a, complex cx.b)
/* returns the complex difference of two complex numbers *y 
{ complex cx.c;
cx.c.r = cx.a.r - cx.b.r;
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cx.c.i = cx.a.i - cx.b.i; 
return cx.c;
complex Cmul(complex cx.a, complex cx.b)
/* returns the complex product of two complex numbers */ 
{ complex cx.c;
cx.c.r = cx.a.r * cx.b.r - cx.a.i * cx.b.i; 
cx.c.i = cx.a.i * cx.b.r + cx.a.r * cx.b.i; 
return cx.c;
complex Cdiv(complex cx.a, complex cx.b)
/* returns the complex quotient of two complex numbers (cx.a over cx.b) */ 
{ complex cx.c; 
double r, den;
if (fabs(cx.b.r) >= fabs(cx.b.i)) { 
r = cx.b.i / cx.b.r; 
den = cx.b.r + r * cx.b.i; 
cx.c.r = (cx.a.r + r * cx.a.i) / den; 
cx.c.i = (cx.a.i - r * cx.a.r) / den;
> else {
r = cx.b.r / cx.b.i;
den = cx.b.i + r * cx.b.r;
cx.c.r=(cx.a.r * r + cx.a.i) / den;
cx.c.i=(cx.a.i * r - cx.a.r) / den;
>return cx.c;
complex Conjg(complex cx.z)
/* returns the complex conjugate of a complex number */ 
{
complex cx.c; 
cx.c.r = cx.z.r; 
cx.c.i = -cx.z.i; 
return cx.c;
}
complex Csqrt(complex cx.z)
/* returns the square root of a complex number. */
{ complex cx.c; 
double x,y,w,r;
if ((cx.z.r == 0.0) && (cx.z.i == 0.0)) { 
cx.c.r = cx.c.i = 0.0; 
return cx.c;
} else i
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x=fabs(cx.z.r); 
y=fabs(cx.z,i); 
if (x >= y) {
r = y/x;
w = sqrt(x)*sqrt(0.5*(1.0+sqrt(1.0+r*r)));
} else {
r=x/y;
w=sqrt(y)*sqrt(0.5*(r+sqrt(1.0+r*r)));
}
if (cx.z.r >= 0.0) { 
cx.c.r = w;
cx.c.i = cx.z.i / (2.0*w);
} else {
cx.c.i = (cx.z.i >= 0) ? w; -w; 
cx.c.r = cx.z.i / (2.0 * cx.c.i);
}
}return cx.c;
complex RCmul(double x, complex cx.a)
/* returns the product of a real number and a complex number */ 
{ complex cx.c; 
cx.c.r = X * cx.a.r; 
cx.c.i = X * cx.a.i; 
return cx.c;
>
complex Csin(complex cx.a)
/* returns the sine of a complex number */
{ complex cx.b;
cx.b.r = sin( cx.a.r ) * cosh( cx.a.i );
cx.b.i = cos( cx.a.r ) * sinh( cx.a.i );
return cx.b;
}
complex Ccos( complex cx.a )
/* returns the cosine of a complex number */
{ complex cx.b;
cx.b.r = cos( cx.a.r ) * cosh( cx.a.i );
cx.b.i = -1.0 * sin( cx.a.r ) * sinh( cx.a.i );
return cx.b;
}
y********************************** END OF FILE
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A .4 B essel Functions
To generate Bessel function of complex arguments, the file ‘B essel, c’ is included in a library, 
the implementation of which is described in A.2. ‘B esse l, c ’ contains the function definitions 
of Jq{z), Ji{z) and J2 {z) and requires the definition of a complex structure described in A.3. In 
order for ‘B e s s e l.c ’ to work in Dstool, the program must be compiling in Fortran and linking 
to the Fortran NAG libraries, as described in appendix A .I.
The NAG library Fortran routine has particular parameters which need to be explained. 
Each of these parameters takes the same name in each of the following function definitions. 
The NAG routine is a general one, generating a series of Bessel functions in ascending order. 
Particularly relevant parameters are i.members, denoting the number of complex members in 
the series and d_order_f i r s t  describing the order of the Bessel function generating the first 
member of the series. As always, variables are passed by address in Fortran, requiring the use 
of pointers in the C program.
/ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * /  
#include <stdio.h>
#include "My.header.h"
y******************************* DEFINITION OF J_0(Z) ***************************y
complex BessJOcomp(complex cx.arg, complex *cx_zO)
/* cx.arg is the complex argument of the Bessel function */
/* cx_zO_ptr is a pointer to the complex variable J_0(cx_arg) *y 
{ static char c.scale = ’u ’;
int i.members, i.null.comps, ifail ;
double d.order.first, d„arr[2], d_result[2];
d.order.first = 0.0; 
d.arrfO] = cx.arg.r; 
d.arrCl] = cx.arg.i; 
i.members = 1 ; 
i.null.comps = 0; 
ifail = 0;
slTdef.(fed.order.first, d.arr, fei.members, &c.scale, d.result,
&i.null.comps, feifail);
y* calling Fortran routine */
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if (ifail != 0)
{ printf("BesselJ: slTdef failed; ifail = %g\n", ifail);
/* error message */
}
cx_zO->r = d.result [0]; /* real part of J.O(cx.arg) */
cx.zO->i = d.result[1]; /* imaginary part of J.O(cx.arg) */
}
/******************************* DEFINITION OF J_1(Z) ***************************/
complex BessJlcomp(complex cx.arg, complex *cx.zl.ptr)
/* cx.arg is the complex argument of the Bessel function */
/* cx.zl.ptr is a pointer to the complex variable J.l(cx.arg) +/
{ static char c.scale = ’u ’;
int i.members, i.null.comps, ifail ;
double d.order.first, d.arr[2], d.result[2];
d.order.first = 1.0; 
d.arr[0] = cx.arg.r; 
d.arr[1] = cx.arg.i; 
i.members = 1 ; 
i.null.comps = 0; 
ifail = 0;
sl7def_(&d_order.first, d.arr, fei.members, &c.scale, d.result,
fei.null.comps, feifail);
/* calling Fortran routine */
if (ifail != 0)
{ printf("BesselJ: sl7def failed; ifail = %g\n", ifail);
/* error message */
}
cx.zl.ptr->r = d.result[0]; /* real part of J.l(cx.arg) */
cx.zl.ptr->i = d.result[1]; /* imaginary part of J.l(cx.arg) */
y******************************* DEFINITION OF J.2(Z)
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complex BessJ2comp(complex cx.arg, complex *cx.z2.ptr)
/* cx.arg is the complex argument of the Bessel function */
/* cx.z2.ptr is a pointer to the complex variable J.2(cx.arg) */
{ static char c.scale = ’u ’;
int i.members, i.null.comps, ifail ;
double d.order.first, d.arr [2], d.result [2];
d.order.first = 2.0; 
d.arr[0] = cx.arg.r; 
d.arr[1] = cx.arg.i; 
i.members = 1; 
i.null.comps = 0; 
ifail = 0;
slTdef_(fed.order.first, d.arr, &i.members, fee.scale, d.result,
&i.null.comps, feifail);
/* calling Fortran routine */
if (ifail != 0)
{ printf("BesselJ: slTdef failed; ifail = %g\n", ifail);
/* error message */
}
cx_z2.ptr->r = d.result[0]; /* real part of J.2(cx.arg) */
cx.z2.ptr->i = d.result[1]; /* imaginary part of J.2(cx.arg) */
>y********************************** END OF FILE ***********************************y
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A ppendix B
Flow Source Code
This appendix contains the source code needed to generate the longitudinal and radial velocities 
of the ‘Low Reduced Frequency Solution with and without the effect of diffusion. It is assumed 
th a t the complex operation functions and Bessel functions defined in appendix A.4 can be 
successfully called.
B .l  A coustic Flow w ith  no Diffusion
The simplest way to define the flow variables u and v is to write two functions lo n g .f  low and 
r a d i a l . f  low each taking the appropriate flow parameters and flow variables as arguments. In 
order to define these two functions, another function p rop .func  representing the propagation 
function needs to be called by the routine. All three functions are defined in the file ‘flo w .o ’. 
u and V are then each called by a command one line long.
B .1 .1  Function  D efin itions
The parameters taken by prop .func, lo ng .flow  and r a d ia l .f lo w  represent the parameters 
and variables governing the physical flow. Consistent names have been given to each parameter 
and variable throughout the function definitions. Each parameter and variable is represented 
by the names given throughout §3 and §4, with Greek letters written in the phonetic English 
equivalent.
"flow,c"
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y**********************************************************************************/ 
#include <math..h> #include "My.header.h"
y ***************************** DEFINITION OF PROP.FUNC ****************************y
complex prop_func( double gamma, double sigma, double s, complex *result ) 
y* function definition of the propagation constant */
{ complex cx.a, cx.a.JO, cx_a_J2, cx.f.JO, cx_f.J2, cx.b, cx.c, cx.d, 
cx.e, cx.f, cx.g, cx.h, cx.i;
cx.a.r = (-1.0*sigma*s/sqrt(2.0)); 
cx.a.i = (sigma*s/sqrt(2.0));
BessJOcompCcx.a, fecx.a.JO);
BessJ2comp(cx.a, &cx.a.J2);
/* initialize a and find J_0(a) and J.2(a) */
cx.b = Cdiv(cx_a_J2, cx.a.JO);
/* find J.2(a) over J.O(a) */
cx.c = RCmul((gamma-1.0), cx.b);
cx.d.r = gamma; 
cx.d.i = 0.0;
cx.e = Cadd(cx_d, cx.c);
y* add gamma to (gamma-1) multiplied by J.2(a) over J.O(a) */
cx.f.r = (-1.0*s/sqrt(2.0)); 
cx.f.i = (s/sqrt(2.0));
BessJOcomp(cx.f,&cx.f_J0);
BessJ2comp(cx.f,&cx.f.J2) ;
/+ initialize f and find J.O(f) and J_2(f) */
cx.g = Cdiv(cx_f_JO, cx.f.J2); 
/* find J_2(f) over J.O(f) */
cx.h = CmuKcx.g, cx.e); 
^result = Csqrt(cx.h);
/+ result is complex Gamma */
y***************************** DEFINITION OF LONG.FLOW ****************************y
double long.flow(double gamma, double sigma, double s, complex B, 
double xi, double eta, double tau, double *result)
/* function definition for longitudinal flow */
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{ double d_exp;
complex cx.a, cx.a.JO, cx.b, cx.b.JO, cx.c, cx.d,
cx.e, cx.f, cx.g, C X . B ,  cx.Gamma, cx.terml, cx.term2, 
cx.termS, cx.term4, cx.terml.term2, cx.term3.term4, cx.whole;
cx.a.r = ((-1.0)*eta*s/sqrt(2.0)); 
cx.a.i = (eta*s/sqrt(2.0));
BessJOcorap(cx.a, fecx.a.JO);
/* initialize a, find J.O(a) */
cx.b.r = ((-1.0)*s/sqrt(2.0)); 
cx.b.i = (s/sqrt(2.0));
BessJOcomp(cx.b, fecx.b.JO);
/+ initialize b, find J.O(b) */
cx.c = Cdiv(cx.a.JO, cx.b.JO);
/* c is J.O(a) over J.O(b) */
cx.d.r = 1.0; 
cx.d.i = 0.0;
cx.terml = Csub(cx.d, cx.c);
/* subtract c from 1.0 */
y***************** TERM 1 ***************************************y
prop.func( gamma, sigma, s, fecx.Gamma) ;
cx.e.r = 0.0;
cx.e.i = ((1.0)/gamma);
cx.term2 = Cmul(cx.e, cx.Gamma);
/* find the propagation function and multiply by i/gamma */
y *****************  term 2 ***************************************y
C X . B  = RCmul((-1.0), B ) ; 
cx.f.r = cos(cx.Gamma.i*xi); 
cx.f.i = (-1.0)*sin(cx.Gamma.i*xi); 
d.exp = exp((-l.0)*cx_Gamma.r*xi); 
cx.g = RCmul(d.exp, cx.f); 
cx.termS = CmuKcx.B, cx.g);
/* exp(-Gamma*xi) terra split up into cosine, sine and exponential 
parts and multiplied by -B */
y***************** t erm 3 ***************************************y
cx.term4.r = cos(tau); 
cx.term4.i = sin(tau);
/* exp(i*tau) part */
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y***************** TERM 4 ***************************************y
cx_terml_term2 = Cmul(cx.terml, cx_term2); 
y********TERM 1 and TERM 2 multiplied ********y
cx_term3.term4 = Cmul(cx.termS, cx.term4); y********TERM 3 and TERM 4 multiplied ********y
cx.whole = Cmul(cx.terml_term2, cx.term3.term4); y******** whole complex expression ********y
*result = cx.whole.r;
/* real part */
}
y**************************** DEFINITION OF RADIAL.FLOW ***************************y
double radial.flow(double gamma double sigma, double s, complex B, 
double xi, double eta, double tau, double *result)
/* function for radial flow *y
{ double d.exp;
complex cx.a, cx.b, cx.c, cx.d, cx.f, cx.f.11, cx.g,
cx.g.JO, cx.h,ex.j, cx.k, cx.k.Jl, cx.l, cx.l.JO, cx.m, cx.n, 
cx.o, cx.p, cx.q, cx.r, cx.terml, cx.term2, cx.termS, cx.termA, 
cx.termB, cx.termC, cx.termD, cx.termA.termB, cx.termC.termD, 
cx.whole, cx.Gamma;
cx.a.r = (eta)/(2.0); 
cx.a.i = 0.0;
/* initialize a to eta/2 */
prop.func( gamma, sigma, s, fecx.Gamma);
/* find the propagation constant */
cx.b = Cmul(cx.Gamma, cx.Gamma);
cx.c.r = 1.0;
cx.c.i = 0.0;
cx.d = Cadd(cx_c, cx.b);
/* d is the propagation constant squared plus 1 */
cx.terml = Cmul(cx.a, cx.d);
/* e is eta/2 multiplied by d */
y ***********************TERM 1*******************************y
cx.f.r = ((-1.0)*sigma*eta*s/sqrt(2.0)); 
cx.f.i = (sigma+eta+s/sqrt(2.0));
BessJlcomp(cx.f, fecx.f.Jl);
/* initialize f and find J.l(f) */
cx.g.r = ((-1.0)*sigma*s/sqrt(2.0));
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cx.g.i = (sigma*s/sqrt(2.0));
BessJOcomp(cx_g, &cx_g_JO);
/* initialize g and find J_0(g) */
cx_h = Cdiv(cx_f_Jl, cx.g.JO);
/* J.l(f) over J_0(g) */
cx.j.r = (1-gamma)/(sigma*s+sqrt(2.0)); 
cx.j.i = (1-gamma)/(sigma*s*sqrt(2.0));
/* initialize j */
cx.term2 = CmuKcx.j, cx.h);
/* multiply j by J.l(f) over J.O(g) */
y* * * * * * * * * * * * * * * * 2 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * y
cx.k.r = ((-1.0)*eta*s/sqrt(2.0)); 
cx.k.i = (eta*s/sqrt(2.0));
BessJlcomp(cx.k, fecx.k.Jl);
/* initialize k, find J_l(k) */
cx.l.r = ((-1.0)*s/sqrt(2.0)); 
cx.l.i = (s/sqrt(2.0));
BessJOcomp(cx.l, fecx.l.JO);
/* initialize 1, find J.O(l) */
cx.m = Cdiv(cx.k.Jl, cx.l.JO);
/* J.l(k) over J.O(l) */
cx.n.r = (-1.0)/(s*sqrt(2.0)); 
cx.n.i = (-1.0)/(s*sqrt(2.0));
/* initialize n */
cx.r = Cmul(cx.b, cx.n);
/+ multiply the propagation function squared by n */ 
cx.termS = Cmul(cx.r, cx.m);
y***********************"%"ERM 3*******************************y
cx.o = Cadd(cx.terml, cx.term2); 
cx.termB = Csub(cx„o, cx.termS);
/* termB is terml, plus term2, minus termS */
y***********************XERM B*******************************y
cx.termA.r = 0.0; 
cx.termA.i = (-1.0)/gamma;
/* termA is -i/gamma */ •
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f * * * * * * * * * * * * * * * * * * * * * * * T E R M  A * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * /
cx.p.r = cos(cx_Gajmna.i*xi) ; 
cx.p.i = (-1.0)*sin(cx_Gamma.i*xi); 
d.exp = exp((-l.0)*cx.Gamma.r*xi); 
cx.q = RCmul(d.exp, cx.p); 
cx.termC = Cmul(B, cx.q);
/+ exp(-Gamma*xi) term split up into cosine, sine and exponential 
parts and multiplied by -B */
/***********************1’ERM C*******************************/
cx.termD.r = cos(tau); 
cx.termD.i = sin(tau);
/* exp(i*tau) */
cx.termA.termB = Cmul(cx.termA, cx.termB);
/* termA multiplied by termB */
cx.termC.termD = Cmul(cx.termC, cx.termD);
/* termC multiplied by termC */
cx.whole = Cmul(cx.termA.termB, cx.termC.termD);
/* whole complex expression */
*result = cx.whole.r;
/+ real part and result */
y********************************** end of file ***********************************y
B . l . 2  D sto o l Source C ode
The function definitions are implemented easily into the Dstool system definition. Dstool 
requires tha t to define a differential equation, expressions must be given to an array f [ j ] ,  
representing the ^  of a system of dimension y. The dependent variables are represented by 
the array x [ j ]  and the independent variable is the (y element of x. The parameters of
the system are declared to an array p.
For the program defining the velocity field of the acoustic flow the following values have been 
taken for the predefined arrays f , x and p. f  [0] =  27t ^ ,  f  [ 1 ]  =  S t t ^ ,  x [ 0 ]  =  x [ l]  =  /?, 
x[2] =  p[0] =  s, p [ l ]  =  and p[2] =  ^ { B } .  Recall that arrays in C are indexed
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from  0.
\ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * j
int Acoustic(f,x,p) 
double *f,*x,*p;
{
if (x[0]>=0) {
double gamma, sigma, long.result, radial.result ; 
complex B; 
gamma = 1.401; 
sigma = 0.72;
B.r = pCl] ;
B.i = p[2] ;
long_flow( gamma, sigma, p[0], B, x[0], x[l], TW0PI*x[2],
&long_result);
radial.f low (gamma, sigma, p[0], B, x[0], x[l], TW0PI*x[2],
feradial.result);
f [0] = TWOPI*long_result; 
f [1] = TWOPI*radial_result;
}
X [2] is r  rescaled by a factor of 27t, s o  that the period of oscillation becomes 1; this facilitates 
the plotting of the acoustic flow in Dstool.
B .2 A coustic Flow w ith  Diffusion
To define the system representing the Lagrangian flow field for acoustic flow with the effects of 
diffusion, a function needs to be introduced that represents Gaussian white noise. The Fortran 
NAG library contains a function that does this, called routine G05FDF. G05FDF is called by a 
function tha t we have defined named w h ite .n o ise . w h ite .n o ise  generates an array of three 
random numbers, the components of which are then introduced into the system describing the 
velocity field.
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B .2 .1  F unction  D efin ition
The routine G05FDF must be passed parameters describing the mean and variance of a random 
Gaussian distribution, in the following code these are represented *mean_ptr and *v ar_ p tr 
respectively.
‘white.noise.c’/**********************************************************************************/ 
#include <math.h>
#include "My.header.h"
double white.noise ( double *mean.ptr, double *var.ptr, double result[3])
/* function definition of the ‘white noise’ generator */
{ int i.n;
double gOSfdf.O; 
i.n = 3;
g05fdf.(mean.ptr, var.ptr, &i_n, result);
}
y********************************** END OF FILE ***********************************y
B .2 . 2  D sto o l Source C ode
This subroutine needs to be able to have access to ‘com p lex .c’, ‘B e s s e l.c ’ and ‘flo w .o ’. The 
velocity is expressed in cartesian coordinates with x[0], xCl] and x[2] representing the 
horizontal coordinate Xi and the vertical coordinate X2 respectively. Subsequently, f  [0], f  [1] 
and f  [2] represent ^  and The parameter p[0] represents s, p [ l]  and p[2] represent 
the real and imaginary parts of B,  p[3] represents the Péclet number and p[4] is the reduced 
frequency k.
‘Diffusion.flow.def.c’y**********************************************************************************y 
#include <model.headers.h>
#include "My.header.h"
int Diffusion.flow(f,x,p)
double *f,*x,*p;
{ if ( x[0] > 0 ) {
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/* xi must positive */
double gamma, sigma, eta, long.result, radial.result, 
cart.result, mean, var, ran[3] ;
complex B;
gamma = 1.401; 
sigma = 0.72;
B.r = p[l] ;
B.i = p[2] ;
eta = sqrt(x[l]*x[l] + x[2]+x[2]);
/* initialize acoustic flow variables */
mean = 0.0; 
var = 1.0;
/* initialize white noise parameters */
long.flow( gamma, sigma, pCO], B, x[0], eta,
TW0PI*x[3], felong.result);
radial.flow( gamma, sigma, p[0], B, x[0], eta,
TW0PI*x[3], feradial.result); 
white.noise! femean, fevar, ran);
/* random function generating white noise 3-D array +/
cart.result = radial.result/eta;
/* cartesians */
if ((0.9 < (x[1] +x[1] +x[2] *x[2] ) ) fefe ((xCl]*x[l]+x[2]*x[2]) 
<= 1 . 0))  {
/* if particle is near wall*/
f [0] = TWOPI*(long.result + 
p [4]/(sqrt(2.0*TWGPI*p[3]))*ran[0]));
f[l] = TWOPI*(x[l]*cart.result +
1.0/(sqrt (2 . 0*TW0PI*p[3] ) )*(x[l] *x [l]+x[2] *x[2] ) ) * 
(-1.0*x[l] *f abs(ran[l] *x[l]+ran[2] *x[2] )
- X [2] * (ran [2] *x [1] -ran [1] *x [2] ) ) ) ;
f [2] = TWOPI*(x[2]*cart.result +
1.0/(sqrt (2 .0*TW0PI*p[3] ) )*(x[1] *x[1] +x[2]*x[2])) * 
(-1.0*x[2] +f abs(ran[l] *x[l]+ran[2] *x[2] )
+ X [1] * (ran [2] *x [1] -ran [1] *x [2] )));
else if ( (x[l]*x[l]+x[2]*x[2] ) <= 0.9) {
/* if particle not near wall */
f [0] = TWOPI*(long.result +
p[4]/(sqrt(2.0*TW0PI*p[3]))*ran[0]);
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f[l] = TWOPI* (x [1] *cart .result + 
1.0/(sqrt(2.0*TW0PI*p[33))*ran[l]);
f[2] = TWOPI*(x[2]*cart_result + 
1.0/(sqrt(2.0*TW0PI*p[3]))*ran[2]);
y********************************** END OF FILE ***********************************y
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A ppendix C
A Com parison of Conventional 
M echanical V entilation and H igh  
Frequency V entilation in the Treatm ent 
o f H yaline M em brane D isease
C .l Introduction
When a very premature infant is born it may not be fully adapted to live in our environment. 
The kidneys, digestive system, systemic circulation and the lungs may not be fully developed. 
In a special care baby unit one of the main aims is to support the neonate so that growth and 
development can take place.
From week 25 of gestation until birth, the airway generations down to the last prospective 
respiratory bronchioles are present. Attached to these bronchioles are a bunch of irregularly 
shaped saccules. These saccules grow and divide to form transitory ducts and saccules. With 
alveolarisation the transitory ducts and saccules finally turn into alveolar ducts and alveolar 
sacs. Alveolar formation starts as early as week 36 of gestation and continues postnatally.
If the lungs are not fully developed it is possible tha t the neonate will be suffering from 
respiratory distress. Respiratory distress syndrome is the major cause of mortality in preterm 
infants. More neonates are now surviving due to use of assisted ventilation and surfactant
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therapy. Since the advent of the use of assisted ventilation there has been an increase in the 
incidence of lung disease in neonates. It has been suggested that a form of lung disease, BPD, 
represents a late repair stage of severe respiratory distress syndrome in infants tha t would have 
otherwise died.
The aim of assisted ventilation of the premature neonate is to support the respiratory system 
while the infant develops and to minimise any side effects due to this intervention. There are two 
main categories of artificial ventilation, conventional mechanical ventilation and high frequency 
ventilation. It is my task to compare the effectiveness of these two types of ventilation when 
used in the treatm ent of one of the major causes of respiratory distress, hyaline membrane 
disease.
C .1 . 1  R espiratory D istress Syndrom e
Susceptibility to the respiratory distress syndrome (RDS) increases as gestational age decreases 
and is believed to be related to the state of lung maturity. It occurs commonly in infants of 
less than 36 weeks gestation and is observed in 10% of all premature infants, with the greatest 
incidence (60%) in those weighing less than 1500g Morley (1960).
The symptoms are such tha t the neonate experiences great difficulty in breathing. The usual 
signs of RDS are tachypnoea (raised respiratory rate), an expiratory grunt, cyanosis and sternal 
and subcostal chest wall recession. The muscular effort of breathing can become so great that 
respiratory failure eventually follows. Artificial ventilation is then needed to maintain oxygen 
levels and to remove excess carbon dioxide.
C . l . 2  H yaline M em brane D isease
Hyaline membrane disease (HMD) is the cause of RDS in around 80% of cases. In HMD hyaline 
membranes line the terminal bronchioles and alveoli of the affected lung. The lined air spaces 
are surrounded by extensive areas of lung collapse (atelectasis). This condition is believed to 
be due to a deficiency of pulmonary surfactant.
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C .1.3 Surfactant
Pulmonary surfactant forms a liquid film that lines the alveoli. It lowers the surface tension 
of the alveolar lining fluid and increases the compliance of the lung. This reduces the work of 
breathing w ith each breath. In the case of surfactant deficiency, higher than normal pressures 
are needed to inflate the lung. Smaller alveoli tend to collapse at the end of expiration w ithout 
pulmonary surfactant, requiring a ‘re-expansion’ pressure to reverse the atelectasis. As sur­
face tension is inversely proportional to radius, it can be seen that the comparative smallness 
of a preterm infant’s airways combined with surfactant deficiency leads to severe respiratory 
problems. Consequently, lungs with low compliance (stiff lungs) and areas of atelectasis are 
characteristic of hyaline membrane disease.
C.2 Artificial V entilation
Artificial ventilation provides a flux to enable O2 to get in to the lungs and CO2 to get out. Gas 
exchange occurs only in the alveoli. Therefore the expiratory tidal volume of the lung is made 
up of two parts, the alveolar space and the dead space. The dead space is the total volume of 
conducting airways tha t do not take part in gas exchange. In normal breathing the dead space 
is much less than the alveolar space. Therefore, it was believed that gas exchange took place 
mainly by bulk convection. Animal experiments have shown that at high frequencies adequate 
ventilation is possible with tidal volumes less than the dead space. This implies tha t other gas 
transport mechanisms apart from bulk convection are at work.
C .2.1 C onventional M echanical V entilation
Conventional mechanical ventilation refers to a type of assisted ventilation tha t is close to our 
normal pattern of breathing. CMV uses a similar respiratory rate and tidal volume as the 
individual. The mean airway pressure (MAP) generated by CMV is higher than tha t generated 
by spontaneous breathing. This is because the pressure gradient necessary for spontaneous 
inspiration is produced by a subatmospheric intrapulmonary pressure (caused by an increase 
in lung volume). W ith CMV this pressure gradient is created by increasing the pressure at 
the mouth to above atmospheric. As a result, the intrapulmonary pressure does not go below
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atmospheric, even at the end of expiration. This is referred to as positive end expiratory 
pressure (PEEP).
CMV is also known as positive pressure ventilation (PPV) or interm ittent positive pressure 
ventilation (IPPV). The application of these higher than normal mean pressures increases the 
possibility of lung injury (pulmonary barotraum a), this will be discussed later.
CMV is a general term encompassing many different modes of ventilation. As well as positive 
pressure ventilation, there is negative pressure ventilation, where the patient is enclosed to the 
neck in an airtight chamber. Air is pumped out of the chamber to lower pressure and to perm it 
inspiration. Expiration takes place when air is allowed to flow into the chamber again.
Positive pressure ventilation itself has many variations, most of which are involved in the 
weaning process. This is a process designed to decrease the patient’s dependency on assisted 
ventilation. The following are variations of positive pressure ventilation:
• Interm ittent mandatory ventilation (IMV)
IMV allows the patient to take spontaneous breaths between artificial breaths.
• Patient triggered ventilation (PTV )
PTV enables the patient to initiate a breath. The ventilator then responds and takes
over.
• Synchronised interm ittent mandatory ventilation(SIM V)
This is a strategy combining PTV and IMV.
• Continuous positive airway pressure (CPAP)
CPAP is the application of PEEP to a spontaneously breathing patient.
The aim of this discussion is not to compare the different types of conventional mechanical 
ventilation with each other, but to compare continuous mandatory ventilation with high fre­
quency ventilation. In the medical literature, continuous mandatory ventilation is sometimes 
referred to as conventional mechanical ventilation. I will be using CMV to describe continuous 
mandatory ventilation.
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c .2 .2 H igh Frequency V entilation
Froese and Bryan (1987) suggest that HFV describes assisted ventilation operating at a fre­
quency of at least 4 times the natural breathing frequency of the patient. HFV can be applied 
either internally and externally. Internally applied HFV can be divided into four main cate­
gories:
• High frequency positive pressure ventilation (H FPPV )
HFPPV is CMV operated at frequencies of the order of 60-200 breaths per minute.
• High frequency oscillation (HFO)
HFO uses reciprocating pumps of a piston, diaphragm or bellows to generate an ap­
proximately sinusoidal pressure waveform. Cas is both actively driven into the lung and 
actively withdrawn by the pump-stroke. HFO is operated at 60- 3000 breaths per minute.
• High frequency jet ventilation (HFJV)
This consists of the interm ittent delivery of a je t of gas through a small-bore cannula 
positioned in the airway. Expiratory flow is driven by passive recoil of the lung and chest 
wall. Recoil is the tendency of the lung and chest wall to return to the position occupied 
at the beginning of inspiration. HFJV is commonly operated at frequencies of around 
100-200 breaths per minute, although higher frequencies have been explored.
• High frequency flow interrupter (HFFI or HIFI)
High frequency flow interrupts are related to high frequency jet ventilators. These contain 
a mechanism that chops gas from a high pressure source into pulses.
C .2.3  C ontrol o f V entilation
Most neonatal ventilators are pressure-cycled. Pressure cycling terminates inspiration when 
a particular mouth pressure is achieved. This does not guarantee a particular tidal volume. 
The tidal volumes used in neonatal ventilation are extremely small and are difficult to measure 
accurately. This inaccuracy arises due to the size of the tidal volume compared to the total 
dead space volume generated by the ventilator circuit. Because of the comparatively larger
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tidal volumes involved, adult ventilators tend to be volume cycled. Volume cycling term inates 
inspiration when a preset volume has been delivered.
C.3 D escription of Com plications
The use of assisted ventilation is associated w ith many undesirable complications, both acute 
and chronic. Acute complications include pneumothorax, pneumomediastinum and pneu­
moperitoneum, whereas bronchopulmonary dysplasia is a progressive, chronic, lung disease. 
Many of the trials comparing types of ventilation tend to look at the incidences of complica­
tions for their conclusions. This may not be a reliable indicator for the patient’s neuromus­
cular development later in life. For example, periventricular leukomalacia and intraventricular 
haemorrhage can both lead to permanent cerebral damage although this is not easily detected 
immediately in the neonate.
C .3.1 E xtraneous Air Syndrom es (Air Leaks)
Extraneous air syndromes are a group of clinically recognisable disorders produced by alveolar 
rupture. Air subsequently escapes into tissue in which it is not usually present. Air leak 
syndrome constitutes the most frequent life-threatening complication of assisted ventilation. I 
will briefly outline three of these syndromes; pulmonary interstitial emphysema, pneumothorax 
and pneumoperitoneum:
• Pulm onary interstitial emphysema
Pulmonary interstitial emphysema (PIE) results from air accumulating in the interstitium 
(the space between alveolar sacs). Oxygen requirement increases and carbon dioxide 
retention occurs. PIE frequently progresses to pneumothorax.
• Pneum othorax
Pneumothorax during assisted ventilation is common. It occurs when air enters the pleural 
space. The lung on the damaged side collapses and pressure in the pleural space becomes 
positive. Hypoxia, cyanosis and displacement of the heart away from the affected side 
can result.
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• Pneum operitoneum
Pneumoperitoneum is caused by air m igrating through the diaphragm and accumulating 
in the peritoneum (the sac lining the abdominal cavity).
C .3 .2 Gas Trapping
Gas trapp ing or inadvertent PEEP occurs when a larger volume of gas gets into the lungs 
than gets back out. An increase in intrapulmonary pressure and lung volume ensues, possibly 
leading to reduced cardiac output and air leaks. Gas trapping may happen if the inspiratory 
time is longer than the time allowed for exhalation (referred to as an inverse I;E ratio). The 
lung compliance and airway resistance influence the time taken to exhale by passive recoil 
(decreased compliance is generally associated w ith a shorter exhalation time). The condition 
of the patient’s lungs combined with the I:E ratio determines whether gas trapping will occur.
C .3 .3 B ronchoalveolar H aem orrhage
Bronchoalveolar haemorrhages are lesions occurring at the junction between the bronchiolar 
wall and adjoining alveoli. As the lesion progresses, rupture of blood into the adjoining alveolar 
spaces occurs.
C .3 .4 Periventricular Leukom alacia
Periventricular leukomalacia (PVL) is a cerebral ischaemic lesion (a lesion in the brain caused 
by local anaemia due to arterial narrowing of the blood supply). The arterial narrowing may 
have happened before birth or be linked to post-natal events. These events could include 
air leaks, respiratory distress syndrome and the use of artificial ventilation. High pulmonary 
pressures impede venous return to the heart by constricting blood vessels. Cardiac output is 
reduced and ischaemic damage to the brain may follow.
C .3 .5 Intraventricular H aem orrhage
Intraventricular or intracranial haemorrhage (IVH) is the rupture of blood vessels causing bleed­
ing into the brain. It is hypothesised tha t a sudden increase in systemic blood pressure causes
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IVH. It rarely occurs prenatally and is associated with assisted ventilation, pneumothorax and 
any other event in which acute changes in intra-vascular pressure occur.
C .3 . 6  B ronchopulm onary D ysp lasia
Bronchopulmonary dysplasia (BPD) has a variable definition depending on whether patholog­
ical or clinical characteristics are used. Pathologists may observe changes due to BPD at 3-4 
days of age. Clinicians may diagnose BPD in oxygen dependent infants requiring mechanical 
ventilation beyond 28 days of age. A more recent definition of BPD takes into account the 
increased survival rate of very premature babies. This diagnosis is made if the infant is oxygen 
dependent and requires mechanical ventilation at 36 weeks of age if born more than 8 weeks 
early. BPD progression can be separated into four stages:
• Stage I (mild)
At 2-3 days the clinical and radiological features are identical to those of HMD.
• Stage II (moderate)
From 4-10 days there are increased oxygen requirements. Increasing ventilatory support 
is needed when recovery is expected. There are fewer hyaline membranes and necrosis of 
alveolar epithelium (death of cells lining the alveoli).
• Stage III (severe)
From 10 to 20 days there is prolonged oxygen dependency. There is extensive alveolar 
collapse and interstitial fibrosis (hardening of lung tissue).
• Stage III (advanced-chronic)
At one month BPD has become chronic lung disease. Severe bronchiolar metaplasia 
(change in cell structure) occurs and the lungs become hyper-inflated. Pulmonary hyper­
tension (high blood pressure in the pulmonary circulation), patent ductus arteriosis and 
fibrosis of the outer coat of arteries and arterioles are all characteristics of this stage of 
BPD.
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Factors thought to be involved in the incidence of BPD are prematurity, oxygen toxicity, baro­
traum a and artificial ventilation.
C.4 Strategy
It cannot be stated that one mode of ventilation is better than another. There are no stan­
dardised settings for pressure, respiratory rate or I:E ratios. In a clinical environment, initial 
settings are advised by the protocol. These settings are then adjusted, as necessary, to optimise 
the partial pressures of oxygen and carbon dioxide in the patient’s blood. When using CMV, 
the priority is to use the lowest peak and mean airway pressures required to reduce pulmonary 
barotraum a and support gas exchange. This is a low pressure approach. The aim of many 
studies of HFV is to justify the use of either a high pressure or low pressure strategy. A high 
pressure (or high volume) strategy gives the achievement of volume recruitment a higher pri­
ority than the minimisation of applied pressure. The following are widely used ranges of CMV 
ventilator settings for neonates:
•  Respiratory rate 20-40 breaths per minute
• Peak inspiratory pressure (PIP) 2-2.4 kPa
• Peak end expiratory pressure (PEEP) 0.2-0.5 kPa
• Inspiratory duration 0.3-1.0 second
• Tidal volume 10-15 mlkg~^
There are no such ‘standard’ settings for high frequency ventilation. In clinic, high frequency 
ventilation settings are determined empirically.
C .4.1 Lung Volum e
The aim of alveolar expansion or volume recruitment is to establish an adequate lung volume 
to support gas exchange and reduce shunting. In this context, shunting refers to blood that 
enters the arterial system w ithout going through ventilated areas of lung. Volume recruitment
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only occurs when the lung is inflated above its closing capacity (the sum of closing volume 
and residual volume). A characteristic of the lung is that intrapulmonary pressure at any 
given volume is always higher during inspiration than during expiration. This behaviour is 
called hysteresis. Hysteresis implies tha t there are two pressures associated with the closing 
capacity. These pressures are referred to as the opening pressure and the closing pressure. The 
opening pressure is the pressure at which atelectatic lung begins to open on inflation. Volume 
recruitment will then only be maintained as long as the pressure is kept above closing pressure. 
This is the pressure below which alveoli and airways start to close on exhalation. The opening 
pressure is higher than the closing pressure.
C .4 . 2  Sustained Inflations
A high pressure strategy usually involves volume recruitment manoeuvres. A sustained inflation 
( SI or SIGH ) is a type of volume recruitment manoeuvre. A sustained inflation usually involves 
a period of increased mean airway pressure either static, pulsatile or in the form of conventional 
breaths. There are no standardised ways of giving sustained inflations.
C.5 Hum an and Anim al Studies
The studies tha t I have reviewed are mostly concerned with the use of HFO in comparison 
with CMV in the treatm ent of hyaline membrane disease. The following discussion is mainly 
concentrated on finding an appropriate strategy in the use of HFO.
C .5.1 V olum e and P ressure A pproach
Originally, it was thought that the main advantage of HFO would be the use of decreased mean 
airway pressures. Subsequently, it was speculated tha t a low volume, low pressure approach 
w ith HFO would decrease the risk of barotraum a and air-leaks.
Thompson et al. (1982) compared the relationship between oxygenation and mean airway 
pressure in HFO and CMV in a model of pulmonary injury. They induced haemorrhagic pul­
monary oedema in anaesthetised, adult, beagle dogs. Thompson et al. found that oxygenation
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during HFO depended on mean airway pressure in the same way as CMV. This implies that a 
low pressure strategy could result in a deterioration of oxygenation.
McCulloch et al. (1988) compared a high volume HFO strategy (HFO-HI), a low volume 
strategy (HFO-LO) and CMV in a study on surfactant deficient rabbits. A high volume CMV 
group was not possible as fatal barotraum a ended all such attempts.
The HFO-HI group were found to have a significantly lower incidence of lung injury than 
the HFO-LO and CMV groups. There was no difference in the incidence of hyaline membrane 
formation between the HFO-HI group and the control groups. In the HFO-LO rabbits, at­
electasis was on-going. The application of HFO-LO to an already atelectatic lung produced 
bronchiolar epithelial lesions. The iinibronchiolar epithelial injury in the HFO-LO group was 
not as severe as in the CMV group.
McCulloch et al. suggested that recruited lung volume was lost and extensive damage 
caused by the large pressure and volume cycles associated with CMV. This is because the 
closing pressure of the alveoli was higher than the applied PEEP. If the PEEP in CMV had 
been increased above the closing pressure, dangerously high PIP levels would have been needed.
McCulloch et al. concluded tha t in a lung prone to atelectasis HFO prevents the develop­
ment of additional structural injury only when applied to a re-expanded lung. In their model, 
McCulloch et al. achieved alveolar expansion by deliberate volume recruitment manoeuvres.
The most cited clinical trial using a low pressure, low volume approach in HFOV is the HiFi 
Study Trial, Hi-Fi Study Croup (1989). The HiFi Study Croup concluded tha t HFOV does 
not offer any advantage over CMV in the treatment of respiratory failure in preterm infants 
and is possibly associated with undesirable side effects.
In the HiFi trial, a higher priority was given to minimising mean airway pressure than to 
achieving alveolar expansion with HFOV. The protocol specified using the same initial mean 
airway pressure settings for HFO as for CMV. Bryan (1989) states tha t such a use of low 
pressures in HFO is not effective in a lung with acute atelectasis (a lung affected by HMD). To 
be effective HFOV must briefly exceed opening pressures.
Clark et al. (1992) used a different pressure strategy with HFO when comparing it with 
CMV in the management of neonatal RDS. For the first 72 hours after birth a high mean airway 
pressure was used with HFO to optimise oxygenation and promote alveolar recruitment. By
121
96 hours, oxygenation had usually improved and priority was given to minimising mean airway 
pressure. Clark et al. concluded tha t when using this pressure strategy HFO is as safe as CMV 
in the management of neonatal hyaline membrane disease.
From the above data we can conclude tha t HFOV is associated with less lung injury than 
CMV when used with an appropriate pressure strategy. The large pressure swings of CMV 
cause epithelial injury to an atelectatic lung because the applied PEEP is below the closing 
pressure. A low pressure HFO strategy causes lung injury but not to the same extent as CMV. 
The cyclic pressure swings of a low pressure HFO strategy cause epithelial injury when applied 
to what is effectively a lung with on-going atelectasis. A high pressure HFO strategy involves 
cyclic pressure swings applied to a lung tha t is inflated past its closing volume. This is thought 
to reverse atelectasis.
Note tha t if HFO is started after CMV has been used previously it is not sufficient to 
continue w ith the same mean airway pressures. If the same mean airway pressures are used, 
this constitutes a low pressure HFO strategy.
C .5 .2 V olum e R ecru itm ent and Sustained Inflations
McCulloch et al. stated that a HFO high volume approach cannot be effective w ithout the 
use of sustained inflations. Ogawa et al. and Clark et al. did not use sustained inflation in 
their clinical trials. However, all concluded that HFO was as safe as CMV in the treatm ent of 
respiratory failure.
Volume recruitment manoeuvres were used in the Ogawa and Clark trials. Ogawa et al. 
used manual ventilation to fully inflate the lungs just before starting ventilation. Clark et al. 
used mean airway pressures high enough to maximise oxygenation as soon as ventilation was 
started . Both manoeuvres were designed to achieve alveolar expansion.
McCulloch et al. used pulsatile SPs to promote alveolar expansion in surfactant deficient 
rabbits. A pulsatile sustained inflation was created by using HFO at a very high pressure 
( 30cmH2O ) for 15 seconds. This was repeated each time the Pa02  fell below a certain level.
W hether S i’s or volume recruitment manoeuvres are used, alveolar expansion remains the 
priority. This was overlooked in the HiFi trial. Bryan and Froese (1991) suggested tha t the 
Si’s used in the HiFi trial were not effective. It is possible that in a low pressure strategy the
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intrapulmonary pressure returned to after a SI would not be above closing pressure. Therefore 
volume recruitment would not be achieved.
The above data implies that, to be effective, HFOV must combine a high pressure strategy 
with manoeuvres designed to achieve alveolar expansion. There are many different methods 
of achieving alveolar expansion. One method is to perform a volume recruitment manoeu­
vre immediately after intubation. Lung volume is then gradually increased until a particular 
Pa02  value is reached. This lung volume is then maintained until there is an improvement in 
oxygenation. The other method of achieving alveolar expansion is to use sustained inflations 
throughout the period of ventilation w ith HFO. Usually a sustained inflation is given until 
an improvement in oxygenation is seen. There are many different ways of giving sustained 
inflations, some of which are more effective than others.
W hatever method is chosen to achieve volume recruitment the principle is the same. If 
the lung is inflated to a high pressure and time allowed for volume recruitment and then the 
pressure reduced, lung volume will follow the deflation curve of the hysteresis loop. This results 
in the lung containing more volume for a given pressure than it would had a volume recruitment 
manoeuvre not been performed. This is only beneficial if pressure is kept above the closing 
pressure after the volume recruitment manoeuvre.
C .5 .3 H igh  Frequency O scillation-R escue Treatm ent or Im m ediate  
T reatm ent?
DeLemos et al. compared two HFOV strategies with CMV in the treatm ent of hyaline mem­
brane disease in premature baboons. There were three treatment groups. The HFO-E (early) 
group had HFOV assigned to them immediately after birth. The HFO-L (late) group had 
3 hours of CMV immediately after birth before being assigned to HFOV. The CMV group 
received CMV only from birth.
A slightly different approach was used in each treatm ent group. The HFO-E group received 
a volume recruitment manoeuvre immediately after intubation but received no sustained in­
flations during treatment. The HFO-L group received sustained inflations throughout their 
treatment. Sustained inflations were needed because HFO-L was started at the same mean 
airway pressure as the preceding CMV. Treatment in all groups was then designed to give pri­
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ority to the maintenance of a constant Pa02  level. Mean airway pressures in each group were 
adjusted accordingly.
Mean airway pressures in CMV had to be progressively increased to support the required 
level of oxygenation. At the end of the study, both HFO groups had better oxygenation than 
the CMV group at lower mean airway pressures.
DeLemos et al. found that all of the CMV group had evidence of HMD. The lungs of the 
CMV group were found to have diffuse saccular atelectasis with dilatation of distal conducting 
airways. The lungs of the HFO-E group did not have the classic findings of HMD. The lungs had 
minimal airway dilatation and uniform saccular opening. The effect of HFO-L was intermediate 
between th a t of CMV and HFO-E. HFO-L was not found to alter the progression of HMD, 
unlike HFO-E.
DeLemos et al. concluded th a t when HFOV is initiated at birth w ith a high mean airway 
pressure it prevents the clinical morphological evolution of HMD. Short periods of spontaneous 
breathing or CMV results in progressive changes which are not reversed by HFOV. Coalson and 
deLemos (1989) also confirmed tha t immediate application of HFOV at a high mean airway 
pressure alters the course of HMD in premature baboons. Salle et al. (1993) stated th a t HFO is 
most effective in treating neonatal hyaline membrane disease when started as soon as possible 
after birth.
Bryan and Froese observed th a t in the laboratory it is difficult to achieve alveolar expansion 
after extensive exposure to CMV. In the HiFi Study Trial, all infants assigned to HFO had 
previously received up to 12 hours of CMV. Bryan and Froese note tha t in the HiFi trial any 
adverse outcome due to previous exposure to CMV was attributed to HFOV. We can begin to 
see why the HiFi Study Group concluded tha t HFO offered no advantages over CMV.
C .5 .4 H FO -Short Term  or Long Term  Treatm ent?
In their clinical trial, Clark et al. compared two HFO strategies. One group of premature 
neonates received HFO only, another group received 72 hours of HFOV followed by CMV. 
Clark et al. had expected that the major benefit of the use of HFO would have been early in 
the course of RDS and tha t early transfer to CMV would accelerate the weaning process. On 
the contrary, Clark et al. concluded tha t a short period of HFO does not provide the same
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advantages as continuous HFO. Their results suggest tha t the interaction between CMV and 
lung injury persists beyond the early phase of HMD.
C .5 .5 H ysteresis and C om pliance
McCulloch et al found that a high pressure HFO strategy did not affect the hysteresis or 
compliance of the lung when used to treat surfactant deficient rabbits. HFO ventilation at 
a low lung volume significantly reduced compliance and hysteresis . Most deterioration of 
lung compliance and hysteresis occurred w ith rabbits treated w ith CMV. McCulloch et al. 
suggested that loss of lung compliance in this experiment was related to the formation of 
hyaline membranes.
Froese (1989) notes that animals ventilated w ith HFO at a high lung volume showed some 
recovery of lung mechanics (improved P-V curves). Froese suggests that a high volume HFO 
ventilation pattern may conserve available resources of surfactant.
If lung compliance improves during assisted ventilation, mean pressures must be reduced. 
As compliance continues to improve, volume recruitment manoeuvres and sustained inflations 
become unnecessary. Assisted ventilation used on a healthy lung is likely to result in hyperin­
flation and fatal barotrauma.
C.6 The Incidence of Com plications A ssociated  w ith  A s­
sisted  Ventilation
C .6.1 Air Leaks
Delemos et al found an increased incidence of air leak in premature baboons treated with CklV 
compared to those treated with HFOV. In their clinical trials, Ogawa et al. and Clark et al. 
could only conclude that HFOV does not have a lower incidence of air-leak when compared 
w ith CMV. Clark et al. suggested that the difference in results between their clinical trial 
and DeLemos et al’s baboon experiment is due to the time of initiation of HFOV. Clark et al. 
would have expected to see a more dramatic difference between incidence of air-leak in CkIV 
and HFOV had HFOV been started immediately.
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From the above information it seems that use of HFOV immediately after birth would 
result in a lower incidence of airleak compared to CMV. There are various theories as to why 
this happens. One theory suggests tha t the over-inflation of dilated distal conducting airways 
associated with CMV accounts for the increased incidence of airleak. Another theory suggests 
tha t previously closed airways are reopened when HFOV is applied to the saccular atelectasis 
caused by CMV. The airway epithelial surfaces tha t were adherent to each other are now injured 
and are more prone to air-leaks.
C .6 .2 Cardiac O utput
Bohn et al. (1980) concluded tha t in anaesthetised apnoeic beagle dogs there was no difference 
in mean cardiac output between animals treated with HFO and CMV. Similarly, Thompson 
et al observed tha t in their model of pulmonary injury, cardiac output was independent of the 
type of ventilation used. They compared HFO w ith CMV.
DeLemos et al observed decreased cardiac output towards the end of an experiment on a 
group of premature baboons. They had started HFO immediately after birth on this particular 
group. The deterioration occurred coincidentally w ith a dramatic improvement in chest X-rays. 
DeLemos et al. also reported lung over-inflation at this stage in the experiment. Coalson et al. 
stated tha t when HFO is used with a strategy tha t optimises pulmonary function , it may result 
in inadvertent lung over-distension, decreased venous return and decreased cardiac output.
Hyperinflation of the lung is thought to decrease cardiac output as high intrapulmonary 
pressures restrict venous return. When a high pressure HFO strategy is used lung volume must 
be monitored closely. Lung over-distension will occur if an improvement in lung compliance is 
not accompanied by a decrease in mean airway pressures.
A high pressure HFO strategy must incorporate constant checking for improvements in lung 
compliance otherwise the consequences can be fatal. If an appropriate HFO strategy is used it 
does not seem to hold any advantage over CMV in terms of cardiac output.
C .6 .3 B ronchoalveolar H aem orrhage
Coalson et al. compared pathologic findings associated with HFOV, HFFI and CMV in a 
premature baboon model of HMD. An increase of the incidence of bronchoalveolar haemorrhage
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was seen in HFOV and HFFI ventilated animals when compared with baboons treated with 
CMV. The most severely affected group was the HFFI treated animals.
Coalson et al. note that although the difference in the incidence of bronchoalveolar haem­
orrhage was small it may eventually contribute to the evolution of BPD.
C .6 .4 Intra V entricular H aem orrhage
The HiFi Study Group suggested tha t the use of HFO was associated with an increased incidence 
of IVH when compared with CMV. The HiFi trial spanned 11 neonatal centres where incidences 
of IVH varied from 4% to 48%. Bohn (1989) comments that this and other factors affected the 
outcome of the HiFi trial. He emphasises that the results from some of the centres actually 
show a lower incidence of IVH in infants treated with HFOV. The incidence of IVH is linked 
to many different variables. More studies need to be carried out to decide on the association 
of IVH w ith various types of assisted ventilation.
C .6 .5 B ronchopulm onary D ysp lasia
Clark et al concluded tha t the use of HFOV in the management of RDS contributes to a 
decreased incidence of BPD when compared to CMV. Ogawa et al comment tha t they did not 
find a decreased incidence of BPD associated with HFO. They speculated that this difference 
was due to the use of surfactant replacement therapy. Ogawa used surfactant as a drug of 
first choice in infants suffering from RDS. Clark did not use surfactant therapy at all. Ogawa 
et al also note tha t the high frequency oscillator used was different from that used in Clark’s 
trial. Clark and Ogawa used similar HFO strategies in their clinical trials. It seems th a t the 
incidence of BPD in neonates treated w ith CMV and HFOV is associated with factors other 
than the method of assisted ventilation used.
C.7 Sum m ary
Clinical studies have shown that when used with an appropriate strategy HFO is at least 
as effective as CMV in the treatm ent of hyaline membrane disease. An effective strategy will
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improve oxygenation and lung mechanics whilst preventing the formation of hyaline membranes. 
It should also lower the risk of associated complications such as air leaks, IVH, PVL and BPD.
It seems tha t HFO should be started as soon as possible after birth in an infant suffering 
w ith RDS. A high pressure strategy combined with appropriate volume recruitment manoeuvres 
should be used with constant monitoring for improvement in lung compliance. HFO should be 
carried on long term in preference to using CMV for weaning. This approach has been shown 
to improve pulmonary mechanics, improve oxygenation and prevent the formation of hyaline 
membranes.
All the trials have used slightly different strategies, different ventilators and different drug 
therapies. Therefore, I hesitate to speculate on the comparative incidences of complications 
such as air leaks, decreased cardiac output, IVH, PVL, BPD and bronchoalveolar haemorrhage.
C.8 The Future
The ultim ate aim is to find a form of assisted ventilation that is successful in the treatm ent of 
respiratory distress syndrome whilst optimising the quality of life of the patient. High frequency 
oscillation perhaps has the potential to fulfil these aims but more research needs to be carried 
out. Strategies must be optimised even further. Studies need to be carried out to compare the 
effectiveness of various volume recruitment manoeuvres. Ideally, clinical trials need to test the 
effectiveness of HFO as an immediate treatm ent after birth. In reality, ethical issues need to 
be dealt with before comparing treatments in clinic. This also applies to the testing of HFJV 
in the treatm ent of neonatal hyaline membrane disease. Although, it cannot be assumed that 
a strategy tha t optimises the use of HFO will do the same for HFJV.
There are so many factors tha t need to be accounted for and studied in the use of assisted 
ventilation. For example, the effect of the air humidity in the circuit and the position of the 
endotracheal tube. Can we rely on the measurements presently used for comparison of types 
of ventilation? There is evidence that suggests tha t especially in HFO and HFJV the mean 
airway pressure is not indicative of the actual alveolar pressure.
An understanding of the gas exchange mechanisms being employed in HFO and especially 
HFJV could eventually lead to optimisation of strategies designed to reduce epithelial injury.
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This, in conjunction with more trials and optimisation of methods used in surfactant therapy 
would seem to be the way forward.
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A ppendix D
A D iscussion of th e U se o f Exogenous 
Surfactant Treatm ent in the N eonate, 
w ith  Specific Reference to the  
D evelopm ent o f Chronic Lung D isease
D .l  Introduction
Following speculation that low surface tension was an important attribute of the lining of air 
passages in the lung, Avery and Mead (1959) found in 1959 tha t the material responsible for 
such a low surface tension was absent in the lungs of infants under 1100-1200g and in those 
dying w ith hyaline membrane disease. Subsequently, studies were carried out to determ ine the 
effect of artificially replacing the surface active agent found to be absent in infants suffering 
w ith RDS. This treatm ant is called exogenous surfactant therapy.
D .1 .1  Surface Tension and Surface A ctive A gents
In the 1920’s it was found that inflation of degassed lungs with a liquid required less pressure 
than on inflation with air. This difference in behaviour is due to the force arising at the 
boundary between the liquid lining of the lung and the gas or liquid being used for inflation. 
Molecules at a surface possess more energy than if they were in the bulk of the material
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and the additional energy is manifested as a force at the interface. In the case of a King filled 
with gas, the forces between adjacent molecules of the liquid lining the lung are stronger than 
those at the liquid-gas interface. Therefore, the surface area of the lung lining liquid becomes 
as small as possible. This force is known as surface tension. Surface tension is particularly 
strong at the interface between air and water. For example, a force is produced tha t is strong 
enough to enable a steel needle to be floated on water.
There are substances that change the interfacial energies at a surface and that lower surface 
tension. The more effective of these substances are called surface active agents or surfactants. 
Molecules of surfactant are characterised by the possession of both polar and non-polar regions 
on the same molecule. One part of the molecule is polar or hydrophilic (water seeking) while the 
other part is non-polar or hydrophobic (water repelling). The hydrophobic portion is usually 
a hydrocarbon chain. Due to this dual nature, surfactants tend to locate at interfaces where 
both parts of the molecule can reside in compatible phases. In simple terms, the molecules ‘line 
up’ at the surface and form a monolayer. The existence of two moieties in the same molecule, 
one of which has an affinity for solvent and the other of which is antipathetic to it, is termed 
amphipathy.
D . l . 2 P ulm onary Surfactant
Surfactant has a major role in lung mechanics. The surface tension at the interface between 
the gas in the lungs and the gas exchanging surface of the alveoli makes a very important 
contribution to lung recoil. W ithout surfactant the effect of the recoil would be to cause 
alveolar collapse or atelectasis. If we take the conventional model of the alveolus, a one-sided 
bubble, we can use the Laplace equation to model the effect of surface tension: P — r where P 
is the external pressure difference, is the surface tension and r is the radius of curvature.
We can now see that if the alveolus were to be filled with liquid, the pressure difference or 
recoil would be eliminated. Two other main features can be noted; firstly, there will be a critical 
pressure below which the bubble will collapse and secondly, when two bubbles of different radii 
are connected, the pressure difference between them will cause a flow of gas into the larger 
bubble. All of these effects are resisted to some extent by the lowering of surface tension by 
pulmonary surfactant, although the presence of surfactant does not completely explain alveolar
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stability.
The above conventional theory is based on two assumptions. The first assumption is that 
surfactant only acts at the air-liquid interface of a fluid lining to the alveolus and the second is 
tha t the liquid layer is continuous. These assumptions are open to debate, Hills (1990).
Pulmonary surfactant has a number of properties that are thought to be im portant for 
function; pulmonary surfactant spreads within seconds when applied to a surface and establishes 
an equilibrium surface tension of about 25- 35 dynes/cm and pulmonary surfactant suspended 
in water adsorbs to the surface and establishes equilibrium surface tension in less than 1 minute. 
Pulmonary surfactant also has im portant dynamic properties. Dynamic compression of a film 
of pulmonary surfactant results in a lowering of surface tension from the equilibrium value 
to 10 dyne/cm. Finally, compression and expansion cycles of the surfactant film should be 
reproducible. This implies tha t the surface tension on expansion will return to the equilibrium 
value and the surfactant will respread after compression Jobe and Ikegami (1987). It is also 
suggested that the fluctuation of alveolar surface tension during breathing contributes to the 
turnover of alveolar fluid and th a t low surface tension promotes fluid reabsorption by the 
alveolar capillaries.
D .2 Chem ical C om position of Surfactant
Natural pulmonary surfactant contains around 80% phospholipids, 8% neutral lipids and 12% 
protein by weight. The principal surface active component in pulmonary surfactant is a phos­
pholipid called dipalmitoylphosphatidylcholine or DPPC. DPPC comprises 80% of the total 
phospholipids by weight.
The proteins contained in pulmonary surfactant consist of contaminating protein from 
plasma or lung tissue called human serum and surfactant associated proteins. There are four 
surfactant associated proteins th a t have been identified SP-A, SP-B, SP-C and SP-D. These 
specific proteins regulate mechanisms including surfactant secretion, adsorption of the surface 
film and uptake and recycling of waste surfactant material by the alveolar epithelium. S P - A  
and SP-D are hydrophilic proteins which play an major role on the pulmonary defence system 
by stimulating phagocytosis of bacteria and viruses by alveolar macrophages. The hydrophobic
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surfactant associated proteins SP-B and SP-C accelerate surface adsorption and facilitate the 
spreading of lipids.
D .2 .1  Surfactant P reparations
Exogenous surfactant preparations can be divided into two main groups: synthetic and natural 
surfactants.
Synthetic Surfactants
Two of the following protein free synthetic surfactants are currently being used in clinical 
practice:
1. Colforsceril palmitate (Exosurf ) which consists of DPPC, hexadeconal and tyloxapol. 
Hexadeconal and tyloxapol assist surface adsorption and the spreading of DPPC. Exosurf 
is given in a dose of 67.5 mg/kg (67.5 mg per kilogram of body weight) and instilled into 
the endotracheal tube over 4 to 30 minutes.
2. Pum actant (ALEC or artificial lung expanding compound) contains only DPPC and 
phosphatidyglycerol (PC). ALEC can be deposited into the pharynx before intubation. 
Subsequent doses can be given down the endotracheal tube.
3. In 1984 a synthetic surfactant was made with DPPC and human protein and used in a 
trial in Belfast Halliday et al. (1984). The surfactant was found to produce no significant 
improvements in the outcome of babies less than 34 weeks’s gestation who were treated 
at b irth and is no longer used in clinical practice.
Natural Surfactants
Natural surfactants are derived from natural sources such as lungs or human amniotic fluid. 
Animal surfactants are extracted from the lungs of animals with organic solvents which remove 
the water soluble proteins such as SP-A and SP-D. The hydrophobic proteins SP-B and SP-C 
remain as they facilitate surface adsorption and the spreading of lipids.
• Bovine Surfactants
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1. Surfactant TA: Gitliii et al. (1987), Fujiwara et al. (1990) (Surfacten) was developed 
in Japan. It is made from minced cow lungs. DPPC, palmitic acid and triglycerol 
are added to achieve optimum physical properties. The product contains 84% phos­
pholipids and 1% protein. Surfactant TA is stored as a freeze-dried, white powder. It 
is administered by endo-tracheal instillation at a dose of 100 mg/kg over 5 minutes.
2. Calf Lung Surfactant Extract:Morley (1988) (CLSE, Infasurf ) is made by washing 
surfactant out of the lungs of dead calves with physiological saline. The material 
is then extracted and then purified. CLSE contains 97% phospholipids and 1% 
proteins. It is given in a dose of 90 mg/kg.
•  Porcine Surfactant
1. Curosurf is the only commercially produced porcine surfactant. It is prepared from 
minced pig lungs by extraction and then purified by a combination of washing, 
centrifugation, chromatography and filtration. Curosurf consists of 99% polar lipids 
and 1% hydrophobic proteins (SP-B and SP-C). It is suspended in normal saline at 
a concentration of 80 mg/kg and is given in doses of 100 mg/kg. Surfactant from 
Human Amniotic Fluid Human surfactant has been produced by collecting amniotic 
fluid at elective Caesarean sections for term deliveries. The surfactant is extracted 
and purified by centrifugation and filtration. Recently, because of the risks of viral 
contaminant, human surfactant has been withdrawn from clinical trials.
D .3 M ethods of Treatm ent w ith  Exogenous Surfactants
Although it has been shown tha t exogenous surfactant administration is beneficial in the treat­
ment of RDS, Fujiwara et al. (1980) there are still many variables to be considered. The method 
of administration, the time of administration and the type of surfactant given are among the 
issues to be resolved. Firstly, which is better, natural or synthetic surfactant? It has been 
suggested tha t natural surfactant produces a more acute efiPect when compared to the gradual 
effect seen by synthetic surfactants. This suggests tha t different surfactants may be suitable 
for different clinical situations. It cannot be said that there is a superior surfactant unless
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the situation for administration is known, for example, natural surfactant may be better than 
synthetic surfactant for rescue treatm ent rather than immediate treatment. Once a decision 
has been made whether to use natural or synthetic surfactant, the particular type of surfactant 
must then be selected. Cost is also an important consideration at this stage.
Secondly, the question arises of when to give the surfactant. Clinical trials tend to be subdi­
vided into ‘prophylactic treatm ent’ trials and ‘rescue treatm ent’ trials. Prophylactic treatm ent 
involves treating an infant tha t is at high risk of developing RDS in the delivery room con­
currently w ith the initiation of breathing and resuscitation whereas rescue treatm ent involves 
treating infants at 2 to 24 hours of age after a diagnosis of RDS has been made. Wood (1993). 
It is also of interest to know whether doses of exogenous surfactant would be harmful to a 
neonate not suffering from surfactant deficiency as could theoretically result from prophylactic 
treatm ent.
The method of administration of surfactant may also influence its apparent effectiveness. A 
non-homogeneous distribution of surfactant could create a lung with multiple compliances that 
could result in over- distension of some lung segments, Jobe and Ikegami (1987). Surfactant 
can be delivered as a bolus into each main bronchus or as a single bolus into the lower trachea. 
After instillation, the baby is then manually ventilated or connected to a ventilator to distribute 
the surfactant throughout the lungs. The high pressures involved in assisted ventilation push 
the fluid rapidly into the lungs. It can be seen that methods of administration of surfactant 
involving manual ventilation and possibly the increase of the oxygen concentration of inspired 
gas immediately after instillation would produce clinical improvement even if no surfactant was 
given. From this we can note tha t in extreme cases the method of administration of surfactant 
can enhance, mask or even be more beneficial than the clinical improvements obtained from 
the actual surfactant therapy itself. Surfactant can also be instilled very slowly over 5 to 30 
minutes down an endotracheal tube whilst the baby is being mechanically ventilated. The 
delivery of aerosolised surfactant has been studied in preterm lambs, Lewis et al. (1991) and 
has the advantage that small doses are needed when compared to conventional instillation.
The dose of surfactant used in animal and clinical studies has been developed empirically . 
It has been calculated that, theoretically, as little as 3 mg of surfactant lipid per kilogram of 
body weight would be sufficient to form a continuous monolayer in the lung. Surprisingly, doses
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of 100 m g/kg are commonly given to neonates. It has been observed that babies developing 
idiopathic respiratory distress syndrome have an average surfactant pool size of about 10 mg/kg 
and normal adults have around 11-14 mg/kg, whereas a term new-born has a surfactant pool 
up to ten times the size of tha t of a normal adult.
D .4 Problem s A ssociated w ith  Surfactant Therapy
Charon et al. (1989) conducted an experiment to find out why some infants have no response 
to surfactant therapy. They administered surfactant TA mixed with a radioactive label to 
infants suffering with RDS. No gross maldistribution of surfactant in the lung was evident in 
those infants producing no response or a transient response. It was subsequently suggested 
tha t pathophysiological conditions associated with RDS are more likely to explain suboptimal 
responses after surfactant therapy.
In addition to having an insufficient surfactant pool, it has been shown that infants suffering 
with RDS have proteins in their airways that inhibit the surface tension lowering properties 
of surfactant. Ikegami et al. (1983) demonstrated this by taking airway samples from a group 
of infants immediately after tracheal intubation for respiratory failure. Half of the infants had 
RDS whereas the other half were intubated for other reasons. It was found that the mean 
minimum surface tension of the samples from infants with RDS was higher than tha t of the 
infants w ithout RDS. The supernatant fractions of the airway samples were recovered after 
centrifugation and their effects on the surface tension lowering properties of sheep surfactant 
were studied. Proteins contained in the supernatant fractions of samples taken from infants 
with RDS were found to inhibit the minimal surface tension of sheep surfactant whereas much 
less inhibition occurred w ith the samples from infants thought not to have RDS. The authors 
suggested tha t recovery from RDS is either due to sufficient amounts of surfactant being present 
to overcome the effects of inhibitory proteins or the inhibitors being cleared from the airways.
In a number of clinical trials it is possible to see no improvement in some infants treated 
with exogenous surfactant. An explanation is tha t the surface tension lowering properties of 
surfactant actually given for RDS are also inhibited by proteins present in the infants airways. 
Fuchimukai et al. (1987) studied the inhibitory effects of various proteins on the bovine surfac-
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tant, Surfactant TA. They found tha t the strongest inhibiting action was exerted by fibrinogen, 
followed by human serum. Their results implied that proteins present in the airways interfere 
w ith the activity of Surfactant TA. They suggested that surfactant inhibitors could find their 
way into the lungs because of the presence of serum transudate, found there as a result of 
ventilatory care involving high intrapulmonary pressures. It was postulated that treatm ent as 
soon after birth as possible would not allow time for these inhibitory proteins to migrate into 
the airway.
Fuchimukai et al also noted that with larger concentrations of Surfactant TA adsorption is 
less affected by inhibitors. This suggests tha t a high dose of surfactant is required especially 
w ith severe RDS. It was also found that the inhibitory effects diminished with time, which 
suggests th a t RDS can be treated resulting in a gradual improvement rather than an immediate 
response.
There have been side effects associated w ith pulmonary surfactant. These are pulmonary 
haemorrhage, patent ductus arteriosis, intra ventricular haemorrhage, retinopathy of prematu­
rity and necrotizing enterocolitis. None of the studies that I have reviewed use the incidence of 
any of these conditions as primary outcome measures, therefore I will not be commenting on 
most of these associated risks.
D .5 Hum an and Anim al Studies
Soon after the identification of DPPC as the principal surface active component of surfactant, 
aerosols of DPPC were used to treat RDS and were subsequently found to be ineffective, 
Robillard et al. (1990) . In 1980, Fujiwara and co-workers created an artificial surfactant 
containing natural surfactant extracts and synthetic lipids containing DPPC, this was to be 
Surfactant TA. They carried out a clinical trial, which was one of the first to demonstrate that 
artificial surfactant could successfully be given to infants with RDS. Surfactant replacement 
resulted in improvements in oxygenation and a decrease in ventilatory requirements. In most 
of the patients a patent ductus arteriosis (PDA) became evident after recovery from HMD.
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D .5 .1  P aten t D u ctu s A rteriosis
The ductus arteriosis is a duct joining the aorta and the pulmonary artery in the fetal circu­
lation. The fetus’ lungs are not yet fully inflated and therefore provide a large resistance to 
blood circulation so most of the blood in the pulmonary artery is shunted into the aorta via 
the ductus arteriosis. During the several days after birth of a term baby the ductus arteriosis 
gradually closes and in time closes completely. In premature babies the ductus arteriosis is 
likely to remain open. This causes problems as when the lungs are inflated the resistance of 
the pulmonary circulation is reduced, encouraging a larger volume of blood to flow through 
the pulmonary artery. A patent ductus arteriosis can lead to a left to right shunt where blood 
from the aorta is diverted into the pulmonary artery and sent into the pulmonary circulation. 
A severe left to right shunt can overload the heart and result in pulmonary oedema due to the 
lungs being unable to cope w ith the volume of fluid in the pulmonary circulation.
The development of bronchopulmonary dysplasia is associated with the subsequent lung 
disease and heart failure tha t could result from a large shunting PDA. Surgical ligation can be 
carried out on a persistent PDA or a drug called indomethycin can be given to constrict the 
muscles in the wall of the duct.
D .6 H um an and Anim al Studies Cont.
Fuji war a et al. (1980) reasoned tha t the artificial surfactant replacement therapy was not re­
sponsible for the PDA. They postulated tha t the increased survival of infants with HMD would 
increase the apparent incidence of a PDA. Infants who die of HMD usually have a PDA but 
die before it becomes clinically evident.
D .6.1  P rop h ylactic  versus R escue Treatm ent
There are various advantages and disadvantages to both prophylactic and rescue treatment. 
Rescue treatm ent has the advantage of being selective. The infant’s condition has been sta­
bilised and so the position of the endo- tracheal tube has been verified. A disadvantage of rescue 
therapy is tha t atelectasis and lung injury may have already occurred before the administration 
of surfactant. Rescue treatm ent itself can be divided into early and late or delayed treatment.
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there does not seem to be a specific time of treatm ent where ‘early’ suddenly becomes ‘de­
layed’ as it is used more as a comparative term . For example, the ORISIS trial compares early 
treatm ent at a mean time of 2 hours with delayed treatm ent at a mean time of 3 hours.
When surfactant is used as prophylaxis it is delivered to the lungs before the initiation of 
mechanical ventilation and possible barotrauma. It is also suggested tha t exogenous surfactant 
given at birth may be distributed better in the lung as the process of liquid absorption is 
occurring, Jobe and Ikegami (1987).
Disadvantages of prophylactic treatm ent are tha t the surfactant is given before the patient 
has been stabilised, the position of the endo-tracheal tube cannot be verified and so admin­
istration errors are more likely. The technicality of giving treatm ent as soon after birth as 
possible is also a drawback. There is also a possibility tha t infants who would not have gone 
on to develop RDS are treated unnecessarily. This last factor could bias the results of trials, 
especially those comparing prophylaxis with rescue treatment. If such a trial inadvertently 
included infants w ithout RDS they would have comparatively good blood gases and compara­
tively low ventilatory requirements. The ‘improvement’ would then be automatically attributed 
to the prophylactic administration of surfactant. To avoid this, some trials have incorporated 
the testing of amniotic fluid before birth as an indication of the level of surfactant production 
expected at birth. This testing is designed to exclude the more mature babies, who are less 
likely to have RDS, from groups receiving prophylactic treatment. Morley (1991),(31) states 
tha t trials comparing prophylactic treatm ent with rescue treatm ent are not satisfactory, not 
least because the rescue trials only included seriously ill babies.
Animal studies have shown tha t surfactant treatm ent immediately after birth produces a 
better, more prolonged blood-gas response than surfactant treatm ent after a period of ventila­
tion and severe respiratory failure. Although, these studies favour prophylactic treatm ent , it 
should be noted that very preterm lambs and rabbits have a degree of respiratory failure that 
usually exceeds tha t in infants w ith RDS, Jobe and Ikegami (1987).
There are many conflicting conclusions to be found in clinical studies comparing prophylactic 
treatm ent and early or delayed rescue treatment. This is due to the use of different surfactants, 
different dosing procedures and methods of administration and a great variation in treatm ent 
protocols, trial entry criteria and recognition of clinical conditions i.e. RDS, BPD. Sample sizes
139
and methods of statistical analysis also contributes to the range of differing results.
Of three trials comparing times of treatm ent with CLSE (calf lung surfactant extract) (Dunn 
et al. (1991), Kendig et al. (1991), Kattwinkel et al. (1993)), two favoured either very early or 
prophylactic treatm ent while one favoured later rescue therapy. In their study comparing pro­
phylactic administration of CLSE with early treatment at a mean time of 1.5 hours, Kattwinkel 
et al. (1993) found tha t prophylactic treatm ent had short term benefits for those neonates born 
at 29-32 weeks’ gestation. Interestingly, the protocol required the infants in the prophylaxis 
group to be intubated at birth, this meant that the prophylaxis group received more ventilation 
initially than the rescue group. Studies have shown that mechanical ventilation itself started 
soon after birth has beneficial effects on lung mechanics, so to what extent can the short term 
improvements be attributed to the prophylactic administration of surfactant? Kendig et al. 
(1991) came to a similar conclusion as Kattwinkel et al. (1993) although the mean time of 
rescue treatm ent for Kendig’s trial was around 6 hours ( 3.5 hours later than for Kattw inkel’s).
Prophylactic treatm ent was found to be associated with a higher survival rate, particularly 
among infants delivered at 26 weeks’ gestation. In contrast, Dunn et al. (1991) found no 
significant advantage of prophylactic administration of CLSE over rescue treatm ent up to 6 
hours after birth. They even suggested tha t prophylactic therapy of CLSE was associated with 
a higher incidence of mild chronic lung disease. It is worth noting that the prophylactic therapy 
in this trial consisted of an attem pt to inhibit the infant’s first breath by gentle compression of 
the chest as in Enhorning et al. (1985), other trials will not use this method of administration.
The OSIRIS trial compared the early versus delayed administration of Exosurf. The mean 
age of early administration was around 2 hours and that of delayed administration was around 
3 hours. They concluded tha t early treatm ent lowered mortality, oxygen dependence and the 
incidence of air leaks when compared w ith delayed administration. The differences noted in 
long term oxygen dependency were seen best on analyses based on the expected date of delivery. 
The disadvantage of looking at the number of infants dependent on extra oxygen at 28 days 
of age is tha t it does not differentiate between very immature babies who would be expected 
to need additional oxygen for long periods and more mature infants with RDS who would be 
expected to breathe in air relatively quickly. Looking at the oxygen dependence of the infant 
at the expected date of delivery adjusts for this feature.
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Merrit et al(30) conducted a trial comparing prophylactic administration of human surfac­
tan t isolated from amniotic fluid with rescue adm inistration at 2-4 hours after birth. They 
found no significant difference between the two approaches used in this trial. Infants were only 
included in the prophylactic group if testing of the amniotic fluid indicated tha t surfactant 
deficiency was evident, i.e. only infants in whom RDS was very likely were enrolled. In clinical 
practice it is generally accepted tha t earlier adm inistration of exogenous surfactant is desirable, 
where the risk of developing RDS is high, such as in infants of less than 30 weeks gestation, 
but tha t administration within minutes of birth is probably unnecessary (Cooke (1995)).
D .6 .2 N atural versus S yn th etic  Surfactants in R D S
Since the 198G’s there are trials that have shown that surfactant works whether it is natural 
or synthetic. From the evidence of the current studies it would be impossible to say tha t one 
particular exogenous surfactant is simply superior to all the others, even stating tha t either 
natural or synthetic surfactant is superior seems impossible. There are so many variables within 
studies tha t making a straightforward comparison becomes difficult. For example, natural 
surfactants are generally administered rapidly as a bolus, whereas synthetic surfactants are 
usually administered by intratracheal infusion, such a difference in administration could be the 
cause of an apparent difference in improvement of the patient.
In a trial carried out by Horbar et al. (1987), Exosurf (synthetic) was compared with Sui­
vant a (natural), although they found no difference between treatm ent groups in the incidence 
of death or BPD there was a better initial response to treatm ent with Survanta. It was noted 
tha t the dosing recommendations for Survanta included increases in Fi02 and ventilator rate 
before surfactant administration whereas the Exosurf dosing procedure did not. So, how are 
surfactants strictly compared?
A controlled study comparing the effects of four different surfactants on surfactant deficient 
lambs (Cummings et al. (1992)) did not look very promising as far as Exosurf was concerned. 
In the comparison of sheep surfactant. Exosurf (synthetic), CLSE (natural) and Survanta (all 
given prophylactically) the lambs given Exosurf showed no difference from the control lambs. In 
contrast, the lambs receiving CLSE, sheep surfactant and Survanta al showed improvements in 
oxygenation, lung mechanics and survival. This obviously leads to speculation as Exosurf has
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been used successfully in clinical trials (ORISIS) and even compared favourably with Survanta 
(Horbar et al. (1987)). The reasons for the failure of Exosurf in the aforementioned trial are 
unclear, although it was suggested tha t Exosurf works by a different mechanism than tha t of 
natural surfactant, a mechanism which relies greatly on the level of prematurity. If this is so. 
the use of Exosurf in clinical practice could be severely limited. There is also the possibility 
that different types of surfactant have their own optimum administration methods i.e. perhaps 
Exosurf is more effective as a rescue treatm ent than as prophylactic therapy. It has been 
suggested by another author tha t the doses of Exosurf in the above trial were too low to be 
effective. Finally, how can we be sure tha t a surfactant that is successful when given to infants 
will be as effective when given to animals of varying degrees of prematurity.
In his review of natural versus synthetic surfactants in neonatal RDS, Halliday et al. (1984) 
concludes tha t natural surfactants have a more rapid onset of action than synthetic surfactants, 
allowing oxygen requirements and ventilator settings to be lowered more rapidly after adminis­
tration . These benefits of natural surfactants persist for at least 72 hours. It is unclear though, 
whether such short term benefits are translated into long term benefits such as a reduction in 
BPD or mortality.
D .6 .3 M u ltip le versus Single D oses of E xogenous Surfactant
The literature provides many different conclusions on the administration of multiple doses or 
single doses of surfactant. The conclusions vary with the type of surfactant used as well as the 
time of administration. Multiple dose treatm ent is now recommended for most surfactants i.e. 
Survanta, Exosurf, ALEC and CLSE. W ith Exosurf, Long et al. (1991) showed that two doses 
12 hours apart would enhance survival for 28 days w ithout BPD and would reduce the incidence 
of pneumothorax and PIE. The OSIRIS trial then showed that a regimen including the option 
of third and fourth doses when signs of RDS persist or recur is not clinically superior to a 
regimen of two doses. Berry et al. (1993) found that 5.0 ml/kg and 7.5 m l/kg doses provided 
more improvement than 2.5 m l/kg doses. If these trials employ similar treatm ent protocols, 
knowledge of the optimum dosing strategy can be achieved.
A conclusion similar to tha t in the above Exosurf trials was arrived at in clinical trials 
involving Curosurf. Speer et al. (1992) found that infants receiving a multiple doses of Curosurf
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rather than a single dose needed less oxygen, had less incidence of pneumothorax and a lower 
mortality rate. Later, Halliday et al. (1984) concluded that there was no clinically significant 
difference in efficacy between a low dose regime and a high dose regime.
It seems tha t each surfactant has its own optimum dosing regime. This is usually discovered 
both empirically and with the aid of clinical trials. Although the dose needs to be similar to 
the values found in the lungs of a full term neonate, this amount is far more than is needed to 
form a continuous monolayer in the lungs. Whereas, too much surfactant in the lungs would 
have a detrimental effect.
D .6 .4 B ronchopulm onary D isplasia
The most common indicator of BPD is oxygen dependence at 28 days of age. This is not 
necessarily a good indicator, especially for extremely premature babies who are likely to be on 
extra oxygen at 38 days after birth. A more successful indicator is oxygen dependence at the 
expected date of delivery. The studies of exogenous surfactant therapy seem to use a variety 
of indicators of BPD some of which are not very clearly defined (Halliday (1996)) making a 
comparison difficult.
Although surfactant has been shown in some cases to increase the number of neonates 
surviving w ithout BPD Fujiwara et al. (1990), there is a counter argument. Wood (1993) 
suggests tha t an increased survival rate among infants suffering with RDS would actually 
increase the apparent incidence of BPD. This is because the survivors are precisely those at 
highest risk from BPD.
Long et al. (1991) report th a t the incidence of BPD is not significantly reduced w ith the ad­
ministration of two rescue doses of Exosurf, whereas Dunn et al. (1991) suggest th a t CLSE given 
prophylactically may increase the incidence of OLD when compared rescue doses. As before, 
conclusions vary with type of surfactant, dosing procedures and timing of administration.
BPD is related to many factors associated with immaturity as well as mechanical ventilation 
and surfactant therapy. So, successful surfactant therapy may result in other problems being 
uncovered tha t could equally well lead to pulmonary problems and eventually BPD. A recent 
pilot study carried out by Pandit et al. (1995) has shown promising results. They suggest tha t 
a single dose of CLSE is effective in reducing oxygen requirements in neonates w ith early CLD.
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Clearly, there is still much work to be done on the relationship between exogenous surfactant 
administration and chronic lung disease.
D .7 The Future
Clearly the optimum method of administration of surfactant is not yet known. Even if the 
most effective dosing procedure was found for each surfactant a comparison between types of 
surfactant would still be very difficult due to the varied methods of administration.
Measures of outcome certainly need to be standardised if results are to be compared espe­
cially with regard to bronchopulmonary displasia. The consequences of surfactant treatm ent 
must also be considered, as successful surfactant therapy given to an extremely premature 
neonate may result in many more problems being uncovered, such as PDA.
More trials need to be carried out to answer the many questions arising with surfactant 
administration. It is im portant tha t more studies should be designed to compare different 
types of surfactant, although pharmaceutical companies may not wish to support such trials 
making funding a problem (see Halliday (1996)). Trials should also be designed to combine the 
effects of mechanical ventilation w ith surfactant administration. New methods of surfactant 
administration need also to be looked into, the use of aerosolised surfactant may be successful in 
the future and would certainly reduce costs due to the small doses required when compared to 
conventional administration. New surfactants tha t are being developed using DNA technology 
may prove extremely successful in the future.
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